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Topical treatment of nail disorders such as onychomycosis and nail psoriasis is 
desirable to avoid systemic adverse effects and drug-drug interactions. However, the 
architecture and composition of the nail plate pose a great challenge to the permeation 
of topically applied drugs. To improve the efficiency of drug permeation into and 
through the nail, on-going optimization of topical nail formulations is necessary. 
Presently, to assess drug uptake into the nail post-application of a formulation requires a 
destructive extraction technique, which provides no detail about the precise localization 
of the penetrant nor the time course of chemical permeation, and until now, the basic 
information about the mechanism of drug penetration remains unclear. 
The principal aim of this thesis was to demonstrate the novel application of non-
destructive imaging techniques, including laser scanning confocal microscopy (LSCM), 
two-photon fluorescence (TPF) and stimulated Raman scattering (SRS) to study topical 
nail delivery. The potential use of a number of formulation strategies was investigated 
based on the insight provided by the imaging tools, including (a) using polymeric 
particulate-based systems as drug reservoirs, (b) enhancing drug delivery using physical 
(microneedles) and chemical (penetration enhancers) methods, and (c) development of a 
thermoresponsive lacquer for topical nail treatment. 
SRS microscopy has been successfully used to characterize the concentration-dependent 
uptake of solvents into the nail. LSCM and TPF imaging have permitted direct 
visualization of the ‘fate’ of fluorescently-labelled nanoparticles, which remained only 
at the nail surface and within microneedle-created pores, from which the release of the 
entrapped model ‘actives’ into the nail occurred. The delivery of an antifungal drug 
from a sub-micron particle suspension into the nail has also been demonstrated. 
Increased nail hydration and pre-treatment with penetration enhancer prior to 
microneedle-poration improved drug permeation. In addition, a thermoreversible 
hydrogel has been shown to provide continuous release and delivery of model actives 
into the nail. This aqueous based lacquer offers an attractive, organic solvent-free, 
topical nail delivery system with good feasibility and practicability. Finally, 
intercellular and transcellular penetration pathways were also identified for hydrophilic 
and lipophilic models, respectively. 
Overall, this thesis has provided useful information on the underpinning scientific 
rationale of the application of different formulation strategies for topical nail delivery 








Chapter 1 : Introduction 
 
Overview 
The human nail plate is a very efficient physical barrier comprising many layers of dead, 
keratinized cells which are tightly bound to one another. Nail disorders, especially 
onychomycosis and nail psoriasis, are very common but unfortunately difficult to cure. 
Treatment is time-consuming and the relapse rate is high. Although topical medication 
is simple, attractive and avoids systemic exposure, drug permeation across the nail plate 
is almost always too low to be effective and long-term oral remedy is usually required. 
Optimization of topical nail formulations is therefore essential to address this unmet 
clinical need. 
Various enhancement methods to increase nail penetration have been proposed, 
including physical abrasion, chemical treatment and the use of electric fields. Although 
there has been some progress, the precise modes of action of the different strategies are 
not always understood and conflicting results have been reported; furthermore, the exact 
physicochemical parameters that control nail permeation and transport pathways remain 
controversial.  
The goal of this project is to demonstrate the application of non-destructive imaging 
techniques, specifically laser scanning confocal microscopy (LSCM), two-photon 
fluorescence (TPF) microscopy and stimulated Raman scattering (SRS) microscopy, to 
characterize and determine the mechanisms of a number of novel formulation strategies, 
including the use of polymeric nanoparticles, microneedle arrays, penetration enhancer 






1.1 The nail 
The nail has a highly keratinized structure that forms an efficient shielding cover at the 
dorsal aspect of the distal or ungual phalanges of the fingers and toes. The functions of 
the human nail are manifold. It not only protects the delicate fingertips from traumatic 
injury but also contributes to sensory discrimination (1). It allows the fingers to 
manipulate small objects in a more refined and dexterous way (2). It is also used for 
scratching and grooming. Unlike claws and hooves in other mammals, the human nail 
does not serve as a means of defence and/or attack but is nowadays viewed for more as 
a cosmetic organ (3).   
 
1.1.1 Structure and anatomy of the nail 
The nail apparatus is shown in Figure 1.1 and Figure 1.2. The hard, flat nail plate lies on 
the highly perfused nail bed. The nail plate is enclosed by the surrounding (lateral and 
proximal) nail folds and emerges from the underlying nail matrix. The matrix is hidden 
although the distal portion is sometimes seen as a white, crescent-shaped area, called the 
lunula, especially on the thumb. The eponychium, also called the cuticle, extends from 
the proximal nail fold and adheres firmly to the nail plate surface, to prevent the entry of 
exogenous materials. The hyponychium represents the region underneath the free edge 
of the nail plate while the distal groove is the cutaneous ridge marking the distal 
boundary between the nail unit and the finger pulp. The distal margin of the nail bed is 
observed as a deeper pink (Caucasian) or brown (Afro-Caribbean) transverse band 
(onychodermal band), indicating the site of ‘seal’ between the nail plate and the nail bed 




Figure 1.1: Schematic diagram showing dorsal and transverse views of the nail. 




























Figure 1.2: Schematic diagram showing the subdivisions of the nail matrix and the 
corresponding nail plate layers. Reproduced with kind permission from (2). 
 
Nail matrix 
The nail matrix represents the germinative tissue of the nail apparatus, creating all or 
most of the nail plate. It is a specialized epithelial structure consisting primarily of 
keratinocytes which differentiate and migrate towards the surface. During this process, 
the basal cells become flattened and undergo nuclear fragmentation and condensation of 
cytoplasm, forming flat, keratinous nail plate cells, known as onychocytes (4). The 
direction of nail growth (upward and outward) results from the orientation of the 
proliferating cells which have their vertical axes aligned diagonally. Unlike the 
epidermis, the keratinization process in the nail matrix occurs in the absence of a 
granular layer, and without the formation of keratohyalin. Melanocytes are also present 
in the nail matrix; although they are usually quiescent, they can become activated and 
pigment surrounding keratinocytes. The nail matrix can be sub-divided into 3 regions: 
the dorsal matrix is continuous with the ventral aspect of the proximal nail fold and is 
responsible for the formation of the outermost dorsal layer; the intermediate 
(germinative) matrix produces the majority of the nail plate, while the most distal 
ventral matrix is aligned with the nail bed, contributing to the thin ventral plate (6-9).  
Nail fold 
The proximal and lateral nail folds enclose more than 75% of the periphery of the nail 
plate (1). The proximal nail fold is similar to glabrous skin and has two epithelial 
surfaces, dorsal and ventral. The dorsal aspect is devoid of hair follicles, sebaceous 
gland and dermatoglyphic markings and the ventral side, being thinner, also lacks rete 
ridges. At the junction of the two is the eponychium which consists of sheets of 
overlapping cornified epithelial cells with no nuclei, and serves to protect the nail. The 
proximal nail fold may contribute to the direction of nail growth by guiding it obliquely 





The lateral nail folds are continuous with the adjacent skin at the sides and join medially 
to the nail bed. Their epidermal structure is comparable to normal skin and they are 
responsible to the formation of the transverse curvature of the nail plate by compressing 
it at each side (10).  
Nail bed 
The nail bed extends from the distal margin of the lunula to the hyponychium. It 
consists of a thin epidermal layer and an underlying dermal part. The epidermal region 
is only 2-3 cells thick and has no granular layer. The keratinocytes differentiate rapidly 
to form onychocytes which are incorporated into the deepest (ventral) side of the nail 
plate. The epidermal layer has a unique pattern of longitudinal ridges which are 
complementary to the ridging on the under-surface of the nail plate, allowing its strong 
attachment to the nail bed (1, 2). The dermal region has little fat but no sebaceous or 
follicular appendages and contains connective tissues that attach directly to the 
underlying periosteum and the epidermal basal lamina. Within this fibrous network is 
the vasculature supplying the nail unit, as well as the lymphatics (11).  
Nail plate 
The nail plate is made up of many layers of dead, flattened, keratinized cells which are 
fused to each other via numerous intercellular links, membrane-coating granules and 
desmosomes, to form a hard, dense but yet slightly elastic structure. It is not 
homogenous but comprises three layers: dorsal, intermediate and ventral, with different 
compositions and properties. Their relative thicknesses have been reported to be 3:5:2 
(12).  
The outermost dorsal layer contains relatively high calcium, phospholipid and free 
sulfydryl (SH) groups, but little acid phosphatase activity. The intermediate layer, on 
the other hand, is richer in stable disulphide bonds but is low in calcium, phospholipid 
and SH groups. However, it has a high acid phosphatase activity attributed to the 
retained nuclear remnants. Finally, the thinnest ventral layer is made up of only a few 
cells layers, having a similar composition to the dorsal nail plate with respect to calcium, 
phospholipid and SH groups. However, it also shares a high number of disulphide bonds 
and acid phosphatase activity with the intermediate layer (13).  
Keratins belong to the family of intermediate filament forming proteins and are the 
major components of onychocytes. They can be classified into two types, ‘soft’ 
epithelial keratins, or ‘hard’ hair-type keratins. The latter comprise a higher number of 





and resistant to chemical destruction. Both types of keratins are found in the nail plate, 
although the majority (80-90%) are the hard keratins. Their location and orientation 
however differ in the three layers. Using synchrotron X-ray microdiffraction, Garson et 
al. (8) reported that hair-type keratins are predominantly present in the intermediate 
layer and are perfectly orientated perpendicular to the growth axis; the epithelial-type 
keratins, on the other hand, are present in both dorsal and ventral cells, which are 
dispersed randomly in both perpendicular and parallel directions. Farren et al. (14) 
suggested that the anisotropic fibre arrangement in the intermediate layer is responsible 
for the mechanical strength and hardness of the nail, while the isotropic behaviour in 
dorsal and ventral layers helps to increase the nail’s ability to bend and prevents crack 
formation.  
The lipid content in the nail plate is 0.1-1% w/w, contrasting with the 10% present in 
stratum corneum. Phospholipids are abundant in the dorsal and ventral layers. They are 
thought to locate at the cytoplasmic membrane of the onychocytes, filling the ampullar 
dilations of the dorsal plate and the intercellular spaces in the ventral plate (8). Free fats 
and long chain fatty acids have also been found although, perhaps of extrinsic origin (7). 
The low lipid content may contribute to the much higher flux of water (10 times) across 
the nail relative to that through the skin (15). 
The nail plate has a high water content (10-30%) that depends on the relative humidity 
(RH) of the surroundings. Water acts as a plasticizer, increasing nail elasticity and 
flexibility (16).  
Calcium is the principal metal in the nail plate (0.1% by weight); however, it is believed 
to contribute insignificantly to the hardness of the nail that is provided by the high 
sulphur-containing keratins. Other elements have also been detected in small amounts, 
such as sodium, copper, manganese, zinc and iron (3).  
 
1.2 Embryology of the nail  
The first sign of nail development is seen at 8-9 weeks of gestation. A thickened area of 
epidermis forms an uninterrupted groove, delineating a flattened surface at the end of 
each digit. This is known as the primary nail field, overlying the tip of the terminal 
phalanx (1).  
At 10-11 weeks, a group of cells arises from the proximal groove of the nail field and 
grows in the proximal direction, stopping at about 1 mm from the phalanx. This 





epithelium of the proximal nail fold, while the ventral part will form the distal and 
intermediate matrix epithelium. Meanwhile, the distal groove is accentuated by cells 
formed on the dorsum of the distal tip, the so-called distal ridges. 
The primary nail field grows and differentiates, forming the proximal and lateral nail 
folds by weeks 13-14. The first sign of nail plate growth is also apparent, emerging 
from beneath the proximal nail fold. At this stage, keratinization in the nail bed 
epithelium involves the production of keratohyalin from the stratum granulosum. This 
changes, however, as the nail plate grows over the nail bed at 20 weeks of gestation. 
The granular layer recedes and the keratinization becomes more parakeratotic (17).  
From 20 weeks, the nail plate extends to the distal ridges which now become the 
hyponychium. A well-demarcated eponychium is also observed and by 32 weeks of 
gestation, all components of the nail unit are formed.  
 
1.3 Nail diseases and treatments 
The nail apparatus suffers from a variety of disorders, comprising about 10% of 
dermatologic conditions. The most commonly observed include discoloration, 
thickening, surface abnormalities, nail fold inflammation and nail infections. These 
affect a patient’s quality of life in numerous ways (18). Two major nail diseases, 
onychomycosis and psoriasis, and their treatments are now discussed in greater detail. 
 
1.3.1 Onychomycosis 
Onychomycosis is a fungal nail infection caused by primarily dermatophytes but also by 
yeasts and moulds. It has a prevalence rate of 10-40% of the population, increasing with 
age. The predisposing factors include family history, immunosuppression, diabetes 
mellitus, trauma to the nails, and damp, enclosed footwear (19). Onychomycosis is 
classified into 4 clinical categories (19, 20):  
Distal/ lateral subungual onychomycosis (DLSO) is the most common form which 
the fungi, usually Trichophyton rubrum, invade the nail bed and nail plate proximally 
from the hyponychium.  
Proximal subungual onychomycosis (PSO), also known as proximal white subungual 
onychomycosis (PWSO), occurs when the fungi, usually T. rubrum, invade the nail via 
the eponychium and the proximal nail fold. The infection spreads distally into the newly 
formed nail plate and the nail bed. It is relatively uncommon in the general population 





White superficial onychomycosis (WSO) occurs when the fungi, usually T. 
mentagrophytes, invade the surface of the nail plate directly and later migrate through 
the nail plate and infect the nail bed. It occurs primarily in the toenails.  
Candida onychomycosis is caused by Candida spp., mostly C. albicans which, unlike 
the dermatophytes, do not invade nail keratin under normal conditions. Rather, they 
populate the entire nail plate as a secondary infection in onycholysis (separation of the 
nail plate from the underlying nail bed) and paronychia (infection of the surrounding 
nail folds). This is a rare event usually occurring only in patients who are 
immunocompromised or suffer from chronic mucocandidiasis.   
Total dystrophic onychomycosis represents the end stage of nail disease resulting from 
the progression of any of the four categories above. The nail at this stage is 
hyperkeratotic and dystrophic.  
The treatment of onychomycosis includes nail avulsion (removal of the lesion) and 
drug-based therapies.  
a) Nail avulsion  
This involves partial or total removal of the nail plate by surgery or using chemicals. 
Nail surgery is a painful and disfiguring operation that is not generally accepted by 
patients and is used only in severe nail involvement. Chemical nail removal can be 
performed and is less painful. Keratolytic compounds, such as urea (at 40%) and 
salicylic acid can help soften the nail plate, facilitating its detachment from the nail bed 
(21, 22). 
b) Pharmacotherapy 
Most antifungal drugs, including azoles (the older imidazole, ketoconazole, and the 
newer triazoles, itraconazole and fluconazole), terbinafine and amorolfine affect the 
synthesis of ergosterol, a unique sterol cell membrane component in fungi (Figure 1.3). 
This increases membrane permeability of the fungi, leading to leakage of cellular 
contents and lysis. Alternatively, griseofulvin is active against growing hyphae, inhibits 
nucleic acid synthesis and inhibits fungal cell mitosis (20). Ciclopirox acts as a 
chelating agent, inhibiting iron-dependent mitochondrial enzymes and electron 
transport-related processes. This leads to reduced energy production, accumulation of 
toxic peroxide, reduced uptake of nutrients, and inhibits synthesis of proteins and 







Figure 1.3: Ergosterol biosynthetic pathways and inhibition by allylamines, azoles and 
morpholines. Modified from (24).  
 
Table 1.1 summarizes the recommended dosage regimens and the reported peak nail 
concentrations achieved with different antifungals, as well as their minimum inhibitory 
concentrations (MIC) against the common dermatophytes in onychomycosis. Topical 
therapies appear to deliver higher drug concentrations within the nail (well above the 
MIC ranges) than oral treatments. However, both topical and systemic treatments are 
limited by long treatment duration because (a) drug concentration in the nail plate is 
often not achieved after, at least, a couple of weeks and (b) nail cure is not obtained 
before months. Furthermore, relapses and re-infections are common irrespective of the 





















Table 1.1: Dosage regimens, minimum inhibitory concentrations (MIC) and peak nail 
concentrations of various antifungals.  
Antifungal Dosage regimen a MIC 
b 
(µg/mL) 
Peak in vivo nail plate 
concentrations (µg/g) 
(Administered dose) 
Griseofulvin 500 mg/d -1 g/d until recovery 0.5-2 N/A 
Ketoconazole 200-400 mg/d until recovery 0.03-16 N/A 
Itraconazole 
200 mg/d for 3 months or 
400 mg/d for 7 days and repeat 
after 21-day interval 
0.06-32 0.6-0.9 (200 mg/d for 3 months) 
Fluconazole 
150-450 mg once weekly for 3 





(150 mg/w for 4 weeks) 
Terbinafine 250 mg/d for 6 weeks - 3 months (longer for toenail infections) 0.003-2 
0.39 
(250 mg/d for 4 weeks) 
Amorolfine 1-2 topical applications/week 0.01-0.08 640 (2 applications/week for 15 days) 
Ciclopirox Once daily topical application 0.015-0.125 1780 (1 application/d for 14 days) 
a Dosing regimens referenced from BNF (25) except for fluconazole (26) and ciclopirox (23), 
which are not licensed in the UK. 
b In vitro MIC ranges against dermatophyte species (27-30).   
c Peak nail concentrations (23, 31-34). 
 
Systemic treatments 
A systemically administered drug can migrate from the capillary system and penetrate 
the keratinized nail plate and the nail matrix via diffusion from the nail bed (31).  
Griseofulvin was the only available oral treatment before the introduction of the newer 
antifungals and is only active against dermatophytes. Prolonged treatment that may last 
for more than a year is required for maximal recovery due to the drug’s poor persistence 
in the nail plate at a therapeutic level after oral dosing. Patient compliance is poor, with 
a cure rate of only 3-38%, and relapse is common (20). Nevertheless, the drug is 
generally well tolerated and the most common side effects are hypersensitivity (skin 
rash, urticaria), headache and gastrointestinal disturbance. However, griseofulvin is also 
teratogenic and may induce the metabolism of other drugs, including anticoagulants 
(decreased activity) and oral contraceptives (reduced efficacy) (25). 
Ketoconazole was the first marketed orally administered imidazole and is active against 
Candida as well as dermatophytes. The duration of treatment is similar to griseofulvin 
but its use is limited by the occurrence of side effects and drug interactions (1). 
Although life-threatening hepatotoxicity has been reported to occur very rarely, the risk 





potent cytochrome P-450 (CYP3A4) inhibitor, ketoconazole can reduce the metabolism 
of a range of co-administered drugs including, for example, anti-arrhythmics, 
anticoagulants, simvastatin and ciclosporin (25).  
Itraconazole is a triazole antifungal, active against dermatophytes, yeasts and other 
pathogenic moulds. It has been reported to penetrate the nail plate more quickly (within 
2 weeks of the start of treatment) and to have a long persistence time. As for 
ketoconazole, hepatotoxicity is very rarely reported with this drug. Itraconazole can also 
have significant negative inotropic effects and therefore should not be given to patients 
with ventricular dysfunction or a history of heart failure. The drug also inhibits 
CYP3A4 (22).  
Fluconazole is another broad-spectrum triazole antifungal. It appears to penetrate the 
nail as well as itraconazole (1). The drug has a better adverse effect profile but inhibits 
both CYP3A4 and CPY2C9 in a dose-dependent manner; as a result, a number of drugs 
metabolized via these pathways are contraindicated or require close monitoring.  
Terbinafine is an allylamine antifungal which specifically inhibits squalene epoxidase 
in the ergosterol synthesis pathway. It is effective against a wide range of pathogenic 
fungi at relatively low concentrations. The drug is generally well tolerated and the most 
common adverse effects involve gastrointestinal discomfort and nausea. Roberts (27) 
compared the clinical outcome of terbinafine treatment with that of other oral 
antifungals and reported that the former was the most cost-effective, and provided the 
highest efficacy (cure rate of 70-80%).   
Topical treatments 
Amorolfine and ciclopirox are the currently available antifungals for topical treatment 
of onychomycosis.  
Amorolfine shows strong fungicidal activity against a broad spectrum of pathogenic 
fungi. It is applied as a 5% w/w lacquer. Tolerable, local side effects, such as a burning 
sensation, contact dermatitis, redness, irritation and pain are associated with its use. In a 
large clinical study (35) involving 714 patients having mild infection of the nail (with 
intact lunula or matrix), mycological cure (negative culture and microscopy) was 
achieved in 52.1% and 64.3% of the toenail and fingernail, respectively. The number of 
reported adverse effects was less than 1%.  
Ciclopirox also exhibits a strong and broad fungicidal activity against the whole 
spectrum of fungal pathogens. It is applied as a 8% w/w lacquer. The adverse effect 





clinical studies were 29-36% (US) and 46.7-85.7% (non-US) and a good safety profile 
was reported (36).  
Table 1.2 lists some examples of amorolfine and ciclopirox nail lacquers licensed in 
Europe. The current rationale for topical monotherapy is, however, restricted to early 
infections which involve only the distal 2/3 of the nail plate of up to 2-3 digits or to 
prevent reinfection (22). Oral medication and/or combination therapy (oral and topical) 
is usually required to achieve higher cure rates. 
 
Table 1.2: Some examples of amorolfine and ciclopirox nail lacquers licensed in Europe 








frequency List of excipients 
Amorolfine  5% 
Loceryl® 











Batrafen® Apply once every other day for the first month, 
reduced to at least twice 
weekly in the second 
month then once weekly 
from the third month 
onwards 















In addition to amorolfine and ciclopirox lacquers, the topical therapy market has grown 
rapidly in recent years and a wide range of additional products is currently 
commercialized. Table 1.3 lists some of the examples available in the UK. The cost of 
these treatments is not trivial given that multiple purchases are required for the typically 
lengthy treatments involved. In addition to the use of urea (based on its chaotropic 
action), most of these products are acidic in nature, anticipating that low pH produces a 
fungistatic or even fungicidal activity. This strategy probably has its origin in older 
home remedies and the use of vinegar (5% acetic acid), for example, to treat fungal nail 





pathogenic germs), these treatments have not been rigorously tested in clinical trials. 
The mode of action is unclear and strong scientific support is also lacking. Finally, the 
antiseptic agent, benzalkonium chloride, has also been formulated for the treatment of 
nail disease, but almost certainly suffers from the ubiquitous problem of poor 
permeation and sub-therapeutic concentrations in the nail matrix or nail bed.  
 
Table 1.3: Some of the newer topical products available in the UK for the management 
of fungal nail infection.  
Product name Price a Main ingredients b Claims b 
Scholl fungal 
nail treatment £19.40 /3.8 mL Undisclosed Create a hostile 
environment for 
the fungus by 




(brush) £19.99 / 3.3 mL 
(pen) £22.99 /4 mL 
 
Ethyl lactate, water, acetic 
acid, penetration enhancer, 
film-forming agent 
Nailner® 
(brush) £19.99 /5 mL 
(pen) £19.99 /4 mL 
 
Ethyl lactate, water, lactic 
acid 
Canespro® £29.99 /10 g Urea 40% ointment Waterproof plasters 
Soften and remove 
the infected nail 
ClearZal® £21.49 / 30 mL Benzalkonium chloride, water 
Antimicrobial 
action 
a, Market price based on (38). 
b,c According to patient information leaflet or product packaging. 
 
1.3.2 Nail psoriasis 
Nail psoriasis is a chronic condition affecting 1-3% of the population and has a lifetime 
incidence of 80-90% in individuals with skin psoriasis (16). The disease results from an 
abnormal immunological T-cell activated proliferation and differentiation of 
keratinocytes. Clinical manifestation depends on the region of the nail unit affected. 
Pitting (visible holes in the uppermost layers of the nail plate) is the most common sign, 
indicating nail matrix involvement. Onycholysis, subungual hyperkeratosis (build-up of 
chalk-like materials under the nail plate) and splinter haemorrhages (red or brown 
longitudinal bands due to rupture of the delicate capillaries in the nail bed) are typical of 
psoriasis of the nail bed and hyponychium. Nail discolouration (‘oil-drop’ discoloration 
or salmon-coloured areas) also occurs if the nail bed and, sometimes, the distal nail 
matrix are affected (2, 19).  
Nail psoriasis is difficult to cure and refractory to treatment. Even now, a standard 
therapeutic regimen does not exist and treatment options depend on the type of lesion 
and the patient’s preference. Disease management approaches can be divided into 






Antipsoriatic drugs include immunosuppressants (ciclosporin, methotrexate) and 
retinoids (acitretin). Their efficacy in the treatment of skin psoriasis is evident but little 
is known of their efficacy on the nail. Their use is nonetheless reserved for recalcitrant 
or in extensive disease because of their significant adverse effects (immunosuppressive 
and teratogenic) and drug interactions (2).  
Topical treatments 
Topical treatment of nail psoriasis is less well documented than of the skin. Topical 
medications licensed for the treatment of skin psoriasis are commonly used off-label for 
the management of nail psoriasis. Formulations, such as creams, ointments, gels, lotions 
or lacquers, are applied to the nail plate, the nail folds and/or as close to the nail bed as 
possible by trimming the nail back to the point of cleavage from the nail bed. Occlusion 
is usually recommended and urea and salicylic acid are sometimes co-formulated with 
the drug to maximize permeation (3). Some commonly used topical antipsoriatic drugs 
are as follows: 
Corticosteroid (e.g., betamethasone, clobetasol, fluocinolone and triamcinolone) and 
vitamin D3 analogues (calcipotriol, tacalcitol and calcitriol) are the most popular, 
having anti-inflammatory, antiproliferative and immunosuppressive activities. 
Clinically, improvement of subungual hyperkeratosis by reducing the nail thickness has 
been reported (39).  
5-fluorouracil inhibits DNA synthesis and has been suggested for reducing pitting and 
nail thickening conditions. The use of this drug should, however, be avoided in 
onycholysis which is exacerbated by the treatment (40).  
Anthralin decreases inflammation, increases cellular differentiation and reduces 
proliferation in psoriasis. It provides moderate improvement in psoriatic dystrophies 
especially in cases of nail bed involvement. However, the drug is less effective in 
matrix psoriasis (the source of pitting), probably due to its poor penetration into the 
underlying nail matrix. It is nevertheless a safe option with no known systemic side 
effects (but is not particularly popular as it stains the skin and clothing). 
Tazarotene is a topical retinoid which acts by regulating the differentiation and 
proliferation of keratinocytes, and controls the inflammation. It reduces onycholysis and 
improves nail pitting. Local side effects, including peeling and erythema of the 





Ciclosporin may also be used topically. Pitting and onycholysis have been cleared after 
use of the drug in an oily formulation. Further research into the topical use of other 
immunosuppressants, such as tacrolimus and pimecrolimus, may offer more alternative 
options in the future (2). 
Intralesional injections 
Small doses of corticosteroids (primarily triamcinolone) can be injected directly into or 
near the nail unit and are particularly effective in treating lesions within the nail matrix. 
The proximal nail fold is the optimal and least painful site of injection. Deeper matrix 
and nail bed injections may be required for conditions such as onycholysis, subungual 
hyperkeratosis and nail discolouration, but these are very painful and local anaesthesia 
is essential. While subungual hematomas may occur following intralesional injection, 
skin atrophy, and more severely, atrophy of the underlying terminal phalanx, collagen 
and extensor tendon, can result from the repeated treatment with steroids (2, 40). 
Radiation therapies 
Treatments can be classified as phototherapy or photochemotherapy. The former 
involves the use of ultraviolet (UV) radiation, mostly UVB (" = 290-320 nm) and 
narrowband UVB (" = 313 nm). Photochemotherapy, or PUVA, couples the use of 
UVA (" = 320-400 nm) with oral or topical psoralen, a light-activated skin sensitizer. 
Radiation therapy has been validated for psoriatic skin treatment but not for the nail. 
Their mechanism of action is not fully understood but is probably related to suppression 
of an overactive immune response. The approach is believed to be useful in dystrophies 
arising from the nail bed but not from the matrix. Other types of radiotherapy, including 
superficial radiotherapy (SRT), Grenz ray therapy and electron beam therapy, have 
demonstrated variable efficacy. Potentially serious adverse reactions, such as decreased 
blood flow and a risk of malignancy, may limit the use of radiation in the treatment of 
nail psoriasis and further research in this area is required (2). 
 
1.4 Topical drug delivery to the nail 
Transungual delivery involves the uptake of drug incorporated in a topical formulation 
into the nail plate and its subsequent diffusion into the deeper tissues, possibly reaching 







Figure 1.4: Transungual delivery and key factors that determine its efficacy. 
 
Before entering the nail plate, significant pre-absorptive loss of drug due to routine 
activities is ideally minimized (42). Formulations, such as nail lacquers and protective 
plasters can provide good adherence to the nail surface and lengthen drug-nail contact 
time (16). However, the amount of drug available for diffusion can be severely 
compromised by crystallization when the typically volatile alcohol (a good solvent for 
many drugs administered as nail lacquer) evaporates rapidly after application. Although 
this may lead to transient supersaturation, this metastable state quickly dissipates and 
most of the administered drug precipitates as a solid (and no longer in a diffusible form).  
Once in the nail plate, drug transport within and across the keratin network is influenced 
by many factors. The properties and the conditions of the nail can play an important 
controlling role that can be affected by certain formulation components. The hydrated 
nail plate has been suggested to behave more like a hydrogel (a network of hydrophilic 
polymer chains) than a lipophilic membrane such as that of stratum corneum (43). The 
penetration of solutes through the nail plate has also been described (44) as the passive 
diffusion of substances across a homogenous polymer network (45), involving a ‘free 
volume mechanism’. In this description, thermal movement of the polymer chains 
creates ‘spaces’ or holes, which can be occupied sequentially by permeating molecules 
as they transverse the network. The penetration rate is limited by the formation 
frequency and the free volume of the holes as determined by the temperature, the nature 
of the polymer, and its interaction with the permeant. The theory clearly implies the 
influence of size and shape of the diffusing molecules on the transport kinetics. Drug 
uptake into the nail plate also depends on its ability to partition into the keratin network 
















If the nail plate is treated as a homogenous membrane, passive diffusion of drug in 
steady state can be most simply described by Fick’s 1st law of diffusion (Eq 1.1), where 
an infinite applied dose and a downstream perfect sink are assumed:  
 ! ! !!! !! ! !! ! !! ! !!    (Eq. 1.1) 
 
where J is drug flux (amount per unit area per unit time), Dm is the diffusion coefficient 
of drug in the membrane, Km is its membrane/vehicle partition coefficient, and h is the 
diffusion path length. Cv is the drug concentration in the vehicle and kp is the 
permeability coefficient (= Dm.Km/h). Drug transport across the nail can therefore be 
influenced by various factors determining any of these parameters, which can also be 
altered or enhanced by the formulation.   
 
1.4.1 Factors affecting drug permeability across the nail plate 
Nail properties 
Drug flux across the nail plate decreases with increasing nail thickness. An inverse 
relationship between the flux of 5-fluorouracil (5-FU) and the thickness of healthy and 
diseased nail plate has been demonstrated (47) (Figure 1.5). The authors suggested that 
the permeability through healthy and fungal nail plates was not significantly different 
although heavily infected nails were excluded from the study because of the uneven 
thickness measured, which possibly might produce higher flux due to nail destruction 






Figure 1.5: (a) 5-FU flux across the healthy nail plate as a function of nail thickness (h). 
(b) 5-FU fluxes across healthy (#) and diseased nail plates ($) as a function of the 






The degree of hydration of the nail plate is another factor influencing drug permeability. 
It has been documented that hydration ‘loosens’ nail structure by altering the van der 
Waal’s forces, hydrogen bonding and ionic interactions within the keratin matrix, 
making it more elastic and presumably more permeable to the diffusing molecules (48-
51). An increase in ketoconazole flux through the nail plate with increasing relative 
humidity (RH) on the dorsal side, which in turn increases nail hydration has been 
reported (50) (Figure 1.6). The greatest increase was observed at the region of 80-100% 
RH. It was deduced that the drug diffusivity increased with increasing water in the nail 
plate, similarly to its behaviour in swollen polymeric hydrogels. This is consistent with 
the ‘free volume theory’ and that the plasticizing effect of water increases the segmental 




Figure 1.6: Steady state fluxes (Jss) of ketoconazole through human fingernails as a 
function of relative humidity. Reproduced with kind permission from (50). 
 
Molecular size of penetrant 
An inverse relationship between permeant diffusivity (Dm) within the nail and its 
molecular size/weight is anticipated by the theories of Cohen & Turnbull (52) and Lieb 
& Stein (45). 
 
Cohen & Turnbull !! ! !!! ! !!!! " !!!!(Eq. 1.2) Lieb & Stein !! ! !! ! !!!!!!!!!(Eq. 1.3) 
Substituting into !! ! ! !!!!! !!!!!(Eq 1.1) and taking logarithms: !"# !! ! !"#!!! ! !! !!" ! !"#!! 
(Eq. 1.4) 
!"# !! ! !"#!!! ! ! ! !"#$% ! !"#!! 






D0 represents the diffusion coefficient of a hypothetical molecule having zero molecular 
volume (MV), MW is molecular weight, kp is the permeability coefficient. %, z and k are 
constants, and %’ equals %/2.303. %’’ also includes a conversion factor for the 
substitution of MW for MV (53). The permeability coefficients of a series of alkyl 
nicotinates as well as other substances decrease across human nail plate and bovine hoof 
membrane with increasing molecular size/weight (Figure 1.7). The permeability of the 
nail plate was twice as sensitive to changes in MW as that of hoof membrane, 
suggesting a more tortuous diffusion path in the denser keratin fibre network of the nail 
(44). A similar trend in the nail permeation of a range of drugs has also been observed 
(47). 
Despite the established relationship, a clear cut-off above which compounds become 
unable to permeate the nail plate has not been confirmed. While Mertin and Lippold (44) 
demonstrated the permeation of compounds with MW ranging from 151.2 to 777.1, 
Kobayashi et al. (47) were unable to determine the penetration of drug having a MW 
above 240.   
 





Figure 1.7: Logarithms of the product of diffusivity (Dm) and partition coefficient (Km) 
of chemicals across the nail plate (&, ') and the bovine hoof membrane ((, $) against 
the (a) MW or (b) log MW. Dm.Km expressed in cm2 s-1. (&, () methyl, ethyl, butyl, 
hexyl and octyl nicotinates; (',$) other substances (paracetamol, phenacetin, 
diprophylline, chloramphenicol, iopamidol). Reproduced with kind permission from 
(44). 
 
Hydrophilicity/ lipophilicity of penetrating compound 
The effect of drug lipophilicity on nail permeability remains controversial. As the nail 
plate is generally considered to behave as a hydrophilic gel membrane, the unfavourable 
permeation of hydrophobic drugs is expected. However, the existence of a parallel lipid 
pathway has been suggested (43) based on a study of a series of homologous alkanols 





















experiments on skin (Figure 1.8b), permeability through the nail showed the opposite 
trend from water to octanol. This was explained by the hydrophilic nature of the nail 
plate, and decreased partitioning into the keratin matrix with increasing hydrophobicity. 
At very high lipophilicity (C10 and C12), however, the appearance of a minor lipid route 
was proposed to account for the upturn in transport of these higher alkanols. The role of 
this specific pathway for very hydrophobic compounds was further illustrated by the 
decreased permeation of decanol when the nail plate was delipidized whereas those of 






Figure 1.8: Permeabilities of n-alkanols from dilute aqueous solution through (a) normal 
($) and delipidized nail plate (!), and (b) human epidermis. Re-plotted from (43), (54) 
and (55), respectively.  
 
In contrast, subsequent report on the penetration of nicotinic acid esters (56) (Figure 
1.9a) and p-hydroxybenzoic acid esters (47) (Figure 1.9b), failed to confirm the 
existence of this lipophilic pathway. Very little dependence of the permeabilities of 
these compounds on lipophilicity was observed. Again, the contrast between the 
hydrophilic nail plate and the lipophilic skin barrier was clearly apparent (Figure 1.9c).  
 
 
Figure 1.9: Dependence of permeability on lipophilicity (as expressed by the Log 
octanol-water partition coefficient) (Log P) for (a) nicotinic acid esters across bovine 
hoof membrane ($) and human nail plate (!), (b) hydroxybenzoic acid esters across the 
nail plate, and (c) nicotinic acid esters across human skin in vivo. Reproduced with kind 
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Table 1
Physicochemical parameters and nail permeability coefficients (h =
400!m) of p-hydroxybenzoic acid esters
Drug MW logKowa Pb
p-Hydroxybenzoic acid
methyl ester (MP)
152.15 1.53 3.68 ± 0.08
p-Hydroxybenzoic acid
ethyl ester (EP)
166.18 2.23 2.43 ± 0.48
p-Hydroxybenzoic acid
propyl ester (PP)
180.20 2.75 2.01 ± 0.35
p-Hydroxybenzoic acid
butyl ester (BP)
194.23 3.13 2.38 ± 0.32
p-Hydroxybenzoic acid
amyl ester (AP)
208.25 3.65 2.24 ± 0.39
p-Hydroxybenzoic acid
hexyl ester (HP)
222.28 4.25 1.24 ± 0.32
Each value represents mean ± S.E. (n = 4).
a Kow: octanol/water partition coefficient.
b P: permeability coefficient (×107 cm/s).
esters. It was suggested that the molecular weight makes
a greater contribution to the permeability coefficient than
the octanol/water partition coefficient. The F-values of the
molecular weight or octanol/water partition coefficient were
1.9399 or 0.1058, respectively.
From our findings, it was evident that nail plates behave
as a hydrophilic gel membrane rather than a lipophilic parti-
tion membrane. Although this suggestion agreed with the in-
vestigations of Walters et al. (1983) and Mertin and Lippold
(1997), an additional lipophilic route suggested by Walters
et al. (1985) could not be found in the human nail plate. It
has been reported that lipids are present in the dorsal and
ventral plates, but only at very low levels in the intermediate
plate which forms the main nail body (Jarrett and Spearman,
1966; Kobayashi et al., 1999). In addition, the lipid content















Fig. 2. Relationship between the permeability coefficient (P) and the
octanol/water partition coefficient (Kow) of p-hydroxybenzoic acid esters.
Each value represents the mean±S.E. (n = 4). The abbreviations attached
to the closed circle (!) represent the model drugs in Table 1.
in the human nail plate has been found to be much lower than
in the stratum corneum of skin (Walters and Flynn, 1983).
Thus, there does not appear to be an additional lipophilic
route in the human nail plate.
3.2. Influence of the molecular weight and dissociation on
the permeability coefficient
Nail permeability was found to be independent of the
lipophilicity of the drug used. From the findings in this early
study, the coefficient, f, in Eq. (5) can be assumed to equal







− β′ MW. (6)
We investigated the nail permeability of several model
drugs having various molecular weights. Because the influ-
ence of drug dissociation on the nail permeability is not
clearly understood, the nail permeability of non-ionic and
ionic drugs was evaluated separately.
Table 2 summarizes the pKa, pH of the donor solution,
molecular weight and permeability coefficient of the model
drugs used in this investigation. All the model drugs were
in the non-ionic form in the donor solution. The molecular
weight of the model drugs ranged from 20 to 240. The nail
permeability of drugs having a molecular weight of above
240 could not be determined, because of the low nail perme-
ability. The nail permeation data of p-hydroxybenzoic acid
esters (pKa = 8.4, donor pH = 3.8–5.8) were added to
this investigation because they exist in non-ionic form in the
donor solution.
According to Eq. (6), Fig. 3 shows the relationship
between the permeability coefficient and the molecular
weight of each non-ionic drug. The logarithm of the nail
permeability coefficient decreased as the molecular weight
of the penetrating drug increased. A linear relationship
(r = −0.860, P < 0.01) existed between the permeability
coefficient and the molecular weight of the model drug,
the slope (β′) and the intercept (log(D0/h)) being 0.00856
Table 2
Physicochemical parameters and nail permeability coefficients (h =
400!m) of non-ionic model drugs
Drug pKa pHa MW Pnonb
Deuterium oxide – 7.81 20.0 45.52 ± 4.30
Ethanol – 7.43 46.1 19.81 ± 2.21
Pyridine 5.19 7.35 79.1 6.36 ± 0.40
Benzoic acid 4.19 3.21 122.1 12.84 ± 0.05
5-Fluorouracil 8.0, 13.0 4.65 130.1 2.08 ± 0.13
Antipyrine 1.50 6.37 188.2 0.53 ± 0.07
Aminopyrine 5.00 8.44 232.3 0.09 ± 0.02
Lidocaine 7.92 10.21 234.3 0.39 ± 0.14
Isosorbide dinitrate – 5.72 236.1 1.51 ± 0.29
Each value represents mean±S.E. (5-FU, n = 30; other drugs, n = 3–4).
a The pH in the donor solution.
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We investigated the nail permeability of several model
drugs having various molecular weights. Because the influ-
ence of drug dissociation on the nail permeability is not
clearly understood, the nail permeability of non-ionic and
ionic drugs was evaluated separately.
Table 2 summarizes the pKa, pH of the donor solution,
molecular weight and permeability coefficient of the model
drugs used in this investigation. All the model drugs were
in the non-ionic form in the donor solution. The molecular
weight of the model drugs ranged from 20 to 240. The nail
permeability of drugs having a molecular weight of above
240 could not be determined, because of the low nail perme-
ability. The nail permeation data of p-hydroxybenzoic acid
esters (pKa = 8.4, donor pH = 3.8–5.8) were added to
this investigation because they exist in non-ionic form in the
donor solution.
According to Eq. (6), Fig. 3 shows the relationship
between the permeability coefficient and the molecular
weight of each non-ionic drug. The logarithm of the nail
permeability coefficient decreased as the molecular weight
of the penetrating drug increased. A linear relationship
(r = −0.860, P < 0.01) existed between the permeability
coefficient and the molecular weight of the model drug,
the slope (β′) and the intercept (log(D0/h)) being 0.00856
Table 2
Physicochemical parameters and nail permeability coefficients (h =
400!m) of non-ionic model drugs
Drug pKa pHa MW Pnonb
Deuterium oxide – 7.81 20.0 45.52 ± 4.30
Ethanol – 7.43 46.1 19.81 ± 2.21
Pyridine 5.19 7.35 79.1 6.36 ± 0.40
Benzoic acid 4.19 3.21 122.1 12.84 ± 0.05
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a The pH in the donor solution.
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Conflicting results have been reported on the influence of drug ionization on nail 
permeation. The penetration of drugs in charged and uncharged forms across the nail 
plate has been addressed (47) and indicated that the former were less permeable, and 
that molecular weight (MW) was more important. It was suggested that hydration of the 
ionized drug increased the apparent MW, and thereby lowered the permeability. It was 
also shown (56) that undissociated benzoic acid and pyridine penetrated bovine hoof 
membrane to a greater extent than their ionized forms. It was postulated that 
electrostatic repulsion between the charged keratin membrane and the like-charged 
diffusing molecules explained these findings. The results of these two studies are 
summarized in Table 1.4. Although similar conclusion has been drawn from other work 
(58), Walters et al. (59) found that the permeability coefficient of miconazole, a weakly 
basic drug (pKa = 6.65), was essentially the same in both dissociated and undissociated 
states (at pH ranges from 3.1 to 8.2) (Figure 1.10). The exact impact of ionization is 
unclear, therefore, and it is difficult to see how this parameter might usefully be 
exploited from a formulation standpoint in a practical way. 
 
Table 1.4: Permeability coefficients of ionizable drugs at different pH through bovine 
hoof membrane and human nail plate. 
Drug pKa pH Ionization Permeability coefficient (Kp) 





78.62 ± 16.43 a 





12.84 ± 0.05 b 
0.91 ± 0.136 b 
Pyridine 5.19 2.0 7.4 
Ionized 
Unionized 
19.14 ± 7.05 a 
44.80 ± 10.35 a 
Lidocaine 7.92 4.33 10.21 
Ionized 
Unionized 
0.031 ± 0.003 b 
0.39 ± 0.14 b 
a Kp (x108 cm2 s-1) across bovine hoof membrane. Adapted from (56). 
b Kp (x107 cm s-1) across human nail plate. Adapted from (47). 
 
 
Figure 1.10: pH-permeation profile for miconazole across human nail plate. Figures 






















Effect of vehicles 
The facilitating role of aqueous vehicles on drug permeation into and through the nail 
has been suggested. For example, a five-fold increase in the nail permeability of a series 
of homologous alcohols was observed (54) when applied diluted in water as compared 
to the neat liquids. This was explained by reduced nail swelling when the pure alcohols 
were administered and the lower free volume available between the keratin fibres. It 
was also demonstrated that dilution with dimethyl sulphoxide (rather than water) 
reduced the nail permeation of methanol and hexanol, again pointing to the unique 
hydrating properties of water in the nail and the concomitant effect on permeability.  
The effect of lipophilic vehicles on drug permeation has also been studied. The 
penetration of chloramphenicol from a phosphate buffered solution was compared with 
that from n-octanol and medium-chain triglycerides across hoof membrane and human 
nail plate (60). The drug was saturated in all solvents yet, despite the different 
solubilities, there was no significant difference between the fluxes observed (Table 1.5). 
In this case, despite the potential enhancement upon hydration, the maintenance of 
maximum thermodynamic activity of the drug in the different formulations was the 
dominant factor.  
 
Table 1.5: Maximum fluxes (Jmax) of chloramphenicol (normalized to membrane 
thickness of 1000 )m) from different vehicles across bovine hoof membrane and human 
nail plate. Adapted from (60). 
Vehicle Solubility  (g L-1) 
x104 Jmax (ng cm-2 h-1) 
Hoof membrane Nail plate 
Phosphate buffer, pH 7.4 4.52 ± 0.064 11.31 ± 3.28  2.28 ± 0.59  
n-Octanol 23.21 ± 0.767 9.44 ± 1.89  2.54 ± 0.18 
Medium-chain triglycerides 2.35 ± 0.013 11.28 ± 2.78  Not determined 
 
1.5 Current and novel strategies for transungual delivery 
To successfully treat nail disorders, drugs applied topically should permeate deep into 
the nail plate and reach to the nail bed and nail matrix. To tackle the poor permeability 
of the nail plate, different strategies have been proposed to optimize topical 
formulations, to modify the structure of the nail barrier and to drive drug permeation 






1.5.1 Formulation optimization 
Nail lacquers 
Currently, medicated nail lacquers are the most commonly used transungual delivery 
systems for the treatment of onychomycosis. Conventional nail lacquer contains 
essentially an organic solution of drug, a film-forming polymer and a plasticizer which 
increases the flexibility and durability of the coating. In principle, when the lacquer 
solution is applied on the nail, the volatile solvent evaporates, leaving a hard, water-
resistant film in which the drug is now present at a high concentration and from which it 
can be slowly released and penetrate into the nail. This occlusive film formed on the 
surface also increases hydration of the upper nail layers and may facilitate drug 
permeation as discussed previously.  
To penetrate into the nail plate, the drug must be released from the polymer film which 
may be thought of as a matrix-type controlled-release device. After solvent evaporation, 
the drug is either dissolved or dispersed in the polymer although only the dissolved 
form can be released, and provide the driving force for subsequent diffusion (46).  
The permeation of chloramphenicol from Eudragit RL, poly (methyl methacrylate)-
based lacquers (Figure 1.11a) and the uptake of amorolfine from Loceryl® nail lacquer 






Figure 1.11: (a) Penetration of chloramphenicol through the hoof membrane from 
Eudragit RL lacquers containing different drug concentrations, 2.2% ($), 18.5% (*), 
31.3% (') and 47.6% (+). (b) Amount of amorolfine taken up into porcine hoof horn as 
a function of drug concentration in Loceryl® nail lacquer. Reproduced with kind 
permissions from (60) and (61), respectively. 
 
The nail delivery of a ciclopirox gel formulation (2% w/v) containing propylene glycol 
and urea, a marketed gel (0.77% w/v) and a commercialized lacquer (8% w/v) 
containing water-insoluble, film-forming polymer have been compared (62). After 14 






















concentration, appeared superior to the other two formulations. A significantly higher 
amount of unabsorbed drug was recovered on the nail surface following application of 
the lacquer. This has prompted more research into the use of aqueous-based nail 
lacquers. For example, an experimental formulation based on the water-soluble, film-
forming agent, hydroxypropyl chitosan (HPCH), delivered ciclopirox across bovine 
hoof membranes as well as that from the marketed water-insoluble lacquer (Penlac®) 
(63). Both formulations contained 8% w/w drug and achieved similar fluxes of 
ciclopirox at steady state; however a much shorter lag time was observed for the 
chitosan-based lacquer. Subsequently (64), it was shown that the same lacquer 
containing amorolfine was superior to the market reference (Loceryl®). Based on these 
results, Ciclopoli®, a water-soluble, chitosan-based nail lacquer containing ciclopirox, 
has been marketed recently in some countries. However, more frequent applications are 
required when using water-soluble polymers because the films are easily removed by 
simple washing. In response, a bilayered nail lacquer has been investigated (65) which 
consisting of an underlying drug-loaded hydrophilic hydroxypropyl methylcellulose 
(HPMC) layer with polyethylene glycol (PEG 400) as an enhancer, and an external 
hydrophobic vinyl polymer coating (Figure 1.12a). The occlusive outer layer not only 
increased the uptake of terbinafine into and its permeation across the nail plate 
(probably by augmenting the hydration level of the keratin network), but also provided 






Figure 1.12: (a) Cross-section of the nail plate (A) treated with a bilayered nail lacquer, 
comprising a drug-loaded hydrophilic layer (B) and an external hydrophobic vinyl 
polymer layer (C). (b) Cumulative amounts of terbinafine lost from the control 
hydrophilic lacquer devoid of PEG 400 (grey column), the hydrophilic monolayer 
lacquer (white column) and the bilayered lacquer (black column) during multiple 
washings. Reproduced with kind permission from (65). 
 
Nail patches 
A transungual drug delivery patch consists of a drug-impermeable backing layer, a 




4.  Conclusions 
 
As a first step to formulate a transungual drug delivery system, the characteristics of pluronic 
gel were explored. As the concentration of pluronic gel increased, the pluronic micelles would 
be more closely packed and a gel would be formed more easily even in a lower temperature. 
And the addition of model drug would also affect the gelation temperature of pluronic gel. 
Based on our experimental results as seen in Table 4 & 5, SF and NR/PEG addition would 
decrease the gelation temperature by about 2°C and 14-16 °C respectively. 
 
After doing a series of IVR ? ET and ex-vivo release studies, the Pluronic thermogel PF-127 
was identified as a suitable aqueous nail lacquer for transungual drug delivery. The gel 
increased the residence time of the model drugs on nail plate and at the same time it produced 
a hydration effect which resulted in a greater penetration across the nail plate. These results 
were especially found in 20% pluronic gel and supported by Hui et al. 2004. who compared 
the penetration of Luprox Gel (Medicis, The Dermatology Company, Scottsdale, AZ) and the 
marketed lacquer, Penlac across the nail. Although the formulation of Luprox gel (Carbomer 
gel) was different from that of pluronic gel, the similar hydration effect in the hydrogels 
showed that the pluronic gel was suitable to be used as nail lacquer or even better than nail 
lacquer for greater drug penetration across the nail [30, 38].  
 
However, the pluronic gel formulation had a limitation. It was hydrophilic in nature and could 
be easily and quickly remov d from th  nail surface during routine day-to-day activities, e.g. 
washing hands [30, 34]. 
 
To avoid the weakness of hydrophilic gel, a bilayered nail lacquer could be simulat d from 
Shivakumar et al. 2010 and the lacquer was made of an underlying drug-loaded hydrophobic 
layer and an overlying hydrophobic vinyl layer (Fig. 19). [30, 39] 
Fig. 19: Cross-section of the nail (A) applied with the bilayered nail lacquer showing  





The hydrophilic l ye  adhered to the nail surface while the vinyl layer protected the 
hydrophilic layer from being washed off during daily activities. Then the bilayered lacquer 
was tested on Franz diffusion cells in which the donor cell was charged with 500 µL of 
distilled water and this washing step was repeated 50 times and the cumulative drug 
(Terbinafine HCl) lost after each washing was determined. The results were then compared 
with the monolayered lacquer and the control lacquer (Fig. 20). The bilayered lacquer had an 
outstanding performance and protected the drug from water washing and at the same time 
achieved a similar permeation across the nail [30, 39]. 
 
Fig. 20: The cumulative amounts of terbinafine hydrochloride lost from the control  
(gray filled column), monolayer (unfilled columns), and bilayered (black filled column) 
lacquers during multiple washings. [39] 
 
In the in-vivo release study, although the 20% gel and 25% gel were most preferred by the 
healthy participants according to the opinions in the questionnaire, the 25% gel was not 
suitable when applying on the fungal nails (Fig 21) 
 
 
Fungal nails were always thick and uneven and would require a topical drug delivery system 
which was not viscous and was able to distribute evenly on the nail surface. Therefore, 20% 













simple and convenient system with good adhesion that requires less frequent 
applications. The permeation of ciclopirox across porcine hoof membrane from various 
PSA has been investigated (66). An acrylic adhesive with a hydroxyl functional groups 
(AA-OH) produced the highest delivery. However, the drug crystallized in all matrices 
except one suggesting the need for additional work to improve the formulation approach.  
Donnelly et al. (67) formulated a bioadhesive patch containing 5-aminolevulinic acid 
(ALA), a photosensitizer that has bactericidal and fungicidal activity upon radiation. 
The patch comprised of poly(methylvinylether/ maleic anhydride) (PMVE/MA), 
tripropylene glycol methyl ether (TPM) and ethanol, and was loaded with 50 mg/cm2 
ALA. Being small and polar, ALA penetrated reasonably well into and across the nail 
plate. However, the maximum ALA concentration achieved at the inner nail was less 
than one-tenth of that required to produce a 90% reduction in the viability of C. 
albicans and T. interdigitale, respectively. It appears, therefore, that further steps are 
necessary to improve the ALA penetration, perhaps by filing off some of the nail plate 
or by the use of penetration enhancers. Alternatively, because of the potential for 
toxicity with high level of ALA concentrations, the incorporation of iron chelators to 
enhance photosensitization may need to be considered to allow a lower ALA dose to be 
used.  
 
1.5.2 Nail modification 
Transungual permeation may also be enhanced by underpinning the barrier properties of 
the nail plate using physical abrasion and/or chemical treatment. 
A) Physical enhancement 
Filing 
Filing the nail plate surface is the simplest way to reduce the barrier thickness and 
possibly remove part of the infected area; the procedure is often recommended before 
the application of topical formulation. The increased permeation of 5-FU and 
flubiprofen across the nail plate, which had been filed, has been demonstrated (12).  
Etching 
Acid-etching has been suggested for roughening the surface of the nail, and increasing 
the available surface area for transport. A distinct change in topography is apparent 
when the nail surface is treated with 10% phosphoric acid (68) (Figure 1.13) and this 
results in increased bioadhesion of the ketoconazole-loaded polymeric films as well as 





nail thickness and increases the microporosities within the barrier, facilitating thereby 






Figure 1.13: Atomic force microscopy (AFM) images of the dorsal surfaces of (a) non-
etched, and (b) etched nail plate. Reproduced with kind permission from (68). 
 
Microporation 
The penetration pathways across the compact nail structure might also be shortened or 
by-passed by microporation of the nail plate, for example using an ultra-short laser 
pulse (69). The laser energy is absorbed by water or protein in the nail plate, heating up 
and melting the material, leading to vaporization and thermo-mechanical damage. Using 
ultra-short pulses, the degree of destruction can be controlled to produce small craters 
(300-400 )m) on the nail plate but avoiding cracking or collateral damage (Figure 
1.14a).  
A hand-held device (PathFormer, manufactured by Path Scientific, Carlisle, MA, USA), 
has also been developed to drill microconduits through the nail plate (Figure 1.14b). By 
monitoring the electrical resistance of the nail at the site of treatment, it is possible to 
create holes of a controlled depth without penetrating the nail bed. This procedure was 
shown to be well tolerated, causing minimal pain and discomfort in a small clinical 
study, and it has been suggested for nail trephination in the treatment of subungual 










Figure 1.14: (a) Scanning electron microscopy (SEM) image of a crater formed on the 
nail plate by the application of ultra-short pulse laser (350 fs at 10Hz). (b) Photography 
of a hole drilled on the nail plate using the PathFormer device. Reproduced with kind 
permissions from (69) and (70), respectively. 
 
B) Chemical enhancement 
The use of chemical agents, which can interact with the nail keratin network and 
destabilize its integrity, is a strategy that can improve drug permeation. Some examples 
are discussed below. 
Keratolytic agents 
Keratolytic agents, such as urea and salicylic acid can be used to soften the nail plate 
and facilitate its detachment and chemical dissolution perhaps by weakening the 
intermolecular bonds and disrupting secondary and tertiary keratin structure, to cause 
protein unfolding (71). A pronounced fracture of the nail surface treated with keratolytic 
substances has been demonstrated and the formation of pores in the keratin matrix was 
hypothesized (72). However, despite these structural modifications, incorporation of 
urea (40%) into an antimycotic formulation and pre-treatment with 20% salicylic acid 
for 10 days failed to promote drug transport and no permeation through the nail was 
detected over 60 days. Equally, neither urea nor salicylic acid, both used at 20%, were 
able to enhance water transport through the nail plate (71). 
Reducing agents 
Compounds with free sulfhydryl group (-SH) may destabilize the nail keratin network 
by reducing disulphide (S-S) linkages (16): 
 !"#$%&'! !! !! !"#!"#$! !! !" ! !"#$%&'! !"! !! !! !! ! 
 
Examples include N-acetylcysteine, thioglycolic acid, mercaptoethanol and N-(2-
mercaptopropionyl) glycine (MPG). An increase in the surface roughness and porosity 





been reported (48). The significantly increased permeation of triamcinolone across the 
latter has been observed. It was later confirmed (51) that the perturbation effect of N-
acetylcysteine induced a conformational change in nail protein and increased the 
electrical conductivity of the barrier. An enhanced flux of caffeine across the nail plate 
pre-treated with thioglycolic acid has also been reported (73). Importantly, infrared 
spectroscopy has recorded the disappearance of S-S bond stretching from porcine hoof 
treated with mercaptoethanol, substantiating the reducing effect of thiol compounds 
(66). Moreover, a significant and potentially irreversible effect was induced by MPG, 
and was further increased when co-applied with urea (71).  
Sulphites may also reduce S-S bonds (71): 
 !"#$%&'! !! !! !"#$%&'! !!!!! ! !"#$%&'! !! !!! ! !"#$%&'! !! 
 
However, their variable effects have been less studied than those of thiols. Although the 
improved penetration of 5,6-carboxyfluorescein in the presence of sodium sulphite has 
been reported (74), Malhotra and Zatz (71) did not observe any increase in the 
penetration of water with 10% sodium metabisulphite, either alone or in combination 
with 20% urea. It appears that the relatively weak reducing ability of sulphites means 
that a long treatment period is required to break sufficient S-S linkages and elicit an 
enhancement effect.  
Keratinases 
The use of keratolytic enzymes has also been proposed as an approach to undermine the 
nail barrier. Papain serves as a potential candidate. Indeed, pre-treatment for 1 day with 
this enzyme, followed by 20% salicylic acid for 10 days, promoted the nail permeation 
of imidazole antimycotics (72). The separation of the dorsal nail plate cells (Figure 
1.15) when treated with keratinase has been observed (75). The enzyme appears to 
attack the intercellular matrix protein, which holds cells together, causing them to ‘lift 
off’ the nail plate. Despite the surface corrosion, the deeper nail layer remained 
unaltered, presumably due to the limited penetration of the large enzyme molecule (MW 
, 33000) into the nail plate. However, the more superficial effect may be sufficient to 
enhance ungual drug permeation, an increased penetration of metformin hydrochloride 










Figure 1.15: SEM images of (a) the dorsal surface, and (b) a cross-sectional view of the 
nail plate after incubation with 10 mg/mL keratinase. Reproduced with kind permission 
from (75). 
 
1.5.3 Iontophoretic delivery 
Recently, transungual iontophoresis, the application of a small electrical current to 
provoke the transport of (usually) charged molecules into the membrane has shown 
promise in enhancing drug permeation across the nail. While electrorepulsion is the 
major driving force for charged permeants, electroosmosis is an important flux 
enhancing mechanism for neutral molecules (76). The significantly higher in vitro 
permeation of ciclopirox olamine (77) and terbinafine hydrochloride (78), respectively, 
across human nail plate with iontophoresis has been demonstrated and the feasibility 
and tolerability of the approach has been confirmed in vivo (79, 80). Although 
iontophoresis caused transonychial water loss (TOWL), a marker for nail barrier 
function, to increase, compared with the simply hydrated control; the effect was 
transient, returning to baseline within 1 hour post-application. The efficacy and safety 
of topical treatment with terbinafine using an iontophoretic patch have also been 
demonstrated in a clinical study (80).  
 
1.6 Polymeric nanoparticles  
In this thesis, a novel approach of using polymeric nanoparticles (NPs) in topical nail 
delivery is investigated. Polymeric nanoparticle-based drug delivery systems have been 
widely studied. These are colloidal particles of less than 1 µm in diameter which have 
shown good stability, high loading capacity, the ability to incorporate both hydrophilic 
and lipophilic drugs and the potential to deliver an ‘active’ for sustained periods via 
different routes of administrations. NPs can be produced from natural or synthetic 
polymers, with the latter offering better purity (81). Commonly used polymers in 





(84, 85), poly(lactic-co-glycolic acid) (PLGA) (86, 87), poly(butylcyanoacrylates) (88), 
poly(methyl methacrylate) (89, 90), and polystyrene (91). Polymeric NPs typically fall 
into two categories, namely nanospheres and nanocapsules (Figure 1.16). The former 
have a solid mass and drug may be absorbed at the surface or entrapped within the 
polymer matrix. Nanocapsules are vesicular systems and the encapsulated active is 
either confined within the liquid core or adhered to the surrounding solid polymer shell 
(92). Various preparation techniques have been described and are generally classified 
into (a) in situ polymerization or (b) precipitation of pre-formed polymer. The 
commonly used methods are summarized in Table 1.6 (92-94): 
 
 







Table 1.6: Polymeric nanoparticle preparation methods. 




Monomer is dispersed in water using an emulsifying agent to 
form monomer-containing micelles. An initiator (typically a free 
radical) diffuses into the micelle and polymerizes the monomer, 
leading to the formation of nanospheres.  
Interfacial 
polymerization 
Polymerization occurs between two reactive monomers at the 
interface of two immiscible solvents. This method is commonly 
used to produce core-shell-structured nanocapsules. 
(b) Precipitation of pre-formed polymers (followed by solvent evaporation) 
Nanoprecipitation 
It is also known as the solvent displacement method. Water is 
usually used as a non-solvent into which is added to a water-
miscible solvent containing dissolved polymer. Upon adding the 
polymer solution into the aqueous solution containing 
surfactants, the solvent diffuses rapidly into water. This leads to 
the instantaneous formation of nanoparticles. Finally, the 
polymer solvent is removed by evaporation or centrifugation. 
Emulsion solvent 
evaporation 
Polymer is dissolved in a water immiscible organic solvent, 
which is then emulsified in an aqueous phase containing 
stabilizer. High-speed homogenization or ultra-sonication is 
generally employed to induce the formation of nanodroplets 
during the emulsification process. Subsequent removal of the 
organic solvent leads to the formation of nanoparticles, typically 
nanospheres. 
Salting out 
Polymer is dissolved in a water-miscible organic solvent, which 
is subsequently emulsified into an aqueous phase containing a 
stabilizer and a high concentration of salt or sucrose. The 
resulting emulsion is then diluted with a sufficient amount of 
water. This reduces the salt concentration in the aqueous phase 
and induces the diffusion of organic solvent out of the polymer 
droplets, leading to polymer precipitation in the form of spherical 
nanoparticles.   
 
1.6.1 Polymeric nanoparticle-based formulations for topical application 
Drug encapsulation using polymeric NPs offers an approach to modify the intrinsic 
physicochemical properties of the incorporated molecule and facilitate its percutaneous 
delivery. It appears that NPs not only increase a drug’s availability within the skin but 
also enhance and sustain its penetration into the barrier (95). NPs composed of different 
polymeric materials have been investigated for their potential as reservoir systems for 
topical and/or transdermal drug administration. Some examples are discussed below. 
In cosmetic formulations, the incorporation of antioxidants, retinyl palmitate (96) and 
vitamin K1 (97) in nanocapsules of PLA and PCL, respectively, increased the uptake of 





The application of polymeric NPs on sunscreen formulations has also been investigated. 
A nanocapsule gel-preparation of octyl methoxycinnamate (OMC), a highly lipophilic 
UV filter, provided better protection against UVB-induced erythema than a 
conventional gel. These results were attributed to the accumulation of NPs at the 
superficial layer, which efficiently cover the skin surface and improve the sunscreen’s 
ability to protect against UV damage (98). Subsequently, it was shown that PCL NPs 
produced a 3.4-fold higher level of OMC within the stratum corneum than that from the 
non-particulate formulation (82). Similar results have also been reported on the 
encapsulation of another sunscreen, benzophenone-3, into fatty-acid conjugated 
polyvinylalcohol (PVA) NPs (99).  
Hair follicles represent an important route of uptake for NPs (89, 100, 101). The 
increased in vitro and in vivo penetration of minoxidil, a drug administered topically for 
the treatment of hair loss, into guinea pig skin with poly(!-caprolactone)-block-
poly(ethylene glycol) NPs has been demonstrated (102). Hair growing activities in mice 
in vivo were also enhanced by the use of PLGA nanospheres (86).  
Furthermore, a significantly increased permeation of flufenamic acid, an anti-
inflammatory drug, into the deeper skin layer from PLGA (87) and propyl starch (103) 
NPs has been reported.  
Finally, the antiseptic effect of chlorhexidine-loaded PCL NPs has been evaluated (83). 
While the NPs were found to locate at the skin surface, a higher level of chlorhexidine 
was delivered to the stratum corneum from the NPs than an aqueous solution. A 
sustained antimicrobial activity was also achieved using the particles. It was suggested 
that the NPs provided a direct, prolonged contact for the sustained delivery of 
chlorhexidine into the skin. 
 
1.6.2 Novel use of nanoparticles in the treatment of nail diseases 
The use of NPs in drug formulations for the treatment of nail diseases has received 
limited attention. Two examples are perhaps worth comment although, in both cases, it 
appears that drug delivery is eventually achieved indirectly via the skin (as opposed to 
across the nail plate itself). NanoBio Corp. (Ann Arbor, Michigan, USA) has developed 
an oil-in-water nanoemulsion as a topical antifungal treatment. It contains oil droplets 
(~180 nm diameter) stabilized by a quaternary ammonium surfactant, cetylpyridinium, 
which may also have an anti-infective effect. Broad-spectrum fungicidal activity has 





appendageally and then accesses the infected nail by lateral diffusion from the 
epidermis (104). Although Phase II clinical trials have been completed, no data have yet 
been published. The formulation of terbinafine into the nanoemulsion is a further 
objective (105). Celtic Pharma (London, U.K.) has introduced a transfersome-based 
spray formulation (also with terbinafine as the active) for the treatment of 
onychomycosis. Transfersomes are ultra-deformable lipid vesicles (106). High 
mycological cure rates and good clinical effect on treated nails have been claimed (107). 
The transfersomes are believed to facilitate the percutaneous uptake of terbinafine and 
that lateral diffusion must again take place for the drug to reach the infected nail bed; 
however, the evidence for the proposed mechanism may be described as circumstantial 
at best. 
The potential for using nanoparticles in some way as components of topical nail 
formulations is essentially unexplored, therefore, and a real need exists for more 
credible and objective research in the area to develop a sound rationale for the strategy 
and to provide an underpinning scientific understanding upon which a development and 
optimization programme might be based. This goal is one focus of the research 
described in this thesis. 
 
1.7 Visualization of transungual permeation 
In vitro nail permeation studies typically quantify the amount of active permeating from 
the dorsal side to the ventral, having crossed the entire nail plate. However, very little is 
known about the mechanism of permeation. It is established that water, a small polar 
molecule, penetrates the nail rapidly, but most of the drugs used to treat nail diseases are 
relatively large (compared to water) and rather lipophilic; i.e., not that compatible with 
the hydrophilic nature of the nail. Although in principle pathways of transungual 
permeation include transcellular (transport through the nail plate cells) and/or 
paracellular (transport via the intercellular spaces), there is a paucity of information and 
evidence that speaks to the role of each one for different compounds of interest.  
Furthermore, the establishment of a drug concentration gradient across the nail has not 
been well studied, and the depth to which penetration has occurred as a function of time 
remains poorly defined. Drug distribution across different layers (dorsal, intermediate or 
ventral) of the nail plate has only been determined by destructive methods. For example, 
a treated nail is milled to an approximate depth (62, 108) or sectioned using a 





be assayed for the active. Obviously, these procedures provide only a crude measure of 
the drug level to a particular depth at a single time. To assess depth profiles as a 
function of time therefore requires multiple, different samples and introduces significant 
variability into the measurements. Because of these limitations, there is motivation and 
logic to attempt to visualize nail permeation using non-destructive imaging techniques. 
In this thesis, therefore, laser scanning confocal microscopy (LSCM), two-photon 
fluorescence (TPF) imaging, and a label-free technique, namely stimulated Raman 
scattering (SRS) microscopy, have been examined for this purpose.  
 
1.7.1 LSCM and TPF imaging 
LSCM (Figure 1.17), invented in 1978, permits direct imaging of a fluorescent target at 
multiple depths without mechanical sectioning. In conventional (wide field) microscopy, 
the entire sample is illuminated uniformly and simultaneously. As the emitted light from 
the focal plane is detected at the same time as the out-of-focus light from the areas 
above and below it, blurred images with poor resolution are generated. In contrast, 
illumination in confocal microscopy is not simultaneous but sequential, and is finely 
focussed on the specimen as a spot. There is also a spatial filter, an aperture or pinhole, 
which blocks all fluorescence other than that coming from the in-focus plane of interest. 
Optical sectioning is achieved by scanning x-y planes (i.e., parallel to the plane of the 
sample surface) successively in the z-direction, and thereby allowing a three-
dimensional view of the sample to be obtained (110).  
While LSCM is a single-photon excitation process, TPF (Figure 1.17) utilizes two 
photons, the combined energy of which is sufficient to excite the fluorophore. Using a 
pulsed laser, a high peak power delivers the necessary photon density to generate 
significant excitation at the focal plane and two photons are absorbed by the fluorophore 
simultaneously. With the strong focussing capability of the microscope objective and 
the quadratic dependence of the probability of two-photon absorption on the excitation 
power, high lateral and axial resolution, as well as optical sectioning, are therefore 
achieved (and excitation outside the focal volume is negligible). The longer excitation 
wavelength also results in less scattering, thereby improving imaging penetration depth. 
Because TPF restricts the excitation volume to the focal plane (unlike LSCM), photo-







Figure 1.17: Schematic diagram of the principles of LSCM (left) and TPF imaging 
(right). 
 
Application of LSCM and TPF in skin and nail research 
LSCM and TPF have made important contributions to skin research, providing 
morphological and mechanistic information, particularly in terms of the preferred 
penetration pathways following the use of different enhancement strategies (for 
example, the visualization of vesicle-mediated drug transport). Due to the irregular 
nature of the skin surface, the standard approach of tissue fixation and mechanical 
sectioning is not well suited to the localization of topically-applied nanoparticles, the 
deposition of which into a skin fold or invagination is sometimes misinterpreted as 
evidence of deep penetration into the tissue. LSCM and TPF imaging avoid this 
potential artefact optically sectioning of skin samples that have undergone essentially no 
preparation steps whatsoever (112). Campbell et al. (113), using LSCM, adopted an 
objective, statistical strategy, taking into account the confounding effect of 
autofluorescence and inter/intra-sample variability, to study the distribution of 
fluorescent polystyrene nanoparticles (20-200 nm) in porcine skin. A lack of particle 
penetration beyond the superficial layer (2-3 µm) of the stratum corneum but 






distribution analysis of the particle fluorescent signal confirmed the absence of time-
dependent penetration, even when the skin was partially damaged by tape stripping. 
Using TPF, Stracke et al. (114) traced the time-dependent migration of fluorescein 
(FA)-labelled PLGA nanoparticles (300 nm) encapsulating Texas Red (a model 
penetrant) in excised human skin. While the particles remained on the surface of the 
stratum corneum and deposited within the skin dermatoglyphs, the release of Texas Red 
and its penetration into the skin was clearly visible (Figure 1.18).   
 
Figure 1.18: (a) Planar image at a depth of ~32 µm, and (b) re-constructed orthogonal 
images, of excised human skin exposed to fluorescein-labelled nanoparticles (green) 
encapsulating Texas Red (orange). In the top-left image of (a), the grey scale shows 
keratin autofluorescence and that from the nanoparticles; the top-right and lower-left 
panels show the nanoparticles lodged in a skin ‘crevasse’ and the Texas Red released 
into the skin, respectively; the lower-right panel is an overlay of the previous two 
images. In (b), the sequestered green nanoparticles are seen in skin invaginations, while 
the liberated Texas Red diffuses across the skin. Reproduced with kind permission from 
(114). 
 
Use of fluorescence microscopy in nail research is much more limited. For example, 
LSCM has been used to study the morphological features (115) and to diagnose 
onychomycosis (116) in vivo. Dutet and Delgado-Charro (117), on the other hand, 
imaged the passive and iontophoretically-driven penetration of sodium fluorescein (SF) 
and Nile blue chloride (NBC), into the nail in vitro. From the mechanically sectioned 
transverse images and the three-dimensional reconstructed orthogonal views, the 
slightly deeper penetration of the fluorophores into the nail with iontophoresis was 










Figure 1.19: Representative confocal images showing the penetration of SF (green) and 
NBC (blue) passively and with an iontophoretic current of either 0.1 mA or 0.4 mA. 
Arrows indicate the nail surface to which fluorophores were applied. Panels A1 and B1 
are images from mechanically sectioned samples allowing direct measurement of the 
penetration depth (short red line) and the total nail thickness (long red line). Panels A2 
and B2 are orthogonal images generated from reconstruction of successive x-y planar 
views. The depth of penetration is indicated. Reproduced with kind permission from 
(117). 
 
Limitations of LSCM and TPF 
Despite their attractive ability for optical sectioning, LSCM and TPF are limited by the 
need for fluorescent markers and the laser frequency range(s) available. Typically, 
fluorophores are at best only approximate molecular surrogates for the real drug of 
interest and rarely have representative permeability characteristics. Furthermore, 
although autofluorescence is sometimes beneficial for revealing structural information 
about the sample, it can also interfere with, or even overwhelm, the emission from the 
target fluorophore, especially when the latter is present in small amounts. It follows that 
a preferred imaging tool would be label-free while maintaining high-resolution and z-





























1.7.2 SRS microscopy 
Raman microscopy provides an alternative technique that enables label-free imaging 
(118-120). It is based on the Raman scattering effect (121). When light interacts with a 
molecule, two types of scattering events occur: Rayleigh (elastic) and Raman (inelastic). 
Rayleigh scattering is the predominant mode, in which no energy is transferred from the 
photon to the molecule. Therefore, the scattered photon has the same energy (frequency 
and wavelength) as the incident photon. However, a small fraction (1 in 107) of light 
undergoes Raman scattering. Here, the scattered photon is generated at the Stokes or 
anti-Stokes frequencies, having lower or higher in energy than the incident photon, 
respectively. Stokes transition occurs when the molecule is excited from a ground to a 
‘virtual’ energy state and returns to its vibrational mode; anti-Stokes scattering occurs 
when, at the time of interaction, the molecule is already in excited vibrational state and 
the excess energy is released as it returns to its ground state. Figure 1.20 shows a 
simplified energy diagram that illustrates these concepts. The amount of energy 
required to excite a molecular vibration depends on the masses of atoms involved in the 
vibration, the type of chemical bonds between these atoms, and the interactions between 
the molecule and its environment. Consequently, each molecule has independent 




Figure 1.20: Energy levels and transitions of Rayleigh (elastic), Stokes Raman and anti-
Stokes Raman (inelastic) scattering.  
 
Spontaneous Raman scattering (Figure 1.21a) uses one laser beam to illuminate the 
sample and the Raman signal, which depends linearly on the incident light intensity, is 
typically very weak. The long signal acquisition times also limit the use of spontaneous 






























Coherent Raman scattering, including stimulated Raman scattering (SRS) and coherent 
anti-Stokes Raman scattering (CARS), shown in Figure 1.21b and Figure 1.21c, 
respectively, improves Raman signal by means of non-linear excitation and allows 
imaging at a faster speed. In this case, two laser beams, pump and Stokes, with a 
frequency difference matches the molecular vibrational frequency, irradiate the sample.  
For CARS, a new signal at a different (anti-Stokes) frequency to the incident laser 
beams is generated and therefore, detection is relatively straightforward, using a filter 
and photomultiplier tube. 
For SRS, signal is detected as a change in intensity between the pump and Stokes beams. 
When the energy difference between these two beams matching the energy of the 
molecular vibration, the excited state of the functional group of the molecule is 
populated. To achieve this transition, energy is provided by the incident lasers and due 
to the laws of conservation of energy, a photon from the pump beam is annihilated and a 
photon is created for the Stokes beam. In other words, the intensity of the pump beam 
decreases (stimulated Raman loss, SRL), while the intensity of the Stokes beam 
increases (stimulated Raman gain, SRG). These intensity changes (&I) can be probed as 
chemical-specific contrast.  
At biocompatible laser powers, &I are, however, very small relative to the intensity of 
the excitation beams (I) (&I/I < 10-4) and are typically buried within the laser noise, 
which exists primarily at low frequencies. To circumvent this problem, SRS microscopy 
utilizes a high-frequency modulation transfer scheme (Figure 1.22a). In this approach, 
one excitation beam is amplitude-modulated at a high frequency. The two beams are 
then aligned and interact with the sample, after which, the originally un-modulated 
beam is detected at the reference frequency using a photodiode and lock-in amplifier 
(Figure 1.22b). Since SRS only occurs when both laser beams are present, amplitude 
modulation is transferred from one beam to another and can be sensitively detected. The 
measured SRL or SRG provides each pixel of the image. Three-dimensional optical 







Figure 1.21: Energy level diagrams for (a) spontaneous Raman, (b) CARS and (c) SRS. 
- = molecular vibrational frequency. 
 
  
Figure 1.22: (a) Modulation behaviours of the input and output pulse trains. The 
resulting SRL in the pump beam is detected by the transferred amplitude modulation. (b) 
Diagram of a SRL microscope set-up. The pump beam and the high-frequency 
modulated Stokes beam are focused onto a common focal spot on the sample. After 
interaction with the sample, SRL of the pump beam is collected and detected by a 
photodiode and a lock-in amplifier. Redrawn based on (122). 
 
Advantages of SRS over CARS 
Although both SRS and CARS offer label-free imaging, the former is a more suitable 
technique for monitoring drug delivery. Firstly, SRS offers excellent vibrational 
contrast and chemical selectivity because no signal is detected when the frequency 
difference between the pump and Stokes beams does not match with a vibrational 
frequency of the sample. In contrast, the sensitivity of CARS is limited by its non-
resonant background. Moreover, SRS allows more straightforward image interpretation 
and/or quantitative analysis because the signal output (Figure 1.23) is identical to the 
spontaneous Raman spectra and has linear concentration dependence, whereas CARS 






















































Figure 1.23: (a) Raman peak of retinol by spontaneous Raman scattering, SRS and 
CARS. A peak shift and the non-resonant background are seen in the CARS spectrum. 
SRS signal output is identical to that of the spontaneous Raman scattering. (b) Linear 
dependence of SRS signals on the concentration of retinol. Reproduced with kind 
permission from (122). 
 
Applications of SRS in skin imaging 
The high-resolution, three-dimensional imaging capability of SRS has been 
demonstrated in a study of the physiological structures within the skin (119). Targeting 
the CH2 stretching vibration (2845 cm-1), the lipid rich regions at various depths into 
excised mouse skin, including the stratum corneum, the sebaceous gland and the 
subcutaneous fat layer were clearly visible (Figure 1.24). The distribution of dimethyl 
sulphoxide (DMSO) and retinoic acid (RA) into the skin was also traced by mapping 
the S=O (670 cm-1) and the conjugated C=C bond stretching (1570 cm-1), respectively 
(Figure 1.25) (119). While the hydrophilic DMSO partitioned predominately at the 
protein phase, the hydrophobic RA permeated exclusively through the lipid-rich 
intercellular spaces. Recently, the Xie’s group (123) has also demonstrated the use of 
video rate SRS imaging to observe the penetration of drug and excipients into the skin 
of living mice and human. 
 
 
Figure 1.24: SRS CH2 (2845 cm-1) images of mouse ear skin at the indicated depths of 
(a) 4 µm (stratum corneum), (b) 42 µm (sebaceous gland) and (c) 105 µm (subcutaneous 








Figure 1.25: Top view of (a) DMSO and (b) RA in the stratum corneum, imaged with 
SRS contrast of 670 cm-1 (S=O) and 1570 cm-1 (conjugated C=C), respectively. (c) 
Simultaneous two-colour image of DMSO (green) and CH2 lipid (red) in the 
subcutaneous fat layer at a depth of ~65 µm. Reproduced with kind permission from 
(119).  
 
Saar et al. (124) employed SRS in a study of dermatopharmacokinetics by tracking the 
permeation of ketoprofen in a vehicle of deuterated propylene glycol (PG-d8) into 
murine skin (ex vivo). The penetration of drug and solvent were independently 
monitored by tuning the laser to the relevant wavelength (1599 cm-1 and 2120 cm-1, 
respectively) while the skin itself was captured by tuning to the CH2 stretching 
frequency (2845 cm-1). A time-dependent penetration of ketoprofen and PG-d8 into the 
skin was clearly visible. The chemical disposition profiles were also determined using 
the signal intensities (Figure 1.26). It was found that the signals arising from both the 
drug and the vehicle within the intercellular lipid regions of the corneocytes increased 
steadily over time. A transfollicular route of uptake with limited capacity was also 
identified. The signal of PG-d8 from the hair shaft reached steady state rapidly before 
the first measurement (at 26 minutes post-application).  
 
 
Figure 1.26: (a) SRS image showing the contrast of PG-d8 in the areas surrounding the 
corneocytes (red box) and at the hair shaft (green box). (b) Temporal profiles of PG-d8 
at a depth of 6 µm into the skin. The red and green traces correspond to the areas 
enclosed by the corresponding boxes in (a), representing the intercellular and 

















SRS also provides visible information on the phenomenon of metamorphosis of 
topically administered drug formulations. Figure 1.27a and Figure 1.27b show the 
images of (deuterated) ibuprofen crystals which were found on the surface of mouse 
skin (124) and porcine skin (125), respectively, within 30 minutes post application of 
the drug at ~90% saturation in PG. This offers a direct, visible proof of one reason for 
poor drug bioavailability of topical formulations that the penetration of excipients into 
the skin is faster than the active, leading to drug crystallization in situ.  
 
 
Figure 1.27: SRS images showing the crystallization of ibuprofen-d3, in PG on the 
surface of (a) mouse and (b) porcine skin within 30 minutes post-application. Images 
were obtained at 2120 cm-1. Reproduced with kind permissions from (124) and (125), 
respectively. 
 
1.8 Thesis outline 
This project aims to characterize, and obtain mechanistic insight, into topical nail 
delivery, primarily using different imaging techniques. The main target of this work is 
to explore the potential of polymeric nano- or sub-micron particles to deliver drug into 
and across the nail by tracking their behaviour following topical application. The effect 
of other formulation approaches, including nail perturbation using microneedles, 
chemical treatment with penetration enhancers, and the use of a thermoresponsive nail 
lacquer, are also evaluated.   
Chapter 2 demonstrates the novel application of stimulated Raman scattering (SRS) 
microscopy for direct visualization of the time course and depth of solvent penetration 







In Chapter 3, topical nail delivery using poly-methacrylate nanoparticles is examined. 
The distribution of the nanoparticles and of the model active is imaged using laser 
scanning confocal microscopy (LSCM).  
Sustained drug delivery from poly(!-caprolactone) nanoparticles into microneedle-
porated nails is investigated in Chapters 4 and 5. The distribution of a fluorescent model 
active within the barrier following topical application of nanoparticles is first imaged 
with LSCM; subsequently, the localization both of fluorescently-labelled nanoparticles 
and of a lipophilic ‘active’ on and within the nail are tracked using two photon 
fluorescence (TPF) and SRS microscopies in combination.  
Chapter 6 investigates the delivery of an antifungal drug into and across the nail from 
sub-micron, oil-filled poly(!-caprolactone) particles. The effects on drug permeation of 
nail hydration, and pre-treatment with a chemical enhancer and microneedle-poration, 
are evaluated.  
Finally, in Chapter 7, the development of an aqueous-based, in situ thermogelling 
formulation for topical nail treatment is described. The penetration of hydrophilic and 
lipophilic compounds from the gel into the nail is visualized with LSCM. The gelling 
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Chapter 2 : Assessment of solvent diffusion into the nail plate 
by stimulated Raman scattering (SRS) microscopy 
 
Overview 
Purpose: To visualize and characterize the real-time penetration of topically applied 
solvents into human nail plate using stimulated Raman scattering (SRS) microscopy.  
Methods: Deuterated water (D2O), propylene glycol (PG-d8) and dimethyl sulphoxide 
(DMSO-d6) were separately applied to the dorsal surface of the nail plate. SRS 
microscopy was used to image D2O, PG-d8/DMSO-d6 and the nail through the O-D, -
CD2 and -CH2 bond stretching Raman signals, respectively. Signal intensities obtained 
were measured as functions of depth into the nail and of time.  
Results: The time-dependent penetration of the solvents into the nail was clearly 
observed with the diffusion of D2O being more than an order faster than that of PG-d8 
and DMSO-d6. Semi-quantitative analysis of the permeation profiles strongly suggested 
that solvent diffusion was concentration-dependent and non-Fickian. It appeared that the 
uptake of solvent progressively undermined the integrity of the nail.  
Conclusions: This novel application of SRS has permitted direct visualization and 
semi-quantitation of solvent penetration into the nail plate. The kinetics of uptake of the 
three chemicals studied demonstrated that each altered its own diffusion in the nail in a 
concentration-dependent fashion. The scale of the unexpected behaviour observed may 








The effective treatment of nail disease requires efficient drug delivery into and through 
the barrier. However, the tightly woven keratin network of the nail plate means that 
poor drug uptake following topical administration is common. Despite considerable 
effort to improve formulations and to enhance drug delivery to the nail, progress has 
been slow at best. In general, the approaches adopted have failed to understand the 
complex interplay between drug, formulation components (including solvents) and the 
nail. For example, although it is quite clear that drug uptake from typical ‘lacquer’ 
formulations (comprising the active, a film-forming polymer and a volatile organic 
solvent) is intimately linked to the disposition of the solvent, and effectively stops once 
the solvent has gone, there has been little effort to characterize the transport of these key 
vehicle components into and across the nail. Only the diffusion of water has received 
attention, its overall time-dependent uptake having been measured by various 
techniques (1-3); otherwise, apart from some information on the concentration-depth 
profiles of water and dimethyl sulphoxide (DMSO) in the very superficial, outermost 20 
µm of the nail, there are essentially no time and position-dependent data on the 
movement of chemicals into the nail.  
Stimulated Raman scattering (SRS) microscopy is a label-free imaging technique that 
offers a solution to this challenge. This method has been applied in a range of 
biomedical and pharmaceutical studies involving, for example, visualization in living 
cell (4), characterization of cortical vasculature morphology (5), imaging the 
constituents of solid, oral dosage forms (6) and tracking the dermatopharmacokinetics 
of drugs and excipients in mammalian skin (7-9). In this paper, the first application of 
SRS microscopy to trace and visualize the diffusion of three pharmaceutically relevant 
solvents, water, propylene glycol (PG) and DMSO, as a function of depth and in real 
time, in human nail is presented. The use of deuterated solvents provides unique 
Raman-active molecular vibrations that are easily distinguished spectroscopically from 
those originating in the nail, resulting in excellent image contrast without significant 
modification of molecular weight of the solvents which is a key parameter governing 
transport kinetics across the barrier (10). Because of the linear relationship between the 
SRS signal and the concentration of the chemical, the spectroscopic signature of which 
is being monitored, a semi-quantitative analysis of solvent diffusion across the nail is 





2.2 Materials and methods 
2.2.1 Sample preparation 
Deuterated water (D2O), PG-d8 and DMSO-d6 were purchased from Sigma-Aldrich Co., 
Ltd. (Gillingham, U.K.). Human nail clippings were obtained from healthy volunteers 
and stored at -20°C until use. The University of Bath Research Ethics Approval 
Committee for Health (REACH; EP 11/12 115) granted ethical approval for nail 
sampling, and all individuals donating nails gave informed consent (Forms in Appendix 
1). Each nail sample was carefully cleaned with deionized water and dried with 
absorbent tissue before each experiment. Prior to imaging, 5 µL of neat solvent was 
applied over the nail (~16 mm2 in area) which was then sandwiched between two glass 
coverslips within a Parafilm® frame, which acted as a spacer. The coverslips were 
sealed by melting the Parafilm® and further secured using double-sided tape. This 
ensured that the sample was tightly sandwiched to minimize solvent evaporation and 
sample dehydration during the time-lapse experiments.  
 
2.2.2 Raman spectroscopy 
To identify suitable vibrational bond resonances for each solvent prior to SRS imaging, 
their Raman spectra, and that of a nail clipping sample, were acquired using a Raman 
microscope (Renishaw RM1000, Renishaw plc, Wotton-under-Edge, U.K.) and 
Renishaw v1.2 WIRE software. A 1200-line/mm grating providing spectral resolution 
of 1 cm-1 was used with a diode laser operating at 785 nm. The Raman band (520 cm-1) 
of a silicon wafer was used for calibration. The Vancouver Raman Algorithm (BC 
Cancer Agency & University of British Columbia, Canada) was employed for 
automated fluorescence background removal from the Raman spectra.  
 
2.2.3 SRS imaging 
The SRS microscope consisted of a picosecond laser system and a modified commercial 
inverted laser-scanning microscope with a confocal laser scanner (FV300/IX171, 
Olympus UK Ltd, UK). Synchronized, dual-wavelength picosecond excitation was 
provided by an optical parametric oscillator (OPO) (Levante Emerald, APE, Berlin) 
which was synchronously pumped at 532 nm by a frequency-doubled Nd:Vanadium 
laser (picoTRAIN, High-Q GmB), delivering a 7 ps pulse train at a 76 mHz repetition 
rate. The OPO consisted of a temperature-tuned, non-critically phase matched Lithium 





be continuously tuned from 690 to 980 nm by adjusting the LBO temperature and an 
inter-cavity Lyot filter. A Si PIN photodiode was used to record the intensity variations 
of the OPO signal. The pump-laser fundamental (1064 nm) was also available as a 
separate output and was used as the Stokes beam, which was amplitude modulated at 
1.7 MHz with an acousto-optic modulator (3080-197 Crystal Technologies, West 
Chester, PA, USA).  
The pump beam and the modulated Stokes beam were spatially overlapped using a 
dichroic mirror (1064 DCRB, Chroma Technology Corp, Bellows Falls, USA) and 
temporally overlapped using a delay stage. The collinear beams were directed into the 
microscope and focussed onto the sample using a 20X 0.75 NA air objective 
(UPlanSApo, Olympus) and scanned in two dimensions using a pair of galvanometer 
mirrors. The resulting SRL in the pump beam was collected in the forward direction via 
a 1.0 NA condenser lens (LUMFI, Olympus) and detected by a large area photodiode 
(FDS1010, Thorlabs, New Jersey, USA). A band-pass filter (850/90 nm, Chroma) was 
mounted in front of the detector to block the modulated 1064 nm beam. Finally, a lock-
in amplifier (SR844, Stanford Research Systems, Sunnyvale, CA, USA) was used to 
detect the SRL signal with a time constant of 30-100 )s.  
 
2.2.4 SEM analysis 
Scanning electron microscopy (SEM) was used to investigate solvent effects on the 
integrity of the nail surface. A nail sample was cut into four pieces of approximately 4 
mm2 in area. Three were placed in sealed vials containing 1 mL of either water, PG or 
DMSO for 24 hours at room temperature; the fourth piece of nail served as an untreated 
control. Post-treatment, the nails were dried with tissue, mounted on the aluminium 
stubs using double-sided tape, and imaged by SEM (JEOL SEM6480LV, JEOL Ltd., 
Tokyo, Japan). 
 
2.2.5 Data analysis 
All acquired images were processed using ImageJ (U.S. National Institutes of Health, 
USA). Each data point was normalized against the OPO signal recorded on the PIN 
photodiode to correct for the laser intensity fluctuations. Images of different Raman 
shifts were presented using different colour schemes for ease of interpretation. Signal 
quantification of the image was performed using the ‘plot profile’ or ‘plot z-stack 





3D images were produced using the ‘3D viewer’ function. Data fitting was performed 
using GraphPad Prism® version 5.00 (GraphPad Software, San Diego, CA, USA).  
 
2.3 Results and discussion 
2.3.1 Raman spectra 
Raman spectra of a nail clipping and of the solvents investigated are shown in Figure 
2.1. The unique Raman shifts, specifically -CH2 bond stretching (2855 cm-1) from the 
nail, -CD2 stretching (2120 cm-1) from PG-d8 and DMSO-d6, and O-D stretching (2500 
cm-1) from D2O, are clearly identifiable. The off-resonance signal at 1802 cm-1 serves as 
a suitable background at which neither the nail nor the solvents are Raman-active.  
 
 
Figure 2.1: Raman spectra of the nail and of the solvents studied. 
 
2.3.2 Control images 
Control images (Figure 2.2) from untreated nails were acquired using the -CH2 
stretching vibration; the nail surface was clearly observed. For the skin, this absorbance 
originates primarily from the lipids in the outermost layer, the stratum corneum (SC) (8). 
However, the lipid content of the nail is reported to be very low (0.1-1%) (11) (i.e., an 
order of magnitude or two less than that in the SC) and the -CH2 signal more likely 
originates from keratin, the principal protein component present. No signal from 
untreated nails was observed either off-resonance or at the -CD2 stretching frequency; 
the infrequent and small punctate ‘spots’ on the otherwise uniformly black images are 
due to two-photon absorption (TPA) (12) from residual dirt particles that were not 
removed when the nails were cleaned.  
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Figure 2.2: SRS images of an un-treated nail surface showing -CH2 bond stretching (A), 
absence of -CD2 signal (B) and the off resonance background (C). Scale bar = 50 µm. 
 
2.3.3 Absorption of D2O into the nail 
To observe the absorption of D2O into the nail plate, the SRS microscope was tuned to 
the O-D stretching vibration at 2500 cm-1. After application of the solvent to the nail 
and positioning of the sample on the microscope stage, an x-z line scan (x = 353 µm) 
was performed at t = 10 minutes capturing every 1 µm in the z-direction into the nail. 
This scan (150 lines) was repeated on 9 further occasions, every 2.7 minutes (i.e., until t 
= 34.3 minutes post-application of the D2O). Acquisition of each line scan required 1.07 
seconds. Finally, the nail was imaged by re-tuning the SRS microscope to 2855 cm-1 
and an off-resonance background was recorded at 1802 cm-1.  
The results are presented in Figure 2.3 (and as a video in Supplementary data 2.1) which 
shows superimposed x-z orthogonal views of the O-D signals obtained from each scan 
as a function of time from 5 different regions (35 x 150 µm2) of the D2O-treated nail. 
The SRS image from the -CH2 contrast of the nail permits the surface to be clearly 
delineated; the off-resonance ‘image’ only reveals (as before) a very few bright points 
of light scattering due to residual particulate matter not removed by the cleaning process 
prior to starting the experiment.  
The O-D signal recorded at each 2.7-minute interval is represented by a separate colour 
on the visible spectrum scale shown on Figure 2.3; that is, red corresponds to the 
measurement at t = 10 minutes, yellow to that at t = 12.7 minutes, and so on. These 
scans have then been superimposed (prepared using the ImageJ ‘transparent zero’ 
function), one upon the other, to generate (at each of the 5 different regions visualized) 
an image of D2O diffusion into the nail. Within 35 minutes, it can be seen that the 
deuterated water had diffused approximately 100 µm into the sample. This relatively 
rapid uptake of water into the nail has been inferred from previous investigations (13, 
14) but the transport process has never been visualized before in such a direct fashion. 
The results are consistent with the nail being characterized as a dense hydrogel 
2855 cm-1 2120 cm-1 1802 cm-1 





containing overlapping keratin fibres, which create small, tortuous, pore pathways that 
favour the permeability of small, hydrophilic molecules, such as water (15).  
 
Nail OR O-D   
         
Figure 2.3: Composite SRS x-z orthogonal view images of the penetration of D2O into 5 
regions of the nail as a function of time (the 5 panels on the right of the figure labelled 
O-D). The visible spectrum scale indicates the O-D signals recorded every 2.7 minutes, 
from t = 10 minutes (red) to t = 34.3 minutes (magenta) post-application. The SRS 
image from the keratin in nail is shown in the far left panel (labelled as ‘Nail’), while 
the background, off-resonance control is to the immediate right (labelled as ‘OR’). Scale 
bar = 20 µm. 
 
2.3.4 Penetration of topically-applied PG-d8 and DMSO-d6 into the nail as a 
function of time 
To follow the penetration of PG-d8 and DMSO-d6 into the nail, SRS imaging at 2120 
cm-1 (the -CD2 stretching vibration) was performed. At each time point, as the diffusion 
of these solvents was much slower than that of D2O, images were also recorded for the 
nail (-CH2 at 2855 cm-1) and off-resonance (1802 cm-1). In this case, x-y planar images 
(353 )m x 353 )m) were captured every 1 )m in the z-direction at each measurement 
time. The scan time for each frame was 18.4 seconds. 
The time-courses of PG-d8 and DMSO-d6 absorption into the nail as a function of depth 
are shown in Figure 2.4. While the -CH2 signal from the nail is relatively constant, the 
shorter time measurements (t / 8 hours) reveal that uptake of PG and DMSO occurs 
only into the outer 15-20 )m of the nail. Only after about a day have the two solvents 
reached a depth of about 40-50 )m into the nail. Figure 2.5 illustrates an alternative, 
cross-sectional (x-z) view of PG and DMSO penetration that enables direct visualization 








of PG and DMSO is substantially less than that of D2O (which had permeated 100 )m 
in only ~30 minutes), the molecular size of which is about one-quarter of that of the two 
other solvents: the molecular weights of water, PG and DMSO are 18.0, 76.1 and 78.1, 
respectively; the corresponding molar volumes are 18.0, 73.4 and 71.0 cm3. The 
relatively poorer uptake of PG and DMSO into the nail has been reported (15, 16) and 
their penetration-enhancing abilities are less than clear-cut (16, 17). Rotating 3D 
composite images showing the progressive penetration of PG-d8 and DMSO-d6 into the 


































Figure 2.4: SRS x-y planar images of the penetration of (A) PG-d8 (blue), and (B) 
DMSO-d6 (green) into the nail (red) as a function of time and depth. OR shows the off-
resonance background. Depths of images are indicated along the top while the 
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Figure 2.5: SRS x-z orthogonal sections showing the diffusion of (A) PG-d8 (blue), and 
(B) DMSO-d6 (green) into the nail (red) at various times post-application. Composite 
images show the superposition of -CH2 and -CD2 signals. Scale bar = 50 µm. 
 
2.3.5 SRS signal analysis and interpretation 
To better interpret the results obtained, an attempt to more quantitatively analyse the 
SRS signals (specifically, the measured pixel intensities) from the three solvents was 
undertaken. To do so required a number of potentially confounding factors to be 
addressed, including: (a) definition of the nail surface, (b) fluctuations in SRS laser 
intensity, (c) movement of the sample (e.g., due to swelling), (d) artefacts caused by 
residual particulate matter on the nail, (e) variable off-resonance background signal, and 
(f) confirmation that no significant depletion of solvent at the nail surface had occurred 
by the end of the experiment. 
Because of the natural curvature of the human nail, it is clear that a z-series of x-y 
planar images will not sample the same depth across the entire sample (see Figure 2.6) 
and it was therefore decided to define a virtual surface using the intensity of the -CH2 
signal from nail protein. To do so, 5 regions of the examined nail (35.3 x 35.3 µm2 x-y 
planes for PG and DMSO, 20 µm sections for D2O) were delimited avoiding those 
where either particulate matter or an air bubble in the solvent on the nail clearly 
interfered with the image. For each selected region, the nail surface was defined when 





on one horizontal line (Figure 2.6). This procedure also allowed for correction of any 
sample movement (typically no more than 1-2 µm) to be made as well. The small 
background off-resonance signal, when present, was subtracted from -CH2 and O-D/-
CD2 signals in each image. The average pixel density of the solvent (as a function of 
depth into the nail) was then normalized by that at the defined surface (z = 0 µm), i.e., 
all signals from the solvents were then expressed as a fraction of that at the surface 
reflecting, in theory at least, a relative concentration profile of the compound across the 
nail. The solvent signals at the nail surface did not decay significantly over the time-
course of the experiments confirming that no appreciable depletion had occurred and 
that an effectively infinite dose had been applied to the nail.  
 
 
Figure 2.6: Schematic diagram illustrating the creation of a horizontal nail surface using 
the intensity of the -CH2 signal from nail protein (red) when treated with a solvent 
(blue). This method was adopted to define z = 0 µm. 
 
Nevertheless, despite these efforts to enable more quantitative analysis of the SRS 
imaging results, there remains the unresolved issue of signal attenuation with increasing 
depth into the nail due to light absorption and scattering (a problem ubiquitous to 
confocal imaging). For the moment, no satisfactory and validated approach has been 
developed to circumvent this limitation and it must be recognized that the signals 
emanating from deeper into the nail almost certainly reflect under-estimates of the 
actual amount of chemical present. 
While fully appreciating this constraint, the average pixel intensity data extracted from 
the SRS images are presented graphically in Figure 2.7. The error bars (standard 
deviations) reflect the variability observed across the 5 sampled regions of the nail. This, 
at best, semi-quantitative representation of the results offers useful insight into solvent 
diffusion across the nail as a function of time and position. At shorter time points, the 











diffusion into a semi-infinite medium (18). However, clear deviation from this classic 
model is observed as the time of diffusion increases and distortion of the concentration 
profile of PG and DMSO at t , 1 day, for example, are clearly apparent with more 
solvent taken up than would be expected from simple Fickian diffusion (and recall that 











Figure 2.7: Normalized SRS signal versus nail depth profiles for D2O, PG and DMSO 
as a function of time post-application (n = 5, mean + SD). 
 
Further understanding of the SRS signal profiles is accessible by comparing their 
progressive deviation from the solution to Fick’s 2nd law of diffusion for the semi-




















































































































infinite approximation, i.e., treating the nail as a homogenous plane sheet, with the 
boundary conditions: (i) the normalized solvent signal (S/Sz=0) at the nail surface (z = 0) 
equals 1 at all times, t 0 0, (ii) at t = 0, S/Sz=0 = 0 at z > 0, and (iii) at t 0 0, S/Sz=0 = 0 at 
z = 1. In other words, first, during the course of the experiment, there is a constant 
source of solvent on the nail surface. Second, initially, there is no solvent in the nail. 
And, third, the nail can be considered infinitely thick such that no solvent diffuses all 
the way through during the observation period. 
With these constraints, Fick’s 2nd law can be solved analytically (18) to yield the 
following expression for the evolution of the SRS profiles as a function of time and 
position:  
 
 (Eq. 2.1) 
 
where Di is the solvent diffusivity. As stated above, the shortest time SRS signal 
profiles for the three solvents reasonably followed this monotonic decay function and 
fitting these data to Eq. 2.1 permitted, therefore, an initial value of the solvents’ 
diffusivities to be deduced; the results are in Table 2.1. Notably, the estimated value for 
water is ~40-fold and 25-fold greater than those for PG and DMSO, respectively. 
 
Table 2.1: Solvent diffusivities (mean ± SD; n = 5) deduced from fitting the shortest 
time SRS signal profiles in Figure 2.7 to Eq. 2.1. 
Solvent x1011 Di (cm2 s-1) r2 
D2O 124 ± 60 0.82 – 0.99 
PG-d8 3.07 ± 0.82 0.99 – 1.00 
DMSO-d6 5.02 ± 0.76 0.97 – 0.99 
 
To examine the extent to which the evolution of the SRS signal profiles for the solvents 
subsequently deviated from Eq. 2.1, the data in Figure 2.7 were plotted against the 
normalized parameter, z/(4Dit)2 (18). If the solvent diffusivity remains constant over 
time and position, the profiles as a function of time should be aligned and overlap. 
However, the outcome of this approach (Figure 2.8) shows that this is clearly not the 
case. For D2O, there is already a shift in the profile by 15 minutes, and the deviation 
becomes more pronounced as time increases further. The behaviour observed is 















Rapid nail hydration when immersed in water is well known, and the resulting 
swelling/opening of the keratin structure is manifested by an uptake-dependent increase 
in diffusivity (2). Notably, the diffusion of water is substantially faster than that of the 
other two solvents examined. For PG, the normalized profiles overlapped during the 
first 7 hours of transport, but had clearly deviated by ~1 day, when an obvious ‘shoulder’ 
in the data had appeared (Figure 2.7 and Figure 2.8). The same behaviour was seen for 
DMSO although the deviation began sooner than that for PG. Like water, therefore, the 
results suggest strongly that the progressive uptake of the solvents impacts upon the nail 
structure and facilitates enhanced diffusion. The much swifter passage of water, relative 
to the other two solvents, despite only a 4-fold difference in molar volumes, implies that 
there must be a strong size-dependence to at least one transport pathway across the nail 
that is accessible to water but excludes PG and DMSO. 
The non-ideal diffusion of the solvents across the nail can also be illustrated by 
comparing the areas under the SRS signal profiles in Figure 2.7 with those which would 
have been observed had the transport been purely Fickian with a constant value of Di 
(i.e., following Eq. 2.1). Figure 2.9 shows the outcome of this analysis and highlights 
the evolution and extent of the deviation for each of the three solvents. As described 
above, the impact of water on its own transport is substantial and almost immediate, 
while those of PG and DMSO are more subtle at first, and become more noticeable at 
















Figure 2.8: Normalized SRS signal of D2O, PG and DMSO as a function of the 
composite variable, z/(4Dit)2, using the value of Di deduced from the earliest 
measurements for each solvent. For each solvent, the fits shown were obtained using the 
mean data (n = 5) and the LOWESS (fine) curve fit function in GraphPad Prism®. 
 
 





















































































































Figure 2.9: Areas under the measured SRS signal versus depth profiles (AUC) in Figure 
2.7 (red circles) compared with the corresponding values (black squares) predicted from 
Eq. 2.1 assuming constant values for the solvent diffusivities (mean + SD; n = 5). 
 
SEM images of control nail samples and of those exposed to the three solvents for 24 
hours are shown in Figure 2.10. The untreated nail surface is compact and relatively 
smooth, while solvent treatment appears to have loosened the structure and markedly 
increased surface roughness. It may be inferred, therefore, that the integrity of the outer 
nail has been compromised, at least to some extent, and this is consistent with recent 
research reporting an increase in surface porosity with hydration (19). Further precise 
details as to the molecular mechanism by which the uptake of a solvent facilitates its 
own diffusion across the nail cannot be deduced from the results obtained. Nonetheless, 
the SRS signal profiles, even with the important caveat that light absorption and 
scattering prevent any absolute quantification of the results, are fully consistent with the 
diffusivity of the solvents in the nail exhibiting concentration-dependent behaviour, a 
phenomenon that appears to be common (at least for water) across other keratinized 
tissues, such as hair and the stratum corneum (2, 20). It is worth noting that (because of 
the absorption/scattering limitation) that the effects observed and reported here are 
probably greater than those deduced from the results. Whether the solvent diffusional 
front proceeds uniformly and enhanced transport occurs in a similar fashion across the 
entire nail, or whether there are solvent ‘channels’ opened up at weak points in the 
barrier with increasing time of exposure to provide lower resistance pathways, remains 
to be seen. 
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Figure 2.10: SEM images of the dorsal nail surface, either untreated or exposed to water, 
PG or DMSO for 24 hours. The scale bars are 50 µm for the 4 panels on the left, and 10 
µm for those on the right. 
 
2.4 Conclusions 
SRS microscopy has been successfully used to unambiguously visualize the uptake of 
water, propylene glycol (PG) and dimethyl sulphoxide (DMSO) into the human nail 
plate and to characterize the diffusion of these solvents across the tissue. Analysis of the 
SRS signal profiles revealed the much faster transport of water through the nail, relative 
to PG and DMSO. Furthermore, the results demonstrate that all three solvents 
progressively enhance their own diffusion through the nail: as more solvent is taken up, 
there is a distinct deviation from simple Fickian behaviour. This concentration-





surface that indicates each solvent’s ability to undermine the integrity of the tissue. 
Although the conclusions drawn can be only semi-quantitative in nature because the 
SRS signal profiles are attenuated (due to light absorption and scattering) as a function 
of depth into the nail, the interpretation of the effects observed is not altered by this 
limitation – indeed, if anything, the scale of the solvents’ deduced impact on the nail is 
almost certainly under-estimated. 
The research described is significant as it offers insight into the practical challenge of 
drug formulation for the treatment of nail disease, an important unmet medical need. 
The substantial barrier properties of the nail mean that the rate and extent at which 
topically applied drugs can reach (e.g., fungal) targets in the nail plate are very limited. 
The results presented here show that optimization of delivery platforms to the nail must 
prolong and sustain exposure of the barrier to excipients, such as common solvents like 
water, PG and DMSO, that can facilitate both drug and their own transport. In this way, 
it is envisaged, it should be possible to develop new and improved formulations that 
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Chapter 3 : Topical application of nanoparticles and an 
associated lipophilic dye to the nail 
 
Overview 
Purpose: To investigate the use of poly (methyl methacrylate) (PMMA) and poly 
(methyl methacrylate-co-butyl methacrylate) P(MMA-co-BMA) nanoparticles (NPs) as 
drug reservoirs for sustained topical drug delivery into the human nail plate.  
Methods: The NPs were labelled with fluorescein methacrylate (FMA) and loaded with 
a lipophilic fluorophore, Nile red (NR). The size and morphology of NPs were 
characterized by dynamic light scattering and transmission electron microscopy. The 
disposition of the NPs and NR following topical application to the nail in vitro was 
imaged by laser scanning confocal microscopy (LSCM). An in vitro skin permeation 
experiment was also performed for comparative purposes. Finally, the release of NR 
from the NP suspension into a lipophilic medium (isopropyl myristate, IPM) was 
determined. 
Results: Spherical NPs were produced with diameters of ~20 nm. Confocal images 
showed clearly that both types of NPs located only at the nail surface after 7 days of 
application, with co-localization of fluorescein-labelled NPs and NR observed. Results 
from the skin experiments were similar. Consistent with these findings, negligible 
release of NR into IPM from the NPs occurred. 
Conclusions: As anticipated, there was no evidence that even the very small NPs 
considered were able to penetrate into the nail. Instead, they remained at the surface 
where they retained NR, lipophilic model drug employed. Unfortunately, the affinity of 
NR for the poly-methacrylate-based NPs was such that no release into the nail (or, 
indeed, into a simple IPM receive medium) took place. Further work should therefore 
focus on modifying the NP polymer properties. 
 






Polymeric nanoparticles (NPs)-based drug delivery systems have attracted much 
discussion in the skin research field, especially with respect to their claimed ability to 
enhance the uptake/absorption of various compounds, including anti-inflammatory 
drugs (1, 2), antimicrobials (3, 4), hair growing promoters (5), sunscreens (6, 7), and 
even insulin (8). NPs offer the potential to mask unfavourable physicochemical 
properties of the encapsulated active (e.g. poor solubility), improve drug stability and 
enhance topical delivery (9). NPs have been shown to increase a drug’s residence time 
on the skin at the very least by accumulation on, or near, the surface, within the 
crevasses of the tissue, and via sequestration in and around hair follicles. An obvious 
advantage is that the particles can act as drug reservoirs, maintaining the incorporated 
active in a diffusible form which can be released and partition into the skin over a long 
period of time (3, 10-13). Conventional topical nail formulations have limited 
usefulness, due to both immobilization of drug once the volatile solvent in the 
formulation has evaporated, and the low diffusivity of drug across the compact 
keratinized structure of the nail plate. Exploitation of the reservoir potential of NPs has 
not been explored on the nail, however, and this study aimed, therefore, to examine 
whether sustained drug delivery into the nail might be possible from these polymeric 
structures. 
In this study, NPs made of biocompatible methacrylate-based polymers were 
investigated. Methacrylate polymers have low toxicity and are commonly used as 
adhesive in the transdermal patch formulations (14). Here, poly (methyl methacrylate) 
(PMMA) and poly (methyl methacrylate-co-butyl methacrylate) P(MMA-co-BMA) NPs 
were synthesized using a microemulsion polymerization method, which has been widely 
adopted for the production of stable latex particles (diameter 10-100 nm) with narrow 
size distributions (15). The polymers were fluorescently-labelled by covalent attachment 
of fluorescein methacrylate (FMA) and particles were loaded with another fluorophore, 
Nile red (NR) (Figure 3.1), which acted as a lipophilic model drug for the purpose of 
this study. Laser scanning confocal microscopy (LSCM) was used to visualize the dual-
labelled NPs following their topical application to the nail plate. A skin permeation 








Figure 3.1: Structure of NR. Molecular weight = 318 Da; average of predicted LogP 
(ALOGPS 2.1 program (16)) is 4.07 ± 0.26. 
 
3.2 Materials and methods 
3.2.1 Chemicals 
Methyl methacrylate (MMA, 99%, contains / 30 ppm monoethyl hydroquinone as 
inhibitors), butyl methacrylate (BMA, 99%, contains 10 ppm monomethyl ether 
hydroquinone as inhibitors), fluorescein methacrylate (FMA, 97% pure), Nile red (NR, 
analytical grade), sodium dodecyl sulphate (SDS, 098.5% GC), potassium persulphate 
(KPS), propylene glycol (PG) and isopropyl myristate (IPM) were purchased from 
Sigma-Aldrich Co. (Gillingham, UK).  
 
3.2.2 Nail sample preparation 
Human fingernail clippings (at least 8 mm in length) were obtained from healthy 
volunteers who gave informed consent. Ethical approval was granted by the Research 
Ethics Approval Committee for Health (REACH) (Forms in Appendix 1) of the 
University of Bath. Nails were maintained frozen (-20o C) until use. Prior to the 
experiments, the nail was soaked in deionized water for 30 minutes to restore some 
flexibility, and then mounted in a specially adapted Franz cell (PermeGear Inc., 
Bethlehem, PA, USA) with a diffusion area 0.2 cm2.  
 
3.2.3 Skin tissue 
Porcine skin was obtained from a local slaughterhouse. After cleaning and trimming off 
coarse hairs, the tissue was dermatomed to a nominal thickness of ~750 µm. The skin 
was then frozen at -20o C until use. Before the permeation experiment, the skin was 
thawed and any (remaining) finer hairs were carefully trimmed as close as possible to 






3.2.4 Nanoparticle preparation 
Fluorescein-labelled NPs were prepared by free radical emulsion polymerization (15, 17) 
(Figure 3.2). Monomers, MMA and BMA, were first purified by passing through an 
inhibitor remover column (Sigma-Aldrich, Gillingham, UK). The aqueous phase was a 
0.5% w/v solution of SDS, deoxygenated with nitrogen gas. NR (0.1% w/v) was added 
to the monomer mixture, which comprised FMA (0.06% w/v) in either MMA or 50/50 
by weight MMA/BMA. This solution was added to the aqueous phase and an emulsion, 
containing 6.5% w/v of the organic phase, was formed with vigorous stirring. This 
emulsion was then heated to ~75o C and KPS (0.1% w/v), a free radical initiator 
dissolved in a small amount of water, was introduced to start the polymerization process. 
The reaction was allowed to proceed at constant temperature under nitrogen for 3 hours. 
The resulting NP suspension was then filtered (0.45µm nylon filters, Whatman, 
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Figure 3.2: Polymerization of (a) FMA and MMA, and (b) FMA, MMA and BMA. 
 
3.2.5 Nanoparticle characterization 
The average NP diameters were determined using dynamic light scattering (DLS) 
(ZetaSizer Nano S, Malvern, UK). The polydispersity index (from 0 to 1), which 
describes the particle size distribution, was also measured where a value of 0 indicates a 
monoparticle size distribution, while a value of 1 implies a large variation in particle 
sizes. Measurements were made in triplicate for each sample. The morphology of the 
NPs was studied by drop-casting the suspension onto a carbon coated copper grid and 
KPS 
KPS 
75o C, 3 h 





imaged using transmission electron microscopy (TEM) (JEOL JEM-2000, JEOL Ltd., 
Tokyo, Japan). Negative staining with uranyl acetate was emplyed to improve the 
contrast of the TEM images.  
 
3.2.6 In vitro nail and skin permeation studies 
Nail permeation experiments were performed using vertical Franz diffusion cells 
(PermeGear Inc., Bethlehem, PA, USA) (Figure 3.3). The nail clipping was mounted in 
the nail adaptor with the dorsal surface facing the donor chamber, while the ventral side 
was fully hydrated by the pH 7.4 phosphate buffer solution (PBS). 300 µL of the NP 
suspension was introduced into the donor compartment, which was covered with 
Parafilm® to avoid excessive evaporation. The entire diffusion cell was then placed in 
an incubator at 32o C. Nails were also treated with deionized water and with a solution 
of NR in PG (90% saturation) (6) as negative and positive controls, respectively. After 7 
days, the diffusion cell was dismantled and excess formulation at the surface was 
removed gently with absorbent tissue. The treated nail was then immediately examined 
by LSCM. Skin permeation experiments were performed in the same way without using 
the nail adaptor. The tissue was sandwiched directly between the donor and the receptor 
chamber (2 cm2 diffusion area) and the application time was 16 hours.  
 
 
Figure 3.3: Vertical Franz diffusion cell as used in the nail permeation experiments. 
 
3.2.7 LSCM imaging 
An LSCM 510Meta inverted laser scanning microscope (Carl Zeiss, Jena, Germany) 
was used. An argon laser (488 nm) and a HeNe laser (543 nm) were used to excite 
fluorescein and NR, respectively. The corresponding emission signals were collected 
using a BP 505-530 (green) and LP 560 (red) filters. Dorsal and transversal confocal 





Dorsal images were acquired using an EC Plan-Neo 40x/1.3 M27 oil objective. Optical-
section x-y planar images were obtained every 2 µm in z-direction. To obtain a direct 
transversal view of the nail, a Plan-Apochromat 10x/0.45 M27 air objective was 
employed. The treated nail was sectioned into thin slices, which were then glued to a 
microscope slide with the cross-section orientated towards the objective. All transverse 
images were taken at a few microns below the cut surface to avoid any artefact caused 
by sectioning. For the skin samples, a Plan-Apochromat 63x/1.4 oil DIC M27 oil 
objective was used for imaging and optical sectioning was performed every 1 µm into 
the sample. To rule out the possible interference from the nail/skin auto-fluorescence, 
the laser power and detector settings were minimized so that no signal was detectable 
from the untreated control. Reflectance and/or optical images were captured 
simultaneously to image the nail. All images were processed using ImageJ software (US 
National Institutes and Health, USA). 
 
3.2.8 In vitro release of NR from NP suspension 
The release of NR from the NPs into an oil phase, IPM, was quantified in a membrane-
less system. 0.5 mL of a NP aqueous suspension was placed in an Eppendorf tube which 
was filled with 4.5 mL of IPM. The system was constantly stirred and the oil phase was 
sampled at fixed time intervals and assayed for NR content.  
 
3.2.9 High performance liquid chromatography (HPLC)  
NR was quantified using HPLC-fluorescence detector (Dionex, Sunnyvale, CA, USA). 
A HiQ sil C18W 250x4.6 mm column (KYA Tech, Tokyo, Japan) was employed and 
the mobile phase was methanol-water (95:5) at a flow rate of 1 mL/min. The excitation 
and emission wavelengths were set at 559 nm and 630 nm, respectively. The injection 
volume was 20 )L and the system was maintained at 25o C. The NR retention time was 
6.5 minutes. The limits of detection and quantification were 12.7 ng/mL and 38.6 
ng/mL, respectively.  
 
3.3 Results  
3.3.1 Particles characterization 
The particle size and the polydispersity indices of the prepared PMMA and P(MMA-co-





TEM images (Figure 3.5) showed monomodal size distributions and that individual NPs 
were spherical and of a size that correlated well with the DLS measurements.  
 
Table 3.1: Properties of NPs. 
NP formulation Dyes Mean size (nm) Polydispersity 
PMMA FMA and NR 20 ± 0.18 0.158 ± 0.014 




















3.3.2 LSCM imaging  
FMA is a fluorescently labelled methacrylate monomer. During NP preparation, FMA 
reacts with MMA and/or BMA, forming homo- or co-polymers that fluoresce green 
when excited at 488 nm laser. NR is a lipophilic, model ‘active’ which, when excited at 
543 nm, shows an intense red fluorescence. Using the multi-tracking-mode, the 
localization of both fluorophores was imaged simultaneously. The nail or skin surface 
was morphologically identified in the reflectance images. 
Figure 3.6 shows the x-y planar images from nails with the dual fluorophore-labelled 
NPs and the NR-PG solution. Co-localization of green and red fluorescence is observed 
for both NP formulations with the signals decaying rapidly with increasing depth into 
the nail. On the other hand, NR signal is captured across the entire imaging depth in the 
NR-PG treated nail sample. Because of the natural curvature of the nail, the apparent 
penetration depths in the x-y images may not be accurate reflections of reality. For this 
reason, the planar images were first reconstructed into an x-z cross-sectional view. The 
result (Figure 3.7) indicates that all fluorescence signals from the NPs are constrained to 
the nail surface with no separation of NR from the NPs. In contrast, from the NR-PG 
solution, the fluorophore penetrated to a distance of ~100 )m into the nail. Essentially 
identical results were obtained from nails which were physically sectioned and 





















Figure 3.6: Planar images as a function of depth into the nail after treatment with (a) 
PMMA NPs, (b) P(MMA-co-BMA) NPs and (c) NR-PG solution for 7 days. Panel a1, 
b1 show red fluorescence from NR. Panel a2, b2 show green fluorescence from NPs. 
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Figure 3.7: Reconstructed cross-sectional images of nails 7 days post-treatment. Panel 
(a) presents the reflectance signal from the nail and the glass coverslip (above). Panel (b) 
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Figure 3.8: Images of transversally sectioned nails showing the localization of 
flurophores after the 7-day permeation study. Panel (a) presents the optical micrographs 
of the nail. Panel (b) shows the red fluorescence from NR. Panel (c) indicates green 
fluorescence from NPs. Scale bars = 200 µm. 
 
The disposition of NPs and the associated dye when applied to the skin were studied for 
comparative purposes. Localization of NPs and NR in skin furrows is directly observed 
for both PMMA and P(MMA-co-BMA) (Figure 3.9). Fluorescence from within the skin 
was insignificant. In contrast, the penetration of NR from a simple solution in PG into 
the lipid-rich intercellular domains of the stratum corneum (SC), outlining the 
polygonal shapes of the corneocytes, was clearly visible. Figure 3.10 illustrates the re-
constructed cross-sectional views, which confirm what is seen in the x-y serial images: 
the NPs and their associated NR remain exclusively at the skin surface, while NR 
partitions into, and diffuses through, the SC when applied as a solution in PG. The 
minimal dissociation of the dye from the PMMA and P(MMA-co-BMA) NPs is 
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Figure 3.9: x-y planar images obtained following 16 hours treatment of skin with NPs 
containing NR and with a solution of NR in PG. Panel (a) presents the reflectance signal 
from the skin. Panel (b) shows red fluorescence from NR. Panel (c) indicates the green 
signal from the NPs. Scale bars = 50 µm. 
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Figure 3.10: Reconstructed cross-sectional images obtained following 16 hours 
treatment of skin with NPs containing NR and with a solution of NR in PG. Panel (a) 
presents the reflectance signal from the skin and the glass coverslip (above). Panel (b) 
shows red fluorescence from NR. Panel (c) indicates the green signal of the NPs. Scale 






3.3.3 NR release from NPs 
The release of NR from NPs into an oil phase (IPM) was studied. However, even after 7 
days, the amount of NR found in the receptor medium was below the limit of detection 
(Figure 3.11). Despite good solubility of NR in IPM, it is clear that the dye preferred to 
remain with the NPs.  
 
 
Figure 3.11: Illustration of NR (non)-release from PMMA (left) and P(MMA-co-BMA) 




The results confirm that the NPs studied, despite their rather small diameters of only 
~20 nm, are unable to penetrate into the nail or the skin. There is simply insufficient 
free volume, either trans- or inter-cellularly, to allow translocation to occur (18-21). 
Such polymeric NPs cannot, therefore, act as drug ‘carriers’ across either the skin or 
nail.  
The potential exists, however, for the methacrylate-based NPs to act as drug reservoirs 
for topical delivery to the nail. This was explored here using LSCM to track the 
disposition of a model, lipophilic ‘active’ (NR) after topical application of two NP 
formulations. Unfortunately, NR separation from the NPs did not occur (as was also the 
case in simple NR release experiments) suggesting a very high affinity of the dye for the 
complex interplay of various parameters, including the molecule’s physicochemical 
properties, its interaction with the polymer, how it distributes within the system 
(adhesion to the surface, entrapment in the polymer matrix or combination of both), 
properties of the NPs themselves (hydrophobicity, hydrophilicity, rigidity and 








of NR release obtained here may be a consequence of several factors. For example, the 
highly hydrophobic nature of the polymers may serve as a good solvent for NR (22), 
resulting in a very low leaving tendency. It is also possible that the relatively high glass 
transition temperatures (Tg) of PMMA and P(MMA-co-BMA 50/50) (103 o C and 50o C, 
respectively (15)) renders their solid cores too rigid for ‘leakage’ of the entrapped NR to 
occur. Furthermore, the presence of the anionic surfactant, SDS, may create an electrical 
double layer (23) around the NPs conferring high stability to the suspension and 
inhibiting the partitioning out of NR into the surrounding environments.  
 
3.5  Conclusions 
Small (~20 nm) PMMA and P(MMA-co-BMA) NPs when applied to the nail for a 
period of 7 days remained on the surface. The same behaviour was seen on skin, albeit 
for a shorter exposure time (16 hours). The potential value of the NPs as reservoirs from 
which to sustain drug delivery over a prolonged period could not be determined, 
however, because of the high affinity of the lipophilic ‘active’ for the particles used in 
this work. It follows that further work is required using less hydrophobic actives and 
modifying the NP polymer properties to lower the glass transition temperature closer to, 
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Purpose: To demonstrate the sustained release of an active from poly(!-caprolactone) 
nanoparticles (NPs) into microneedle-treated human nail.  
Methods: NPs were prepared and loaded with a model active, the lipophilic fluorophore, 
Nile red (NR). NP size and morphology were determined by dynamic light scattering 
and transmission electron microscopy, and the in vitro release of NR from a NP 
suspension was characterized. The disposition of NR following topical application to 
intact nail and to nail porated with microneedles was imaged using laser scanning 
confocal microscopy (LSCM) as a function of time over 7 days. 
Results: The polymeric NPs were spherical with diameters of ~150 nm. Post-
application to the nail, sustained release of NR from the NPs were observed. Confocal 
imaging clearly showed NR localization between the nail plate cells. Microneedle-
created pores shortened the penetration pathway of the active across the nail, and 
permitted lateral diffusion of NR to occur more rapidly into the deeper regions of the 
nail. 
Conclusions: Sustained NR delivery into the nail from polymeric NPs was achieved. 
The model active penetrated the nail via an intercellular penetration route. When the 
nail was pre-treated with microneedles, NR delivery was clearly enhanced. The NPs 
appeared to accumulate both on the nail surface and within the microneedle-generated 
pores, from which the loaded active was released and diffused laterally into the nail. 






Biocompatible and biodegradable polymeric nanoparticles (NPs) have been proposed as 
constituents of topical formulations to act as drug reservoirs from which sustained 
delivery into the skin and increased local bioavailability can be achieved (1-3). The 
objective of the research described in this paper is to examine whether this strategy 
might be applied to improve the treatment of nail diseases. On the skin, the highly 
convoluted surface, and the entrances to appendageal structures, such as follicles, offer 
sites at which NPs can accumulate with prolonged residence times during which release 
of their drug payload is possible. In contrast, the nail surface has a less dramatic 
topography and is self-evidently not perforated by hairs or sweat glands. To provide 
sites in the nail into which drug-loaded NPs can be sequestered, pre-treatment with a 
microneedle array is considered here. This ‘poration’ approach has, of course, been the 
subject of intensive study with respect to drug delivery into and through the skin, where 
piercing the stratum corneum creates new, low-resistance pathways through which the 
active may gain facile and rapid access to the underlying viable epidermis (and, 
ultimately, the systemic circulation) (4). While it is unlikely that a microneedle array 
can completely penetrate through the nail, the opportunity exists to create fissures into 
which NPs may be deposited, and from which a prolonged and slow release of an active 
can then occur.  
In this study described below, NPs were prepared from poly(!-caprolactone) (PCL), a 
hydrophobic, biocompatible and biodegradable semi-crystalline polymer. Drug release 
from these NPs is generally efficient due to the polymer’s low glass transition 
temperature (Tg = -60o C). For this reason, PCL has been frequently used in the 
formation of colloidal vectors (5), and NPs prepared from this polymer are stable (6), 
have successfully encapsulated various drugs, and have sustained and enhanced drug 
delivery into the skin (7-9). Here, NPs were synthesized from PCL using a solvent 
displacement (or nanoprecipitation) method (10). This is a simple, reproducible method, 
which has been widely adopted for the production of nanospheres or nanocapsules. Nile 
red (NR), acting as a lipophilic model drug, was incorporated into the NPs, and laser 
scanning confocal microscopy (LSCM) was employed to visualize the distribution of 






4.2 Materials and methods 
4.2.1 Chemicals 
Preformed polymer PCL (MW: 10,000), polysorbate 85 (Tween 85), NR (analytical 
grade), propylene glycol (PG) and isopropyl myristate (IPM) were obtained from 
Sigma-Aldrich Co. (Gillingham, UK).  
 
4.2.2 Nail sample preparation 
Human fingernail clippings (at least 8 mm in length) were obtained from healthy 
volunteers who gave informed consent. Ethical approval was granted by the Research 
Ethics Approval Committee for Health (REACH; EP 11/12 115) of the University of 
Bath (Forms in Appendix 1). Nails were maintained frozen (-20o C) until use. Prior to 
the experiments, the nail was soaked in deionized water for 30 minutes to restore some 
flexibility. Microporation was performed using a commercially available dermaroller 
(Infinitive beauty®, Birmingham, UK), comprising 250 µm long titanium needles, which 
was applied to the dorsal side of the hydrated nail by rolling it back and forth a total of 5 
times.  
 
4.2.3 Nanoparticle preparation 
NR-loaded PCL NPs were prepared by solvent displacement method (7). An acetone 
solution (10 mL) containing 5 mg of NR and 125 mg of PCL was injected drop-wise 
into 50 mL of an aqueous solution containing 3% (w/v) of Tween 85. NPs were formed 
rapidly, creating an opalescence suspension. The acetone was subsequently removed 
under reduced pressure and the NP suspension was further concentrated to a final 
volume of 20-30 mL, which was then filtered (0.45 µm nylon filters, Whatman, 
Maidstone, UK) to remove any un-encapsulated precipitated aggregates.  
 
4.2.4 Nanoparticle characterization 
The nanoparticle size and polydispersity index were measured (n=3) using dynamic 
light scattering (ZetaSizer Nano S, Malvern, UK), following a 100-fold dilution of the 
suspension.  
NP morphology was imaged using a JEOL JEM-2000 transmission electron microscope 
(TEM) (JEOL Ltd., Tokyo, Japan) at an accelerating voltage of 120 kV. Each specimen 
was prepared by drop-casting the NP suspension onto a carbon coated copper grid, 





The amount of NR entrapped in the NPs was calculated from the difference between the 
quantity found after complete dissolution of the particles in acetonitrile (Qtot), and that 
in the aqueous supernatant (Qsup) after ultrafiltration-centrifugation of the suspension at 
6000 rpm for 30 minutes (MWCO 3000, Millipore Corp., Watford, UK). All 
experiments were performed in triplicate. The entrapment efficiency (%) was given by: 
{100 x [(Qtot - Qsup) / Qinput]}, where Qinput represents the amount of NR used in the 
preparation process. 
 
4.2.5 NR release  
NR release from the NPs into an oil phase was quantified in a membrane-less system. 
0.5 mL of an aqueous NP suspension was placed in an Eppendorf tube and 4.5 mL of 
isopropyl myristate (IPM) was added. The system was constantly stirred and the oil 
phase was sampled at fixed time intervals. Subsequently, the samples were assayed for 
NR content. The release of NR from a solution in PG (at the equivalent NR 
concentration as in the NP suspension) was performed as a positive control.  
To obtain the solubility of NR in IPM, a saturated solution was prepared by stirring 
excess solute into the solvent over a period of 48 hours. The final suspension was then 
filtered through a nylon membrane (pore size = 0.45 µm) and the concentration of NR in 
the filtrate was quantified (n=3). 
 
4.2.6 High performance liquid chromatography (HPLC) 
NR was quantified using HPLC-fluorescence detector (Dionex, Sunnyvale, CA, USA). 
A HiQ sil C18W 250 x 4.6 mm column (KYA Tech, Tokyo, Japan) was employed and 
the mobile phase was methanol-water (95:5) at a flow rate of 1 mL/min. The excitation 
and emission wavelengths were set at 559 nm and 630 nm, respectively. The injection 
volume was 20 )L and the system was maintained at 25o C. The NR retention time was 
6.5 minutes. The limits of detection and quantification were 12.7 and 38.6 ng/mL, 
respectively.  
 
4.2.7 In vitro nail permeation  
NR uptake into non-porated nail was first evaluated in vertical Franz diffusion cells 
(PermeGear Inc., Bethlehem, PA, USA, diffusion area = 0.2 cm2). The nail was 
mounted with the dorsal surface facing the donor chamber; whereas the ventral side was 





300 µL of the NP suspension was then introduced into the donor compartment, which 
was covered with Parafilm® to avoid evaporation. The entire diffusion cell was then 
placed in an incubator at 32° C. Nails treated with deionized water served as negative 
controls. After 7 days, the diffusion cell was dismantled and excess formulation at the 
surface was removed gently with absorbent tissue. The nail was then immediately 
examined by LSCM. 
NR uptake as a function of time into microneedle-porated nail was then accessed after 
application of 10 µL of the NP suspension onto the dorsal surface of the samples, which 
were then sandwiched between two glass coverslips and sealed securely with double-
sided tapes and Parafilm® to avoid evaporation. Confocal images of selected regions of 
interest were then recorded as a function of time. Identical control experiments were 
performed using untreated nails. 
 
4.2.8  LSCM imaging 
An inverted laser scanning microscope (510Meta, Carl Zeiss, Jena, Germany) was used. 
A HeNe laser (543 nm) was employed to excite NR and the emission signals were 
collected using a LP 560 filter. Planar (x-y) and cross-sectional confocal images were 
captured to assess the localization of the fluorophore on or within the nail. Dorsal 
images were acquired using an oil objective (EC Plan-Neo 40x/1.3 M27). To obtain a 
direct transverse view of the nail, an air objective (Plan-Apochromat 10x/0.45 M27) 
was employed. In this case, the treated nail was thinly sectioned and the slices were then 
glued to a microscope slide with the cross-section orientated towards the objective. All 
transverse images were recorded from a few microns below the cut surface to avoid any 
artefact caused by the sectioning. To rule out interference from the nail auto-
fluorescence, the laser power and detector settings were minimized so that no signal was 
detectable from the untreated control. Reflectance and/or optical images were captured 
simultaneously to image the nail. 
 
4.2.9 Data analysis 
All confocal images were processed using ImageJ software (US National Institutes and 
Health, USA). Fluorescence signal quantification at various nail depths was performed 






4.3 Results and discussion 
4.3.1 Nanoparticle characterization 
The average NP diameter was 152 ± 3 nm with a relatively small polydispersity index 
of 0.149 ± 0.0076 (Figure 4.1); the individual particles were spherical (Figure 4.2). The 
encapsulation efficiency of NR in the polymeric NPs was 89 ± 0.76%, a result 
consistent with the other studies (13, 14), which have reported the high loading 
efficiency of lipophilic compounds. No free NR was detected in the suspension 
presumably due to the compound’s very low water solubility. The final NR 
concentration in the nano-suspension was 206 ± 2 µg/mL.  
 
 
Figure 4.1: Size (diameter) distribution profiles of the NR-loaded PCL NPs (n=3).  
 
 
Figure 4.2: TEM images of NPs of PCL, loaded with NR. Scale bars = 100 nm. 
 
4.3.2 In vitro release studies 
The solubility of NR in IPM was found to be 379 ± 7.7 )g/mL and the concentrations 
measured in the release study were always less than one-tenth of this value confirming 
that sink conditions were maintained. The cumulative (%) release of NR from a solution 





4.3. From the former, 80% is released within 3 hours; for the NPs, this level of release 
was achieved only after 12 hours. The release of NR from the NPs appears to be 
biphasic, with a faster component during the first 3 hours (attributable to the relatively 
rapid dissociation of surface-bound NR), followed by a slower phase controlled 
presumably by diffusion of the entrapped marker from within the polymer matrix. 
Figure 4.4 provides a clear visual representation of NR release from the NPs at early 
and late times during the experiment. These results may be contrasted with the 
previously reported effective non-release of NR from NPs based on poly-methacrylate, 
a polymer with much higher glass transition temperature (Tg) than PCL. In addition, the 
difference may also be influenced by the size and NR-loading differences between the 
two types of NPs. 
 
 
Figure 4.3: In vitro release of NR from a solution in PG, and from a polymeric (PCL) 
NP suspension, as a function of time (mean ± SD, n=3). 
 
 
Figure 4.4: Visualization of NR release from a PCL NP suspension into IPM after 0.5 
hours (left) and 12 hours (right).  
 




























4.3.3 LSCM imaging 
In vitro uptake of NR into non-porated nails 
The distribution of NR on or within the non-porated nail after post-application of the 
NP suspension for 7 days was examined using LSCM. Images from 3 representative 
nail samples of 3 different volunteers are shown in Figure 4.5 and Figure 4.6. The 
former shows cross-sectional (x-z) reconstructions of the sequentially acquired planar 
(x-y) images; both reflectance and fluorescence signals are presented. An intense, bright 
red band of fluorescence from NR is observed on and within the superficial part of the 
nail, with a measurable signal perceptible down to depths of approximately 70-90 µm. 
These observations are completely consistent with the direct, transverse visualization of 
mechanically sectioned nail slices depicted in Figure 4.6. It follows that, over 7 days, 
NR was released from the NPs and successfully permeated into the nail plate to a depth 
corresponding to about 30% of its total thickness. Furthermore, the results are 
completely consistent with the ~150 nm diameter NPs being unable themselves to 
transport across the densely interdigitated onychocytes. 
 







Figure 4.5: Reconstructed cross-sectional images obtained following 7 days of 
permeation. Panel (a): reflectance signal from the nail plate. Panel (b): NR fluorescence. 






 (a) (b) (c) 
 
   
 
   
 
   
Figure 4.6: Illustrative images of 3 transversally sectioned nails: (a) optical micrographs, 
(b) NR fluorescence, and (c) the merged images. Scale bar = 200 )m. 
 
The transport pathway of NR across the nail may also be identified. Figure 4.7 (and as 
videos in Supplementary data 4.1a,b) provides illustrative x-y planar images of an 
example, showing the reflectance signal and NR fluorescence at approximately 10 )m, 
20 )m and 30 )m depths into the nail. The reflectance images reveal the fairly regular 
polyhedral, squamoid shape of the onychocytes that measure about 30 )m across (11, 
12). Localization of NR at the intercellular regions was clearly visible, a point 
reinforced by the simultaneously acquired fluorescence images. As expected, the 
hydrophobic NR has high affinity for these more lipid-rich domains, even though the 
total lipid content of the nail plate is low (0.1-1%) (13). Indeed, the permeation of 
lipophilic compounds has been considered unfavourable, despite suggestions that 
transport, in fact, has little dependence on a drug’s lipophilicity (14, 15), and the 
identification of transport pathways remains an open question. Nonetheless, nail plate is 
known to contain phospholipid particularly in the dorsal and ventral layers (16), and the 
intercellular spaces (25-35 nm) are reported to be filled with a ‘mortar’ that contains 





may therefore provide a sympathetic environment for small, hydrophobic molecules and 
constitute a potential lipophilic pathway for nail permeation. Bright (i.e., NR-stained) 
punctate features were also observed, increasing in number with depth into the nail and 
may correspond to nuclear remnants (retained shrunken or fragmented nuclei), also 
known as ‘pertinax bodies’ (18).  
 
 
Figure 4.7: Planar images (x-y) of NR disposition in a nail at depths 10, 20 and 30 )m: 
(A) reflectance signal; (B) NR fluorescence. Scale bars = 50 )m. 
 
In vitro uptake of NR into non-porated and porated nails as a function of time 
Subsequently, the disposition of NR following application of a PCL NP suspension to 
both non-porated and microneedle-porated nails was assessed as a function of time; the 
results are visualized in Figure 4.8. In intact nails, there remains the most intense signal 
at the surface where the NP formulation is localized; however, as time progresses, 
release and penetration of NR produces a slowly increasing level of fluorescence in 
deeper regions of the nail.  
The impact of microneedle poration is self-evident from the distinctly different images 
seen in Figure 4.8b. First of all, when the microneedle device is rolled back and forth 
over the nail surface, not only are rectangular-shaped pores created, but unavoidable 
scratch marks are also made (as can be seen in the images). While there is still intense 
NR fluorescence at the nail surface, there is also a large signal from within the pores, at 
short times post-application, demonstrating that the NPs themselves are localized here. 








the NP ‘reservoirs’ on the surface and within the pores, but also the enhanced lateral 
diffusion of the fluorophore from the sides of the pores. As observed in the 7-day 
experiment on non-porated nails, intercellular NR penetration is apparent in nails that 
have been microneedle-porated. As hypothesized, therefore, the microneedle-created 
pores in the nail fulfil a similar role to that described for skin furrows and hair follicles 
when NP formulations are applied topically (19), in addition to shortening the diffusion 
path-length of the penetrant once released from the carrier.  
The reconstructed x-z orthogonal image of a non-porated nail (Figure 4.9) recorded 48 
hours after the start of the experiment reveals an intense signal from the NP formulation 
at the surface and that NR, which has been released, has penetrated ~25 µm into the nail 
plate. In contrast, the corresponding images from a microneedle-porated nail (Figure 4.9) 
shows not only the concentration of NPs at the surface but that they have also filled the 
pore and gained access to the nail down to a depth of ~70 µm. Moreover, a red ‘haze’ in 
the surrounding nail tissues is clearly observed indicating that enhanced, lateral NR 
release has taken place. 
Figure 4.10 provides semi-quantitative support for this conclusion and presents the 
average fluorescence signal across the orthogonal images as a function of depth into the 
intact and porated nails. While the signal at 0-10 µm originates primarily from the 
superficial formulation layer in both samples, the fluorescence rapidly drops to baseline 
with increasing depth into the intact nail. The signal profiles from the porated nail 
manifest the strong fluorescence peaks within the pore. While the regions distant from 
the pore show rapid signal decay with depth, those close to the pore reveal the presence 




























Figure 4.8: LSCM visualization of NR disposition as functions of time and depth into (a) 
the intact and (b) the microneedle-porated nail (shown in the reflectance images). Scale 











Figure 4.9: Reconstructed cross-sectional images recorded 48 hours after application of 
NR-loaded PCL NPs to intact and microneedle-porated nails as a function of depth. 
Panel (a): reflectance signal from the nail plate. Panel (b): NR fluorescence. Scale bars 
= 50 )m. 
 
  
Figure 4.10: NR fluorescence signal intensity profiles recorded 48 hours after the start 
of the experiment across the orthogonal images of intact and microneedle-porated nails 
as a function of depth. Grey highlighted areas indicate regions immediately surrounding 
the pores. 
 
Overall, the results of this study lead to the model, by which NPs deliver their payload 
into microneedle-porated nail, shown in Figure 4.11. The long residence time of NR 
fluorescence on the nail surface and within the pore attests to the non-penetrability of 
the NPs and themselves across the barrier, as has been inferred in a number of 
publications reporting their ‘fate’ on the skin (19-22). The diffusion of fluorescence, 
increasing with time and distance from the surface/pore supports the release of NR from 
the NPs and its subsequent penetration into the nail. Absolute confirmation, nonetheless, 
requires both particle and penetrant to be simultaneously and unambiguously tracked, a 
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Figure 4.11: A model for the delivery of an ‘active’ payload from a NP formulation 
applied to a microneedle-porated nail. 
 
4.4 Conclusions 
A lipophilic fluorophore, Nile red (NR), has been encapsulated into polymeric 
nanoparticles (NPs). Subsequently, the disposition of NR following topical application 
to intact nail and to nail porated with microneedles was imaged using laser scanning 
confocal microscopy for 7 days. Post-application to the nail, sustained release of NR 
from the NPs was observed. Confocal imaging clearly showed NR localization between 
the nail plate cells. Microneedle-created pores (a) created sequestration sites for the NPs 
from which NR release continued throughout the experiment, and (b) permitted lateral 
diffusion of NR to occur more rapidly into the deeper regions of the nail. To 
substantiate these conclusions, further experiments are required in which both particle 
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Chapter 5 : Disposition of nanoparticles and an associated 
lipophilic active into micro-porated nail: imaging using 




Purpose: To characterize the release of a lipophilic active from poly(!-caprolactone) 
nanoparticles (NPs) into microneedle-porated human nail using stimulated Raman 
scattering and two-photon fluorescence microscopy. 
Methods: Poly(!-caprolactone) was synthesized from !-caprolactone and covalently 
labelled with a fluorescent tag. NPs were prepared from this polymer and loaded with a 
model lipophilic ‘active’, octyl methoxycinnamate (OMC). The NPs were applied to 
human nails that had been microneedle-porated and two-photon fluorescence (TPF) and 
simulated Raman scattering (SRS) were used to visualize the distribution of the 
particles and OMC, respectively, after 3 hours and 7 days of application. 
Results: The stability of the covalent linkage between the polymer and the fluorescent 
tag was confirmed. The NPs were spherical with an average diameter of 135 nm. A high 
entrapment efficiency of OMC (96 ± 1.95%) into the NPs was achieved. Co-localization 
of NPs and OMC on the nail surface and within the ‘trenches’ created by the 
microneedles was observed 3 hours post-application. After 7 days, however, OMC had 
been progressively released from the NPs and had penetrated deeper and laterally into 
the nail. The location of the NPs, in contrast, remained unchanged.  
Conclusions: The independent visualization of the NPs using TPF, and of the model 
active by SRS, provides unambiguous evidence that the polymeric particles act as drug 
reservoirs, confined to the nail surface and to the microneedle-created pores, from 








The nail plate is an effective barrier that significantly restricts the permeation of drugs 
and results in the fact that current topical therapy to treat nail disease is often 
unsuccessful. To address this unmet clinical need, a number of strategies are under 
investigation to improve drug delivery into and through the nail, including chemical 
penetration enhancers (1, 2) and iontophoresis (3, 4). A novel colloidal formulation 
approach using polymeric nanoparticles (NPs) has been assessed in this work. A key 
component of the research is visualization of the disposition of the NPs and their 
associated ‘active’ payload following topical application to the nail. The resulting 
information is anticipated to provide useful support for the further development and 
optimization of topical nail formulations. 
It has been previously demonstrated that laser scanning confocal microscopy is a 
valuable imaging technique to track the distribution of fluorescent compounds in the 
nail. However, to follow unambiguously the disposition of both the active and the NP 
carriers requires two fluorophores with distinct excitation and emission spectra. 
Furthermore, the range of available fluorophores is far from representative of typical 
drugs (for example, in terms of their structural and physicochemical properties) and 
extrapolation of their behaviour to the therapeutic situation must be undertaken with 
caution. 
Stimulated Raman scattering (SRS) microscopy is an imaging tool with which to tackle 
this problem. SRS is a label-free, non-destructive imaging technique based on molecular 
vibrational spectroscopy, and its high-resolution 3D imaging capability has led to 
application in a wide range of research areas (5). The use of SRS to assess solvent 
diffusion into the nail plate has been described in Chapter 2. The technique has also 
been employed, together with fluorescence microscopy, to visualize skin structure (6), 
and the uptake of drug into fluorescently-tagged lysosomes in living cells (7). Here, 
SRS and two-photon fluorescence (TPF) imaging are used in combination to probe the 
fates of poly(!-caprolactone) (PCL) NPs and an associated lipophilic ‘active’ in 
microneedle-porated human nails. 
 
5.2 Materials and methods 
5.2.1 Chemicals 
!-caprolactone, polysorbate 85 (Tween 85), octyl methoxycinnamate (OMC) and tin(II) 





(Gillingham, UK). 5,10,15,20-tetrakis-(4-aminophenyl)porphyrin (TAPP) was obtained 
from Tokyo Chemical Industry Co. (Tokyo, Japan).  
 
5.2.2 Nail sample preparation 
Human fingernail clippings (at least 8 mm in length) were obtained from healthy 
volunteers who gave informed consent. Ethical approval was granted by the Research 
Ethics Approval Committee for Health (REACH; EP 11/12 115) of the University of 
Bath (Forms in Appendix 1). Nails were maintained frozen (-20o C) until use. Prior to 
the experiments, the nail was soaked in deionized water for 30 minutes to restore some 
flexibility. Microporation was performed using a commercially available dermaroller 
(Infinitive beauty®, Birmingham, UK), comprising 250 µm long titanium needles, which 
was applied to the dorsal side of the hydrated nail by rolling it back and forth a total of 5 
times.  
 
5.2.3 Synthesis of TAPP-labelled PCL 
Star-shaped PCL with a TAPP core was synthesized (Figure 5.1) (8). TAPP (0.025 
mmol), stannous octoate (0.0025 mmol) and !-caprolactone (0.7 g) were introduced into 
a 10 mL round-bottom flask under argon and the polymerization process was carried out 
with stirring at constant temperature (110o C) for 72 hours. When the reaction was 
completed, the cooled product was dissolved in dichloromethane, and subsequently 
precipitated by drop-wise addition to cold stirring methanol. The precipitate (TAPP-
PCL) was filtered and dried at 40o C. 1H NMR spectra of the synthesized TAPP-PCL in 
deuterated chloroform (CDCl3) was recorded on a Bruker Avance TM III spectrometer 







Figure 5.1: Synthesis of star-shaped TAPP-PCL. 
 
5.2.4 Nanoparticle preparation 
Fluorescently-labelled NPs loaded with OMC were prepared using the synthesized 
TAPP-PCL. An organic phase comprising OMC (5.1% w/v) and TAPP-PCL (125 mg) 
in 10 mL of acetone was injected slowly into 50 mL of an aqueous solution of Tween 
85 (3% w/v), forming a turbid suspension. The acetone was subsequently removed 
under reduced pressure and the NP suspension was further concentrated to a final 
volume of ~20-30 mL, which was then filtered (0.45 µm nylon filters, Whatman, 
Maidstone, UK) to remove any precipitates.  
 
5.2.5 Nanoparticle characterization 
The nanoparticle size and polydispersity index were measured (n=3) using dynamic 
light scattering (ZetaSizer Nano S, Malvern, UK), following a 100-fold dilution of the 
suspension. 
NP morphology was imaged using a JEOL JEM-2000 transmission electron microscope 
(TEM) (JEOL Ltd., Tokyo, Japan) at an accelerating voltage of 120 kV. Each specimen 
was prepared by drop-casting the NP suspension onto a carbon coated copper grid, 
which was then cryo-desiccated before imaging. 
The amount of OMC entrapped in the NPs was calculated from the difference between 
the quantity found after complete dissolution of the particles in acetonitrile (Qtot), and 
that in the aqueous supernatant (Qsup) after ultrafiltration-centrifugation of the 
suspension at 6000 rpm for 30 minutes (MWCO 3000, Millipore Corp., Watford, UK). 
All experiments were performed in triplicate. The entrapment efficiency (%) was given 









OMC concentration was quantified using high performance liquid chromatography 
(HPLC) (Jasco, Great Dunmow, UK) with UV detection at 310 nm. A mobile phase 
consisting of acetonitrile-water (85:15) at pH 2.5 (adjusted using orthophosphoric acid) 
was pumped at 1 mL/min through a Acclaim® C18 (5 )m) 150x4.6 mm column. Each 
injection was 10 µL and the retention time was 9.5 minutes. The limits of detection and 
quantification were calculated as 2.6 µg/mL and 7.9 µg/mL, respectively.  
 
5.2.6 Raman spectroscopy 
The Raman spectra of OMC and of a human nail sample were recorded (Renishaw 
RM1000 Raman microscope and v1.2 WIRE software, Renishaw plc, Wotton-Under-
Edge, UK). A 1200-line/mm grating providing spectral resolution of 1 cm-1 was used 
with a diode laser exciting at 785 nm with up to 300 mW power. The Raman band (520 
cm-1) of a silicon wafer was used for calibration. The Vancouver Raman Algorithm (BC 
Cancer Agency & University of British Columbia, Canada) permitted automated 
removal of fluorescence background from the Raman spectra. 
 
5.2.7 SRS and TPF imaging 
The distribution of OMC and TAPP-PCL NPs on and within the microneedle-porated 
nails after either a 3-hour or 7-day application was determined. The nails were mounted 
in vertical Franz diffusion cells (see Chapter 4) and 10 µL of an aqueous NP suspension 
was applied to an area of 0.2 cm2. Before imaging, the samples were sandwiched 
between two glass coverslips and sealed securely with double-sided tapes and Parafilm® 
to avoid evaporation. The central areas of the nails were subsequently imaged.  
SRS and TPF imaging were carried out sequentially using a custom-built, multi-modal, 
inverted microscope with a confocal laser scanner (FV300/IX171, Olympus UK Ltd, 
UK).  
Synchronized, dual-wavelength picosecond excitation was provided by an optical 
parametric oscillator (OPO) (Levante Emerald, APE, Berlin) which was synchronously 
pumped at 532 nm by a frequency-doubled Nd:Vanadium laser (picoTRAIN, High-Q 
GmB), delivering a 7 ps pulse train at a 76 mHz repetition rate. The OPO consisted of a 
temperature-tuned, non-critically phase matched Lithium Triborate (LBO) crystal, 
which allows the OPO signal (employed as the pump beam) to be continuously tuned 
from 690 to 980 nm by adjusting the LBO temperature and an inter-cavity Lyot filter. A 





pump-laser fundamental (1064 nm) was also available as a separate output and was used 
as the Stokes beam, which was amplitude modulated at 1.7 MHz with an acousto-optic 
modulator (3080-197 Crystal Technologies, West Chester, PA, USA). The pump beam 
and the modulated Stokes beam were spatially overlapped using a dichroic mirror (1064 
DCRB, Chroma Technology Corp, Bellows Falls, USA) and temporally overlapped 
using a delay stage. The collinear beams were directed into the microscope and focussed 
onto the sample using a 60x 1.2 NA water immersion objective (UPlanSApo, Olympus) 
and scanned in two dimensions using a pair of galvanometer mirrors. The resulting SRL 
in the pump beam was collected in the forward direction via a 1.0 NA condenser lens 
(LUMFI, Olympus) and detected by a large area photodiode (FDS1010, Thorlabs, New 
Jorsey, USA). A band-pass filter (850/90 nm, Chroma) was mounted in front of the 
detector to block the modulated 1064 nm beam. Finally, a lock-in amplifier (SR844, 
Stanford Research Systems, Sunnyvale, CA, USA) was used to detect the SRL signal 
with a time constant of 30-100 )s.  
TPF was excited using the OPO signal output at 816 nm with the 1064 nm beam 
shuttered. The signal was collected in the epi-direction and detected by a 
photomultiplier tube (R3896, Hamamatsu, Hertfordshire, UK). The absence of nail 
autofluorescence detected with the laser and detector settings used in the experiment 
was confirmed by imaging a control, untreated nail sample. 
 
5.2.8 Image analysis 
All images acquired were processed using ImageJ (US National Institutes and Health, 
USA). Each SRS data point was normalized against the OPO signal recorded on the PIN 
photodiode to correct for the laser intensity fluctuations. Images of different Raman 
shifts and/or fluorescence signal were presented using different colour schemes for ease 
of interpretation. 
 
5.3 Results and discussion 
5.3.1 Fluorescently-tagged nanoparticle synthesis 
The reactant fluorophore, TAPP acted as an initiator during the stannous octoate-
catalyzed polymerization of !-caprolactone. The 1H NMR spectrum of the TAPP-PCL is 
shown in Figure 5.2, the features of which clearly indicate that TAPP was covalently 





the detected TAPP fluorescence originated only from NPs, the disposition of which 
could therefore be tracked unambiguously. 
 
 
Figure 5.2: 1H NMR spectrum of TAPP-PCL. 
 
5.3.2 Particles characterization 
The TAPP-PCL NPs entrapped OMC, a lipophilic UV filter commonly used in topical 
sunscreen products. OMC was chosen because it is known to be efficiently loaded into 
polymeric NPs (9-11) due, at least in part, to its high lipophilicity (average LogP = 5.46 
(12)). Furthermore, OMC is a liquid in room temperature and can act itself as the oil 
phase in the nanoprecipitation process. The average NP diameter was 136 ± 1 nm with a 
polydispersity index of 0.26 ± 0.01 (Figure 5.3); individual particles were spherical 
(Figure 5.4). The final OMC concentration in the suspension was 17.8 ± 0.4 mg/mL and 














Figure 5.4: TEM images of OMC-loaded, fluorescently-tagged NPs. Scale bars = 500 
nm. 
 
5.3.3 Raman spectroscopy 
The chemical structure of OMC and the Raman spectra of the chemical and of a nail 
sample are shown in Figure 5.5. In the OMC spectrum, the absorbance centred at 1600 
cm-1 originates from the aromatic C-C stretching. In contrast, there is little or no signal 
at this frequency in the nail spectrum. Although TAPP may also be expected to 
contribute to a SRS signal at 1600 cm-1, the fluorophore can be uniquely identified and 







Figure 5.5: Chemical structure of OMC (left), and the Raman spectra of the chemical 
and of a nail sample (right). The arrow indicates aromatic C-C bond stretching from 
OMC at 1600 cm-1. 
 
5.3.4 SRS and TPF imaging 
The disposition of OMC and TAPP-PCL on and within the microneedle-porated nail 
following application of the NP suspension for 3 hours and 7 days were imaged by SRS 
and TPF microscopies. SRS was tuned sequentially to 2855 cm-1 to image (principally) 
the -CH2 bond stretching vibration from the nail, 1802 cm-1 to record any off resonance 
background, and 1600 cm-1 to image the aromatic C-C stretch from OMC. TPF 
microscopy was used to locate the fluorescently-tagged NPs. The x-y planar images 
(236 µm x 236 µm) were captured in 2 µm depth increments (but are shown only every 
4 µm to economize on space). The scan time for each stack was 18.4 seconds.  
Although -CH2 signal originated uniquely from the nail in the previous study examining 
the uptake of perdeuterated solvents (Chapter 2), this assignment is less specific here 
because both OMC (as shown in Figure 5.5) and the PCL polymer also include -CH2 
groups in their structures and contribute therefore to this resonance. 
The off-resonance signal verified that there was essentially no background when the 
laser was tuned away from the target vibrational resonances. Only occasional light 
scattering from small residual dirt particles on the nail surface and an extremely low 
endogenous signal from the nail were detected. 
The aromatic C-C signal could have originated from both OMC and TAPP, as 
mentioned before, but the TPF signal allowed specific and unequivocal imaging of the 
NPs. 
Figure 5.6 shows the x-y planar images of SRS and TPF signals obtained at different 
depths into the nail pre-treated with a microneedle roller. The rectangular, ‘trench-like’ 
structures created are clearly visible. At 3 hours post-application, the images confirm 








the co-localization of the aromatic C-C signal (OMC) and the TAPP fluorescence on the 
nail surface and within the pores. The overlaid images reveal essentially perfect 
alignment of the signals at all imaging depths and that minimal separation of OMC from 
the NPs is apparent on this short time-scale. 
After 7 days, on the other hand, while the fluorescence from the NPs remains 
exclusively confined to the nail surface and within the pores, the SRS signal from OMC 
indicates its release from the NPs and subsequent diffusion away from the surface/pore 
into the nail itself. 
Figure 5.7 shows the three-dimensional reconstruction of a representative microneedle-
created ‘trench’. The fluorescence signal from the NPs is visibly intense on the nail 
surface and within the internal confines of the ‘trench’, but no movement of the NPs 
beyond these boundaries has occurred. In contrast, the diffusion of OMC (denoted by 
the SRS aromatic C-C signal) into the nail is clearly visualized, supporting the 




























Figure 5.6: SRS (panel A-C) and TPF (panel D) images recorded as a function of depth 
after (a) 3 hours, and (b) 7 days application of OMC-loaded, fluorescently-tagged NPs 
to microneedle-porated nails. (A) -CH2 resonance primarily from the nail. (B) Off-
resonance signal. (C) Aromatic C-C vibration from OMC. (D) TPF from the NPs. (E) 







Figure 5.7: Three-dimensional reconstruction (prepared using ImageJ ‘volume viewer’ 
plugin) of a representative microneedle-created pore, 7 days post-application of a NP 
suspension onto the porated nail, showing the distribution of (A) -CH2 resonance 
primarily from the nail. (B) TPF from the NPs. (C) Aromatic C-C signal from OMC. (D) 
Overlay of panels B and C. Scale bar = 50 )m. 
 
As reported before, the microneedle-porated ‘trenches’ provide sites into which NPs can 
accumulate. Taken together, the SRS and TPF images clearly confirm that, 7 days post-
application, OMC has been released into, and has started to diffuse within, the nail 
while the fluorescently-tagged NPs remain confined to the surface and within the pores. 
These results concur fully from the observations reported in the previous chapter where 
the release of a fluorescent ‘active’ from unlabelled NPs was inferred from confocal 
microscopy imaging. The data presented here confirm this deduction unambiguously: 
the NPs do indeed act as immobile reservoirs, sequestered on the nail and in the 
physically created pores, sustaining the prolonged release of an active payload over an 
extended period of time. 
 
5.4 Conclusions    
The release of octyl methoxycinnamate (OMC), a lipophilic active, from fluorescently-







using stimulated Raman scattering and two-photon fluorescence microscopy has been 
demonstrated, While co-localization of NPs and OMC on the nail surface and within the 
‘trenches’ created by the microneedles was observed a few hours post-application, after 
one week, OMC had been released from the NPs permeating deeper and laterally into 
the nail. Over the same time, in contrast, no movement of the NPs was perceptible. The 
results provide clear evidence that the NPs function as reservoirs for lipophilic 
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Chapter 6 : Release and nail permeation of ciclopirox in vitro 
from conventional and sub-micron particle formulations 
 
Overview 
Purpose: To investigate the release and nail permeation of antifungal drug, ciclopirox 
(CPX), from lacquer and sub-micron particle-based formulations and to evaluate the 
effects of nail pre-treatment on drug uptake.  
Methods: The release and nail permeation of CPX from a commercially available 
lacquer and from a suspension of sub-micron poly(3-caprolactone) particles with an oil-
filled core were determined in vitro. The size, morphology and drug encapsulation 
efficiency of the particles, and the in vitro release of CPX therefrom, were characterized. 
Drug permeation and uptake experiments were performed on human nail samples that 
were either intact, or microneedle-porated, or pre-treated with 10% N-acetyl cysteine 
and then microneedle-porated. 
Results: Spherical particles, from which sustained release of CPX was achieved, were 
produced with an average diameter of 317 nm. After 14 days of application, CPX was 
taken up into all nails treated with the particle suspension; however, complete 
permeation of drug was only achieved across fully hydrated nails that had been 
microneedle-porated following pre-treatment with N-acetyl cysteine. The lacquer, in 
which the drug concentration was 25-fold higher than that in the particles, delivered 
significantly more CPX into the nails but, again, the drug did not penetrate across the 
entire structure without the {microneedle + N-acetyl cysteine} pre-treatment. 
Significant drug crystallization on the nail surface was also observed post-application of 
the lacquer. 
Conclusions: Although the delivery of CPX into the nail from sub-micron particle 
suspension was less than that achieved by a marketed commercial lacquer formulation, 
the amount of drug taken up nonetheless exceeded its minimum inhibitory concentration 
against pathogens, such as T. rubrum and T. mentagrophytes, which cause 
onychomycosis. Further work is clearly required, however, to increase drug loading into 








Onychomycosis is the most common nail disorder and is currently treated with orally 
and/or topically delivered antifungal drugs. Neither approach is particularly successful: 
oral administration requires long courses of treatment with attendant problems of 
systemic side effects and drug-drug interactions, while topical delivery is significantly 
impeded by poor drug penetration across the highly keratinized structure of the nail. 
Indeed, the clinical outcome of topical treatments with medicated nail lacquers is 
typically so unsatisfactory that topical monotherapy is only recommended for the 
treatment of mild infections (1).  
The use of nano- and sub-micron polymeric particle-based delivery systems for the 
topical treatment of skin diseases has been the subject of considerable recent research 
(2). One focus of the work described in this chapter is to explore the potential use of 
such particulate formulations in the topical treatment of nail disease. The ability of 
poly(!-caprolactone) nanoparticles to sustain the release of a model ‘active’ into the nail 
has been demonstrated (Chapter 4-5). Here, the approach is applied to the delivery of 
ciclopirox (CPX) (Figure 6.1), a common antifungal drug, into and across the nail. The 
use of microneedle, and {microneedle + chemical enhancer} pre-treatments to enhance 
drug uptake and permeation were also investigated. The performance of the particle 
suspension was compared to that of a commercially available nail lacquer.  
 
 
Figure 6.1: Structure of ciclopirox (CPX). Molecule weight = 207.3 Da.  
 
6.2 Materials and methods 
6.2.1 Chemicals 
Preformed polymer PCL (MW: 10,000), poloxamer 188 (Kolliphor® P188), oleic acid 
and N-acetyl-cysteine were purchased from Sigma-Aldrich Co. (Gillingham, UK). 
Ciclopirox olamine (MW 268.4 Da) was obtained from Fagron Iberica (Barcelona, 
Spain). Ciclopoli® Nagellack (Taurus Pharma, Bad Homburg, Germany) was purchased 






6.2.2 Nail sample preparation 
Human fingernail clippings (at least 8 mm in length) were obtained from healthy 
volunteers who gave informed consent. Ethical approval was granted by the Research 
Ethics Approval Committee for Health (REACH; EP 11/12 115) of the University of 
Bath (Forms in Appendix 1). Nails were maintained frozen (-20o C) until use. Prior to 
the experiments, the nail was soaked in deionized water for 30 minutes to restore some 
flexibility. Microporation was performed using a commercially available dermaroller 
(Infinitive Beauty®, Birmingham, UK) with titanium needles (250 µm in length) that 
was applied to the dorsal side of the hydrated nail by rolling it back and forth a total of 5 
times. Chemical pre-treatment involved soaking the entire nail in an aqueous (10% w/v) 
N-acetyl cysteine solution for 24 hours. 
 
6.2.3 Sub-micron particle preparation 
100 mg of ciclopirox olamine, dissolved in 1 mL of oleic acid, was introduced into an 
acetone solution of PCL (250 mg in 20 mL). The resulting mixture was injected drop-
wise into an aqueous phase (100 mL, comprising 0.5% w/v Kolliphor® 188 in 100 mM 
sodium acetate pH 5 buffer solution) with vigorous stirring (1000 rpm) to form a milky 
suspension. The acetone was then removed under reduced pressure and the CPX-
particle suspension was filtered (0.45 µm nylon filters, Whatman, Maidstone, UK) to 
remove any large precipitates. 
 
6.2.4 Sub-micron particle characterization 
Particle size and polydispersity index were measured (n=3) using dynamic light 
scattering (ZetaSizer Nano S, Malvern, UK), following a 100-fold dilution of the 
suspension. 
Particle morphology was imaged using a field emission scanning electron microscope 
(FESEM) (6301F, JEOL Ltd., Tokyo, Japan) equipped with a cryo transfer system (Alto 
1500CT, JEOL) which comprises a cryo (preparation) chamber and a cold stage. The 
particle suspension was pipetted onto a filter paper and placed in the cryo-specimen 
holder. The sample was then snap-frozen by plunging into liquid nitrogen slush and 
transferred under vacuum into the specimen process stage. The specimen surface was 
cleaved with a cold knife integrated within the chamber and then lightly etched (ice 
sublimation) in a controlled manner. Finally, the sample was loaded onto the cold stage 





The amount of CPX entrapped in the particles was calculated from the difference 
between the quantity found after their complete dissolution in acetonitrile:water (50:50) 
(Qtot), and that in the aqueous supernatant (Qsup) after ultrafiltration-centrifugation of the 
suspension at 6000 rpm for 30 minutes (MWCO 3000, Millipore Corp., Watford, UK). 
All experiments were performed in triplicate. The entrapment efficiency (%) was given 
by: {100 x [(Qtot - Qsup) / Qinput]}, where Qinput represents the initial drug input. 
 
6.2.5 In vitro CPX release 
The release of CPX from (a) the particle suspension, (b) a solution of CPX in water at 
the equivalent concentration to that in the suspension, and (c) Ciclopoli® nail lacquer, 
was determined under ‘closed’ conditions (Figure 6.2). 300 )L of formulation was 
placed in an Eppendorf tube, which was covered with a dialysis membrane 
(Spectra/Pore® regenerated cellulose membrane 1,000 MWCO; Spectrum Laboratories, 
USA) and closed with a pierced cap, to provide a diffusion area of 0.78 cm2. The 
inverted Eppendorf was placed inside a centrifuge tube filled with the receptor solution, 
20 mL of pH 7.4 phosphate buffer saline (PBS). The system was constantly stirred and 
maintained at 32° C. The receptor solution was sampled at fixed time intervals and 
assayed for CPX content. For the lacquer, CPX release was also measured in the same 
way but under ‘open’ conditions (Figure 6.2), where the donor compartment was 
exposed to ambient conditions.  
 
 
Figure 6.2: Schematic diagram showing the setup for CPX release studies in ‘enclosed’ 
(left) and ‘open’ (right) conditions. 
 
6.2.6 Nail permeation of CPX 
Nail permeation experiments were performed using a diffusion cell set-up (Figure 6.3), 
















analytical purposes, the drug concentration in the withdrawn samples. The nail (with or 
without pre-treatment) was mounted in the specialized adaptor (PermeGear Inc., 
Bethlehem, PA, USA, diffusion area = 0.2 cm2) with the dorsal surface facing the donor 
chamber, while the ventral side was hydrated by 500 µL of pH 7.4 PBS, containing 30 
mg/L sodium azide to prevent microbial growth. 300 µL of either the particle 
suspension or the lacquer was introduced into the donor compartment, which is either 
exposed to air or enclosed. The entire set-up was placed in an incubator at 32°C and 
gently shaken throughout the experiment. 300 µL of the receptor medium was sampled 
every 48 hours and replaced with fresh receptor medium. The permeation study lasted 
for 14 days. 
 
 
Figure 6.3: Schematic diagram showing the setup for nail permeation studies. (a) Cross-
sectional view of the assembly. The donor compartment is either (b) exposed to air or (c) 
enclosed.  
 
6.2.7 Recovery of CPX from nails 
At the end of the permeation study, the nail was removed from the diffusion cell and 
thoroughly washed with deionized water. The central region of the nail, which was 
exposed to the drug formulation, was separated from the peripheral areas (Figure 6.4), 
weighed and then reduced to small fragments that were placed in an Eppendorf tube 
with 1 mL of an ethanol-water (70:30) mixture. The Eppendorf was then tightly sealed 
with Parafilm® and drug extraction from the nail was carried out by shaking the tube at 
room temperature for 7 days. Subsequently, the solution was passed through a Cronus® 














validated by spiking a nail with a solution containing a known quantity of CPX and 
leaving it to dry for 4 hours. The excellent recovery of 93 ± 6% (n=3) implies that CPX 
does not bind irreversibly to any significant extent to the nail. Analysis of the extraction 
medium following contact with nail samples in the absence of any CPX confirmed that 
there was no interference with the assay due to extraction of endogenous compounds. 
 
 
Figure 6.4: Area of nail exposed to CPX formulations (circled in red) and the peripheral 
area of the sample. 
 
6.2.8 High performance liquid chromatography (HPLC) 
CPX was quantified using HPLC (Dionex Sunnyvale, CA, USA) with UV detection at 
305 nm. A 5 µm Purospher® STAR RP-18 endcapped 150 x 4.6 mm column (Merck 
KGaA, Darmstadt, Germany) was employed. The mobile phase was a 68:32 v/v mixture 
of acetonitrile and an aqueous solution containing 20 mM orthophosphoric acid and 
0.05 mM EDTA disodium salt, flowing at 1 mL/min. The injection volume was 40 µL 
and the system was maintained at 25° C. The retention time of CPX was 3.6 minutes. 
The limits of detection and quantification were calculated as 0.21 and 0.63 µg/mL, 
respectively. 
 
6.2.9 Data analysis 
Data analysis was performed with Graph Pad Prism version 5.00 (Graph Pad Software, 
San Diego, California USA). The apparent steady-state fluxes of CPX across the nail 
were estimated from the slope of the linear part of the cumulative permeation profiles. 
The lag time was estimated by extrapolation to the time-axis in the usual way. The 
amounts of CPX extracted from the nails treated with the lacquer or the particle 
suspension, and pre-treated as previously described, were compared using a two-way 







Bonferroni post-test. The quantities of CPX extracted from the particle suspension-
treated nails, either microneedle-porated or exposed to N-acetyl cysteine and then 
porated, were compared using unpaired t-tests. The level of statistical significance was 
set to p / 0.05 in all cases.  
 
6.3 Results and discussion 
6.3.1 Sub-micron particle characterization 
Although CPX olamine salt has reasonably good water solubility (32.8 mg/mL) (3), 
drug-loaded sub-micron particles were prepared using the solvent displacement 
(nanoprecipitation) method (4), which is more typically used to entrap poorly water-
soluble compounds. It has been proposed that incorporation of a liquid core in which 
drug solubility is relatively high can increase its entrapment in the polymeric particles 
(5). Equally, modification of the pH of the continuous aqueous phase to lower drug 
solubility therein can also promote entrapment into the particles (6-8). Here, both 
strategies were adopted. First, oleic acid (OA), a naturally occurring fatty acid and a 
commonly used skin penetration enhancer, is a good solvent for CPX (> 200 mg/mL) 
(9), and was used therefore as the oil-core, in which to solubilize the drug in the sub-
micron particles. Second, as CPX is a weak acid (pKa ~8.07), its partitioning into the 
particles during their precipitation was promoted by using a pH 5.0 acetate buffer as the 
aqueous phase. The predominantly unionized nature of CPX at this pH, and its 
associated lower solubility (10), diminished its tendency to migrate into the continuous 
phase, and to remain within the particles, both during preparation and upon subsequent 
storage.  
The average particle diameter was 317 ± 8 nm with a reasonably small polydispersity 
index of 0.172 ± 0.025 (Figure 6.5); the individual particles were spherical (Figure 6.6). 
The concentration of CPX in the suspension was 3.08 ± 0.01 mg/mL. The encapsulation 
efficiency was 58.7 ± 0.3 % and a small amount of free, unencapsulated CPX (2.98 ± 







Figure 6.5: Size (diameter) distribution profiles of CPX-loaded PCL particles (n=3). 
 
 
Figure 6.6: SEM images of CPX-loaded PCL particles. Scale bar = 1 µm. 
 
6.3.2 In vitro release studies 
The release kinetics of CPX from (a) a solution in water, (b) the particle suspension and 
(c) Ciclopoli® nail lacquer are shown in Figure 6.7. From the aqueous solution, 33% 
was released within 30 minutes, and 100% by 6 hours. Drug release from the particles 
showed a classic, initial burst effect (14%) during the first ~8 hours, and about half of 
the drug loading had been liberated after 48 hours. It is reasonable to suggest that the 
early release of the drug is attributable both to diffusion of the small amount of 
unencapsulated drug, as well as the rapid loss of the water-soluble CPX from the 
external surface of the particles (6, 11, 12). The subsequent, slower release of drug was 
presumably determined by its diffusion from the particle oil core and through the 
polymeric shell.  
The CPX release profiles from the particles were fitted to the Higuchi and Korsmeyer-
Peppas models (Figure 6.8), which have been widely used to analyze these types of data 
(13). The Higuchi, ‘square root of time’ approach (14) is founded on the appropriate 





(15) examines whether the data indicate any significant deviation from Fickian 
behaviour. In this case, the slope of a log-log plot of cumulative release versus time 
provides an exponent (4) which, if / 0.5, is indicative of Fickian diffusion. Values of 4 
! 1, however, suggest that drug release behaviour is more complex and that at least one 
parallel process, in addition to simple diffusion, is taking place. As seen in Figure 6.8, 
both models fit the data rather well, with r2 values close to 0.97. The value of the 
Korsmeyer-Peppas 4 was 0.69, indicative of a degree of deviation from simple 
diffusion. 
 
Figure 6.7: Cumulative percentage of CPX payload released as a function of time from 
aqueous solution, particle suspension, and Ciclopoli® nail lacquer (mean ± SD, n=3). 
The release experiments were performed under either ‘closed’ (black lines) or ‘open’ 






Figure 6.8: Fits of the (a) Higuchi, and (b) Korsmeyer-Peppas models to the profiles of 
CPX release from the particle suspension (mean ± SD).  
 
The commercially available product, Ciclopoli®, is an organic nail lacquer containing 
8% w/w CPX as a free acid, ethyl acetate, ethanol, cetylstearyl alcohol and the 
hydrophilic polymer, hydroxypropyl-chitosan. It is noteworthy that the drug amount in 
this formulation is ~25-fold higher than that in both the particle suspension and the 
CPO-PCL particle suspension














































aqueous solution. For the lacquer, CPX release was evaluated under ‘closed’ and ‘open’ 
conditions, with the latter mimicking the air exposure that would occur with the 
practical use of lacquer, where the volatile solvent evaporates upon application, 
forming, in principle, a clear film on the nail surface. However, instead, drug 
crystallization was observed within 30 minutes under ‘open’ conditions (Figure 6.9) and 
had also occurred by 6 hours when the system was ‘closed’. Intriguingly, the release 
profiles for the two conditions were essentially identical (Figure 6.7), despite the 
different rates at which CPX crystallization was observed. The appearance of solid drug 
is hardly surprising, most likely due to rapid solvent evaporation and its faster 
penetration (relative to CPX) across the membrane. At the same time, though, water 
from the receptor chamber is unquestionably (and probably quickly) diffusing in the 
opposite direction to an extent that will at least keep a portion of the CPX in dissolved 
and diffusible form in the donor compartment. The end result of these concomitant 
processes appears to be that, by the end of the release experiment after 48 hours, the 
cumulative percentage of the CPX payload delivered from the lacquer is about 25% 
under both ‘closed’ and ‘open’ conditions.  
 
  
Figure 6.9: CPX crystals formed over time on the ‘donor’ surface of the membrane 
during the in vitro release test of the nail lacquer, Ciclopoli® under ‘open’ conditions. 
 
6.3.3 Nail uptake of drug and permeation measurements 
The first experiments compared the uptake and permeation of CPX from the lacquer and 
the particle suspension under ‘open’ conditions into and through nails that were either 
(a) intact, (b) microneedle-porated, or (c) treated with N-acetyl cysteine before 
microneedle poration. The results are summarized in Table 6.1. 
CPX delivered from Ciclopoli® only permeated through nails, which had been 
microneedle-porated and pre-treated with N-acetyl cysteine. Drug crystallization was 
observed at 1.5 hours post-application and persisted thereafter until the end of the 
experiment (Figure 6.10). Although the lacquer is claimed to form an invisible film 
upon application to the nail (16), this was refuted by the detailed microscopic 
examination performed.   





Table 6.1: CPX uptake into and permeation through human nails under ‘open’ 
conditions.  
Formulation Ciclopoli® Sub-micron particle suspension 
CPX applied (mg/mL)  80 3.07 










()m) 320 ± 53 347 ± 32 313 ± 42 295 ± 38 300 ± 30 310 ± 78 
CPX permeated in 14 
days ()g/cm2)d 
< LoDc 87.9 ± 50.0 <LoD
c 














aMNs = microneedles 
bN-AC = N-acetyl cysteine. 
cLoD = limit of detection. 
dMean ± SD; n=3 or 4. 
 
  
Figure 6.10: Solid crystals formed during the nail permeation study of Ciclopoli®. 
Photos were taken at the times indicated along the top. 
 
The CPX permeation profile from the lacquer across the N-acetyl cysteine pre-treated, 
microneedle-porated nail is shown in Figure 6.11. The apparent steady state flux and the 
lag time were 6.68 ± 1.75 )g d-1 cm-2 and 10 hours, respectively. N-acetyl cysteine is a 
sulphydryl (S-H)-containing amino acid derivative that cleaves disulphide bonds in the 
keratin matrix, and has been reported to promote drug permeation across bovine hoof 










Figure 6.11: Cumulative delivery (n=3, mean + SD) of CPX from Ciclopoli® across N-
acetyl cysteine pre-treated and microneedle-porated nails.  
 
In previously published work, when the same lacquer was applied to bovine hoof slices 
(80-120 µm), a very short lag time (~1.3 hours) and a high CPX flux (equivalent to 153 
± 29 )g d-1 cm-2) were reported (18). This finding is consistent with the fact that the 
keratin structure in bovine hoof membranes is much looser and considerably more 
permeable (up to 30-fold) (19, 20) than healthy human nails. Across infected human 
toenails, the apparent flux of CPX from Ciclopoli® within 5 days was 0.52 ± 0.20 )g d-1 
cm-2 (21). It appears therefore that the pathological effect of dermatophytes on nail 
structure certainly increases its permeability over that of the intact, normal nail, but is 
less damaging than a combination of N-acetyl cysteine and microneedle pre-treatments. 
Post-application of the polymer particle suspension, a transparent film formed on the 
nail surface after evaporation/penetration of water. While CPX was clearly taken up into 
the nail over 14 days (Table 6.1), it had not permeated sufficiently to be detectable in 
the receptor solution, even when microneedle or {chemical + microneedle} pre-
treatments were used. Two-way ANOVAs were performed to compare the uptake of 
CPX into the nail from the two formulations as a function of the pre-treatments 
employed. It was found that uptake from the lacquer was significantly higher than that 
from the particle suspension (p < 0.05), but that, for both formulations, uptake was 
statistically indistinguishable (p > 0.05) between intact nails, those porated with 
microneedles, and those pre-treated with N-acetyl cysteine prior to microneedle 
poration. Given that nail density is known (1.33 g/mL) (22), it was possible to calculate 
the concentration ranges of CPX in the nail after treatment with the lacquer and particle 
formulations: 2.94-14.3 mg/mL and 0.43-1.97 mg/mL, respectively. Importantly, these 
values are well above the reported minimum inhibitory concentration (MIC) range 
(0.015-0.125 µg/mL) (23) of CPX against dermatophytes causing onychomycosis, 
including T. rubrum and T. mentagrophytes.  














As CPX permeation from the particle formulation could not be quantified under ‘open’ 
conditions, the experiment was repeated under occlusion maintaining, thereby, the nail 
in a fully hydrated condition. The nails were either (a) microneedle-porated, or (b) 
treated with N-acetyl cysteine before microneedle poration. The results are summarized 
in Table 6.2. 
 
Table 6.2: CPX uptake into and permeation through human nails under ‘closed’ 
conditions. 
Formulation Sub-micron particle suspension 
Nail pre-treatment MNsa N-ACb + MNsa 
Nail thickness ()m) 353 ± 96 333 ± 128 
CPX permeated in 14 days ()g/cm2)d < LoDc 10.2 ± 5.90 
CPX uptake in 14 days ()g/mg)d 0.56 ± 0.24 0.88 ± 0.13 
aMNs = microneedles 
bN-AC = N-acetyl cysteine. 
cLoD = limit of detection. 
dMean ± SD; n=3 or 4. 
 
Once again, CPX uptake into the nail in 14 days was not influenced by the pre-
treatment performed. While the pre-application of microneedles was not enough to 
allow CPX delivery across the nail, the immersion in N-acetyl cysteine prior to physical 
poration did promote drug permeation, with an apparent steady state flux of 1.32 ± 0.51 
)g d-1 cm-2 and a lag time of ~6 days (Figure 6.12). Evidently, the additional impact of 
fully hydrating the nail (an approach known to increase its porosity (24, 25)) has 
enabled CPX to completely permeate the barrier. Although the flux from the particle 
suspension is significantly lower (~5-fold) than that from the lacquer, it is again worth 
noting that the loading in the former is substantially (by a factor of about 25) less than 
that in the commercial formulation.  
 
 
Figure 6.12: Cumulative delivery (n=3, mean + SD) of CPX from the polymer particle 
suspension across N-acetyl cysteine pre-treated and microneedle-porated nails. 
 















Presently, drug permeation across the highly keratinized structure of the nail remains a 
daunting challenge. The currently available, medicated nail lacquers suffer from rapid 
drug precipitation shortly post-application due to the evaporation of volatile solvent, 
rendering a large fraction of the applied active unavailable for subsequent partitioning 
into and diffusion across the barrier. The results described here demonstrate that small 
polymer particles, which encapsulate the drug, may be able to maintain a reservoir from 
which the release of the compound could be sustained over an extended period of time 
without the risk of crystallization. Clearly, there is room for further optimization and 
development of such formulations for topical drug delivery to the nail; not only to 
increase the applied ‘payload’ of the active, but also to take advantage of combined 
enhancement strategies (as illustrated here) to achieve a maximally useful outcome.  
 
6.4 Conclusions 
The release and nail permeation of ciclopirox (CPX) from a commercially available 
lacquer and from a suspension of sub-micron poly(3-caprolactone) particles with an oil-
filled core have been assessed. Experiments have been carried out on human nail 
clippings that were either intact, or microneedle-porated, or pre-treated with 10% N-
acetyl cysteine and then microneedle-porated. CPX was taken up into all nails treated 
with the particle suspension; however, complete permeation of drug was only achieved 
across fully hydrated nails that had been microneedle-porated following pre-treatment 
with N-acetyl cysteine. Even though CPX delivery into the nail from the sub-micron 
particle suspension was less than that achieved by the lacquer formulation, the amount 
of drug taken up substantially exceeded its minimum inhibitory concentration against 
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Chapter 7 : Pluronic F127-based thermogelling formulations 
for topical nail delivery 
Overview 
Purpose: To investigate the potential use of Pluronic F127 (PF-127)-based hydrogels to 
deliver drugs to the nail plate by examining their in situ gelling behaviour in healthy 
volunteers and by assessing their ability to release model compounds in vitro and to 
deliver fluorescent markers into the nail.  
Methods: Hydrogels with several concentrations of PF-127 were prepared and their 
gelling temperatures were determined. The fluorescent markers sodium fluorescein (SF) 
and Nile red (NR) were used as models for hydrophilic and lipophilic actives, 
respectively. The two markers were incorporated into the gels and their effect on the 
gelling temperature and their in vitro release profile was characterized. Next, the 
penetration of dyes into human nail clippings under two experimental conditions was 
assessed by laser scanning confocal microscopy (LSCM). The first experimental 
condition involved a continuous occluded, 7-day application and the second, a 
discontinuous un-occluded, 7-day application consisting of daily cycles of an 8-hour 
application followed by a washing step and a 16-hour period without formulation. The 
latter mimicked a potential practical use (night application only) of the formulations. 
Results: Gels with 20%, 25% and 30% w/v of PF-127 were selected for their gelling 
properties and further investigated. As expected, the presence of PF-127 slowed the in 
vitro release of the model compounds with respect to the free solution. The three PF-
127 concentrations delivered the markers into the nail plate at similar depths. Typically, 
the two markers penetrated 30% or less of the nail thickness during the 7-day study and 
as anticipated, the continuous, occlusive approach led to greater penetration than the 
discontinuous, un-occluded approach. The confocal images suggested that SF and NR 
penetrated the nail plate via the transcellular and intercellular pathways, respectively. 
Finally, the gelling properties were confirmed in vivo and the feedback from the 
volunteers suggested that the formulations would be well accepted by users.   
Conclusions: Thermogelling PF-127-based formulations were easy to apply and to 
prepare. The aqueous based formulations provided continuous release of the markers for 
at least 6 hours and deliver them to the nail plate. Further characterization of the 






Onychomycosis is a common, persistent nail disorder which is responsible for ~ 50% of 
all nail diseases. Antifungal drugs can be taken orally to treat the infected nail and, 
through the distribution process, a small fraction of the dose reaches the nail bed and is 
slowly incorporated into the nail plate. While reasonably effective, oral therapy is 
limited by potential side effects and drug interactions. Another intervention is nail 
avulsion or surgical removal of the infected nail plate which is an extremely traumatic 
procedure (1, 2). Local treatments can circumvent these problems by targeting the drug 
to the infected area whilst minimizing systemic exposure. For that reason, several 
medicated nail lacquers are available in the market (see Table 1.2 in chapter 1) for the 
treatment of onychomycosis. Nail lacquers are applied as liquids using a brush and form 
an adhesive film on the nail surface upon application. The adhered film has a longer 
residence time on the nail plate than gels, creams and ointments and ideally, the drug in 
the film partitions into and then diffuses across the nail plate into the nail bed to reach 
the concentration required to fight the infection. In practice though, the efficacy of 
medicated nail lacquers is limited (3) so they are only used for superficial infections or 
in combination with oral drugs (4). One cause for the reduced efficacy is the thickness 
and the highly keratinized structure of the nail plate that limits drug permeation so the 
amount of drug reaching the nail bed is insufficient to treat the infection effectively (2, 
5). On the other side, poor formulation is another contributing factor. Most lacquers 
contain high levels of organic solvents that evaporate rapidly upon application. 
Unfortunately, these solvents are often required to solubilize the drug and, after a 
transient state of super-saturation, drug crystallization occurs. The active therefore, 
becomes unavailable for any further partitioning into the nail and its delivery stops. 
In summary, there is a need to improve and optimize nail dosage forms and particularly 
to ensure that nail formulations keep the active available for delivery for extended 
periods of time. The previous chapters have explored the use of nanoparticles as 
potential reservoirs for antifungal drugs; this chapter will explore the potential of 
organic solvent-free, thermoresponsive, in situ gelling hydrogels, relatively simpler 
systems, to deliver drugs to the nail plate. Recent work with ciclopirox olamine showed 
that an aqueous nail lacquer containing 20% PF-127, cyclodextrins and penetration 
enhancers provided better nail and hoof penetration of the actives than a marketed 






This study will investigate further the use of Pluronic F-127 (PF-127)-based systems for 
topical nail delivery. PF-127 is one in the series of polyethylene oxide-polypropylene 
oxide-polyethylene oxide (PEO-PPO-PEO) block copolymers, the members of which 




PF-127 has a nominal molecular weight of 12,500 daltons and contains 70-79% the 
hydrophilic portion, PEO (7, 8). PF-127 is commercially available, odourless, and 
water-soluble. It is considered safe and has been approved by FDA (Food and Drug 
Adminstration) for use as food additives and pharmaceutical ingredients (9). Moderately 
concentrated (above 20%) aqueous solutions of PF-127 exhibit the interesting 
phenomenon of reversible thermal gelation. That is, they present themselves as free-
flowing liquids at refrigerated temperatures and as gels at standard room temperature 
(10). This behaviour is related to the micellar structure of PF-127 over the temperature 
range of 10-40o C. At low temperature, the polymers are fully dissolved and transform 
into a spherical micellar phase when the critical micellization temperature (CMT) is 
reached. The concentration of micelles further increases as the temperature increases 
and once the gelation temperature (Tgel) is reached, the volume density of micelles is 
sufficiently high that the polymers are ‘locked’ into a crystalline cubic structure of hard 
spheres, forming a solid gel (8). It is believed that gelation occurs as result of the 
dehydration of the hydrophilic PEO portion, leading to chain friction and entanglement 
that favours hydrophobic interactions of the PPO domains (7). This distinctive 
thermoreversible gelling behaviour of PF-127 has been widely exploited for the 
formulation of topical drug delivery systems (11-13).  
The present study aims to further characterize PF-127-based vehicles as topical nail 
drug delivery systems and primarily whether they meet some essential criteria. First, 
that the gelling behaviour of PF-127 solutions in vivo allows the quick formation of a 
layer on the nail plate and second, that the actives incorporated in the formulations do 
not crystallize upon formation of this layer and remain available to partition into the nail 
plate for extended periods of time. Additionally, given the water-soluble properties of 
these formulations, a night application of the lacquer is envisaged and therefore delivery 





sodium fluorescein (SF) and Nile red (NR) were incorporated into the vehicles as 
models for hydrophilic and lipophilic actives and their in vitro release profiles were 
characterized. Next, the nail penetration of the two markers incorporated in PF-127 
formulations and applied either continuously or discontinuously was studied using laser 
scanning confocal microscopy (LSCM). A panel of healthy volunteers was involved to 
assess the acceptability of these formulations and their gelling behaviour in vivo. 
 
7.2 Materials and methods 
7.2.1 Chemicals 
Pluronic F-127 (PF-127), sodium fluorescein (SF), Nile red (NR) and polysorbate 80 
(Tween 80) were purchased from Sigma-Aldrich Co. (Gillingham, UK). Polyethylene 
glycol 400 (PEG-400) was obtained from Acros Organic (New Jersey, USA).  
 
7.2.2 Nail sample preparation 
Human fingernail clippings (at least 8 mm in length) were donated by healthy 
volunteers who gave informed consent. Ethical approval was granted by the Research 
Ethics Approval Committee for Health (REACH; EP 11/12 115) (Forms in Appendix 1) 
of the University of Bath. The nail clippings were maintained frozen (-20o C) until use. 
Prior to the experiments, the nail’s thickness was measured using a point micrometer 
(Point Anvil Micrometer, Mitutoyo, Andover, UK). The nail samples were then soaked 
in deionized water for 30 minutes to restore some flexibility before the experiments. 
 
7.2.3 Volunteers 
18 healthy volunteers (13 males and 5 females, age 18-53 years) not suffering from any 
skin or nail diseases and allergies and who had not used any cosmetic nail treatment 
recently were recruited for the in vivo study. Informed consent was obtained from all 
participants. Ethical approval for the in vivo study was granted by the Research Ethics 
Approval Committee for Health (REACH; EP/13/14 27) (Forms in Appendix 2) of the 
University of Bath.  
 
7.2.4 PF-127 gels preparation 
PF-127 gels were prepared using a ‘cold’ method. PF-127 (10, 15, 20, 25, 30 and 35% 






SF-PF-127 gels were prepared by dissolving the necessary amount of SF in cold PF-127 
solutions so the final amount of the marker was 0.1% w/v. 
NR-PF-127 gels were prepared by adding NR dissolved in PEG-400 to cold PF-127 
solutions so the final concentration of NR and PEG-400 were 0.002% w/v and 10% v/v, 
respectively. The mixture was then kept at 4o C with gentle stirring until a homogeneous 
solution was formed.  
 
7.2.5 Determination of gelation temperature (Tgel) 
Tgel was determined as the lowest temperature at which a gel can hold its weight in an 
inverted vial (Figure 7.1). 1 mL of the cold gel solutions were introduced into an 
Eppendorf tube that was placed in a water bath at ~10o C temperature. The temperature 
of the water bath was increased by 1o C every two minutes until the transition to solid 
gel occurred.  
 
 
Figure 7.1: Determination of Tgel by the ‘inverted tube’ method. 
 
7.2.6 In vitro release studies 
The in vitro release of SF and NR from PF-127 gels and control aqueous solutions was 
characterized using the system shown in Figure 7.2. Briefly, 300 )L of the cold PF-127 
formulations were introduced into an Eppendorf tube with a pierced cap (0.20 cm2) and 
sealed with a diffusion membrane. Spectra/Pore® regenerated cellulose dialysis 
membrane (1,000 MWCO; Spectrum Laboratories, USA) and silicone membrane (no. 
7-4107, 75 )m thick; Dow-Corning, Coventry, UK) were used for SF and NR 
experiments, respectively. The Eppendorf tube was inverted and incubated at 32o C for 
10 minutes so the formulation gelled on top of the diffusion membrane. Next, the 






also kept at 32o C. The receptor media were 20 mL phosphate buffer solution (PBS) pH 
7.4 for SF and 10 mL of Tween 80 (5% w/v) in pH 7.4 PBS for NR and were 
continuously stirred. Samples of the receptor were taken at fixed time intervals and 
replaced with fresh solution. The concentration of SF and NR in the samples was 
quantified by HPLC. Control experiments were conducted in the same way and used 
0.1% w/v SF in water and 0.002% w/v NR in PBS containing 5% w/v Tween 80 and 
10% v/v PEG-400 as donor solutions; both dyes were at the equivalent concentrations to 
the PF-127 formulations. 
 
 
Figure 7.2: Experimental setup used for in vitro release studies. 
 
7.2.7 High performance liquid chromatography (HPLC) analysis 
SF and NR were quantified using HPLC-fluorescence detector (Dionex, Sunnyvale, CA, 
USA). A HiQ sil C18W 250x4.6 mm column (KYA Tech, Tokyo, Japan) was employed 
and the system was maintained at 25o C. Table 7.1 shows the details of the 









Table 7.1: Quantification methods of SF and NR using HPLC. 
 Sodium fluorescein (SF) Nile red (NR) 
Excitation wavelength (nm) 488 559 
Emission wavelength (nm) 515 630 
Mobile phase Methanol:0.05 M potassium dihydrogen phosphate buffer pH 7.4 (52:48) 
Methanol: 
water (95:5) 
Flow rate (mL/min) 1 1 
LoD (ng/mL) 3.6 12.7 
LoQ (ng/mL) 11.0 38.6 
Retention time (min) 3.3 6.5 
LoD = limit of detection. 
LoQ = limit of quantification. 
 
7.2.8 In vitro nail permeation studies 
Nail permeation experiments were performed using vertical Franz diffusion cells 
including nail adaptors (PermeGear Inc., Bethlehem, PA, USA, diffusion area = 0.2 
cm2). The dorsal surface of the nails faced the top, donor chamber. The ventral side of 
the nails was kept in contact with the pH 7.4 PBS in the receptor chamber (7.5 mL) 
throughout the experiments. The whole set up was maintained at 32o C. Two types of 
experiments were performed:  
Continuous application experiments: In this case, 300 µL of the gel solution were 
applied and left on the nail surface for 7 consecutive days. Both the donor and receptor 
chambers were covered with Parafilm® to create an occluded environment.  
Discontinuous application experiments: These aimed to investigate the penetration of 
the markers into the nail plate in conditions mimicking a more practical scenario. That 
is, the overnight application of the formulations followed by their removal through hand 
washing in the morning. To simulate the overnight application, 20 µL of PF-127 
solutions were applied onto the nail plate and left for 8 hours. The formulations formed 
a thin layer of gel on dorsal surface and were exposed to ambient air. The receptor 
compartment was occluded throughout the experiments and the ensemble was kept at 
32o C. After this 8 hours dosing period, the gel was removed with deionized water and 
the nail surface was completely dried with cotton wool bud. The formulation-free period 
lasted 16 hours and was followed by a new 8-hour dosing step. This cycle was repeated 
for 7 days.  
At the end of the 7-day continuous and discontinuous experiments, the diffusion cell 
was dismantled and the formulation at the surface of the nail was washed off using 
deionized water and dried with absorbent tissue. The treated area of the nail was then 





7.2.9 LSCM imaging 
An LSCM 510Meta inverted laser scanning microscope (Carl Zeiss, Jena, Germany) 
was employed to image the penetration of the two markers into the nail plate. An argon 
laser (488 nm) and a HeNe laser (543 nm) were used to excite SF and NR, and the 
corresponding emission signals were collected using a BP 505-530 (green) and LP 560 
(red) filters, respectively. Dorsal and transversal confocal images were captured to 
localize the fluorophores on and within the nail. Dorsal images were acquired using an 
EC Plan-Neo 40x/1.3 oil objective. Optical section x-y planar images were obtained 
every 2 µm in the z-direction. To obtain transversal images, the nail clippings were 
sectioned into thin slices, which were then glued on to a microscope slide with the 
cross-section oriented towards the objective. A Plan-Apochromat 10x/0.45 M27 air 
objective was employed to obtain a direct transversal view of the nail. Reflectance 
and/or optical images were captured simultaneously and all images were taken at a few 
microns below the cut surface to avoid artefacts caused by the sectioning.  
The penetration depth (T) of the fluorescent markers was estimated from the transversal 
images. The normalized penetration depth (%T) was determined by normalizing each T 
value with respect to the thickness of the corresponding nail measured in 
simultaneously taken images. To take into account both inter- and intra-individual 
variability, three replicate experiments were performed for each formulation and each 
nail sample was imaged at 3 different regions. All images were processed using ImageJ 
software (version 1.48v, National Institutes of Health, USA).  
 
7.2.10 Data analysis and statistics 
Data analysis was performed using GraphPad Prism version 5.00 (Graph Pad Software, 
San Diego, California, USA). Non-parametric Kruskal-Wallis analysis followed by a 
Dunn’s post-test was used to compare the T and %T values obtained for different nails 
and formulations. The overall difference between the continuous and discontinuous 
application was examined by two-way analysis of variance on the factors ‘treatment 
approach’ and ‘PF-127 concentrations’ followed by a Bonferroni post-test. The level of 
statistical significance was set to p / 0.05.  
 
7.2.11 In vivo application 
The 18 healthy participants were randomly assigned to 3 equal size groups. Placebo 





127 in distilled water were used for the study. Two different formulations were tested in 
each group, so each formulation was tested on 12 individuals. 20 )L of the cold 
formulation were applied to the nail plate using a small paintbrush. Each formulation 
was applied to the five fingernails of one hand. A maximum of 10 minutes was allowed 
for the formation of a thin coating layer on the nail surface. The layer was visually 
inspected for its physical appearance (uniformity, presence of bubbles). The participants 
were asked to complete a questionnaire and to comment on the possible use of the 
formulations as medicated nail lacquers.  
 
7.3 Results and discussion 
7.3.1 Tgel of PF-127 formulations 
The Tgel of unloaded formulations was first determined (Table 7.2). According to 
previous work (14-16), the thermogelling behaviour appears at PF-127 concentrations 
equal or superior to 20%. So, as expected, the 10% and 15% aqueous solutions of PF-
127 did not gel in the 10-60o C range of temperatures investigated. Once the 
thermogelling behaviour was acquired, the results agreed with the previously reported 
linear correlation between polymer concentration (20-35%) and Tgel (14). The increased 
polymer concentration leads to a higher number of micelles which occupy a larger 
volume, and therefore, the sol-gel transition occurs at lower temperatures (17). This 
trend was also observed in this work. A Tgel between 22-30o C would be suitable for in 
situ gelling upon topical nail application and therefore, the formulations with 20%, 25% 
and 30% of the polymer were selected for further in vivo placebo testing and for in vitro 
studies incorporating the two fluorescent markers. The formulation with 35% of PF-127 







Table 7.2: Tgel (o C) of unloaded and loaded PF-127 formulations. NG = no-gel formed. 
PF-127 (% w/v) Unloaded + SF + NR+ PEG-400 
10 NG - - 
15 NG - - 
20 30 28 28 
25 26 23 18 
30 22 19 15 
35 18 - - 
 
Next, the thermogelling behaviour of 20%, 25% and 30% w/v PF-127 solutions loaded 
with SF and NR as models for hydrophilic and hydrophobic actives, respectively, was 
examined. This was required as the sol-gel phase transition is sensitive to the presence 
of co-solutes and a change in Tgel may occur depending on the co-solute 
physicochemical properties and its interactions with the polymer (14, 18, 19).  
Incorporation of SF decreased the Tgel by 2-3o C (Table 7.2). This observation could be 
explained by a ‘salting-out’ effect or namely, the competition for water between the salt 
(SF) and the polymer leading to a reduced ability of solvent (water) for both PPO and 
PEO chains and an increased effective concentration of polymer in the system. This, 
therefore, favours the formation of micelles at lower temperature (20, 21).  
NR-loaded formulations exhibited a further reduction in Tgel (Table 7.2). These 
formulations included 10% PEG-400 for solubilization purposes so the decrease in Tgel 
could be resulted from co-solvent effects by PEG as well as from the presence of NR. It 
has been reported that PEG-400 lowers the critical micelle concentration (CMC) of PF-
127 and therefore, promotes polymer transition into a micellar phase at lower 
temperatures (22). It is also believed that high viscosity conferred by the PEG-400 
provides a stabilizing effect that strengthens the gel texture at lower temperatures (23). 
While PEG can form mixed micelles with PF-127 and preclude the process of micellar 
association of the latter, this effect is mostly caused by PEG with longer chain length 
(Mn = 2000-20,000 g mol-1) (24-26) and is unlikely to occur with PEG-400 (27). 
Finally, the affinity of NR for both the hydrophobic PF-127 chains and the 
polyoxyethylene chains of the PEG-400, may dehydrate the polymers and promote the 
entanglement of adjacent micelles, enabling gelation at lower temperatures (25).  
 
7.3.2 In vitro release of SF and NR from PF-127 gels 
The release profile of SF and NR from 20%, 25% and 30% PF-127 gels and from 





appearance throughout the experiment. Figure 7.3 shows that the presence of PF-127 
slowed down the release of both markers; the gels with 25% and 30% polymer behaved 
very similarly. It has been suggested that the number and size of micelles within the gel 
structure increases, and the availability of aqueous channels decreases, with polymer 
concentration so the pathway for solute diffusion becomes more tortuous (16). The plots 
of amount released (per unit area) against the square root of time (Figure 7.4) show 
good linearity (r2 0 0.95). In principle, the Higuchi diffusion model could be used to fit 
the release data (28) (Eq. 7.1): 
 !! ! ! ! !! ! !!""!!! !!! !!!!Eq. 7.1) 
 
where Q is the amount of solute released per unit area (A); C0 is the initial concentration 
of solute in the vehicle; t is time; and Dapp is the apparent diffusion coefficient which 
can be calculated from the gradient of the Higuchi plot. Dapp decayed exponentially 
(Figure 7.5) with the polymer concentration of PF-127. This agrees with previous work 
(16), suggesting that substantial chain interactions occur at high PF-127 concentrations 
(0 25%) and that further increments in polymer content would have little effect in 
hindering drug diffusion. However, other explanations are possible at least in the case of 
SF experiments performed with dialysis membrane. For example, water diffusion from 
the receptor into the gel could lower the polymer concentration with respect to the 







Figure 7.3: Cumulative release (mean + SD; n=3) of (a) SF and (b) NR from PF-127 
formulations and control solutions. 
 


















































Figure 7.4: Cumulative release (mean + SD; n=3) of (a) SF and (b) NR versus the 






Figure 7.5: Effect of concentration of PF-127 on the Dapp (mean ± SD; n=3) estimated 
assuming the Higuchi diffusion model for (a) SF and (b) NR. 
 
7.3.3 LSCM imaging 
The penetration of SF and NR from PF-127 gels into nail clippings following 
continuous and discontinuous applications was imaged by LSCM. All the PF-127 
formulations maintained a gel appearance throughout the experiment. Nail penetration 
can be very variable (29) so several LCSM images were taken to estimate the depth of 
penetration with better confidence. Despite being laborious, this procedure allowed 
estimation of both the inter- and intra-nail variability and better comparison of the 
formulations tested. Only a representative selection of the images taken is presented in 
this chapter; the complete set of images is presented in Appendix 3.  
Dorsal images captured along the z-direction provided useful mechanistic information 
into the penetration pathways of the markers but might have underestimated the 
penetration depth due to signal loss (by light absorption and scattering) with increasing 
imaging depth; sample thickness also limited imaging beyond the free working distance 
of the objective. To avoid this, the depth of fluorescence (T) inside the nail was 
determined using transversal images, which also provided information about %T or 
penetration depth relative to the entire nail thickness.  
 



















































































































7.3.3.1 SF experiments  
Table 7.3 shows information about the nail clippings used for SF experiments. The 18 
nail clippings were donated by 8 female healthy volunteers. Each formulation was 
tested on 3 nails donated from different volunteers. 
 
Table 7.3: Source (volunteer code, hand and finger) and thickness of the nail clippings 
used in SF experiments. 



























*The first digit of the nail code represents the participant number. L and R stand of left 
and right hand, respectively. F + digit indicate the finger number where F1 is the thumb. 
Nail clippings donated by the same volunteer in different occasions are indicated by the 
letters ‘a’ (first donation) and ‘b’ (second donation). 
 
Figure 7.6 - Figure 7.8 illustrate SF penetration into the nail plate following continuous 
application of the 20%, 25% and 30% w/v PF-127 formulations, respectively. 
Penetration of SF into the nails is clearly visible in both dorsal images and transversal 















Figure 7.6: Representative confocal images illustrating SF (green) penetration into the 
nail (grey) following a 7-day continuous application of the PF-127 20% formulation 
under occlusive conditions. Panel A shows the x-y planar images obtained by dorsal 
imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal re-
constructions of dorsal images. Panel C shows the transversal cuts used for estimating 















   
Figure 7.7: Representative confocal images illustrating SF (green) penetration into the 
nail (grey) following a 7-day continuous application of the PF-127 25% formulation 
under occlusive conditions. Panel A shows the x-y planar images obtained by dorsal 
imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal re-
constructions of dorsal images. Panel C shows the transversal cuts used for estimating 
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Figure 7.8: Representative confocal images illustrating SF (green) penetration into the 
nail (grey) following a 7-day continuous application of the PF-127 30% formulation 
under occlusive conditions. Panel A shows the x-y planar images obtained by dorsal 
imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal re-
constructions of dorsal images. Panel C shows the transversal cuts used for estimating 








Figure 7.9 shows the depth of penetration of SF into each nail sample after 7 days of 
continuous and occluded exposure to the three formulations. The average intra- and 
inter-nail coefficients of variation were 15% and 33%, respectively, supporting the need 
for several measurements per nail clipping and experiment. T measurements were 
preferred over %T to compare the formulations and for the statistical analysis because 
the latter are also modified by the nail thickness. Indeed, as shown by the results, low 
%T values were often associated to thicker nail samples (Table 7.3). On the other hand, 
%T informs about the potential efficiency of the formulations to deliver the markers 
across the whole nail. 
Overall, the 7 days continuous treatment delivered SF, on average, to the first 87-127 
µm of the nail samples corresponding to 22–38% of the whole thickness. Only one 
sample (1LF3) treated with 20% PF-127 showed the penetration of SF beyond 50% of 
nail thickness. We found no significant statistical differences in the penetration depth (T) 
of SF when delivered by the three formulations (Figure 7.9). The statistical difference 
found between the relative penetrations (%T) measured for the 20% and 30% PF-127 









Figure 7.9: SF penetration into nail clippings following a continuous 7-day application 
of PF-127 (20%, 25% and 30%) formulations under occlusive conditions. T and %T 
shown in the top panels and the bottom-left panel represent the average values measured 
for each nail (Mean + SD of 3 images) and formulation. The bottom-right panel 
illustrates the average T and %T for each PF-127 gel (Mean + SD of 9 images from 3 
nails). The superscript letters represent statistical difference (p < 0.05) between the pairs 
of bars. 
 
Next, discontinuous, un-occluded dosing experiments were performed to mimic the 
practical use of the formulations as normally they would be applied overnight and then 
removed in the morning through hand washing. In this case, smaller amounts of the 
solutions (20 )L) leading to formation of a thinner layer on the nail were applied and 
left in situ for 8 hours. A 16 hours period without formulation followed and the cycle 
repeated for 7 days. Figures 7.10 - Figure 7.12 illustrate SF penetration into the nail 
plate following the repeated application of the 20% (Figure 7.10), 25% (Figure 7.11) 














































































































   
Figure 7.10: Representative confocal images illustrating SF (green) penetration into the 
nail (grey) following a discontinuous, un-occluded 7-day application (8 h on-16 h off) 
of the PF-127 20% formulation. Panel A shows the x-y planar images obtained by 
dorsal imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal 
re-constructions of dorsal images. Panel C shows the transversal cuts used for 















   
Figure 7.11: Representative confocal images illustrating SF (green) penetration into the 
nail (grey) following a discontinuous, un-occluded 7-day application (8 h on-16 h off) 
of the PF-127 25% formulation. Panel A shows the x-y planar images obtained by 
dorsal imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal 
re-constructions of dorsal images. Panel C shows the transversal cuts used for 
















   
Figure 7.12: Representative confocal images illustrating SF (green) penetration into the 
nail (grey) following a discontinuous, un-occluded 7-day application (8 h on-16 h off) 
of the PF-127 30% formulation. Panel A shows the x-y planar images obtained by 
dorsal imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal 
re-constructions of dorsal images. Panel C shows the transversal cuts used for 








As expected, the bands of fluorescence observed in dorsal and transversal images of the 
nail were thinner, reflecting the shorter exposure times associated to discontinuous 
dosing. The absolute (T) and normalized (%T) penetration depth of SF into each nail 
and for each gel are summarized in Figure 7.13. Another interesting observation was the 
reduction in the variability observed. For example, we found no statistical significant 
differences among the nails treated with the same formulation.  
Overall, the 7 days discontinuous treatment delivered SF consistently to the first ~50 
µm of the nail corresponding to 15% of the whole thickness. No statistical differences 
were found among the three gels with none delivering SF deeper than 22% of the whole 
nail thickness. Therefore, the marker remained in the dorsal layer of the nail (30). 
Indeed, it remains unclear whether drug permeation across the three nail layers (dorsal, 
intermediate and ventral) differs. While according to some authors the diffusion of 5-
fluorouracil and flurbiprofen across the dorsal layer was the limiting factor for the drug 
permeation into human nail plate (31), other work reported equivalent penetration of SF 









Figure 7.13: SF penetration into nail clippings following a 7-day, (8 h on-16 h off) 
cyclical un-occluded application of PF-127 (20%, 25% and 30%) formulations. T and 
%T values shown in the top panels and the bottom-left panel represent the average 
measured for each nail (Mean + SD of 3 images). The bottom-right panel illustrates the 
average T and %T for each formulation (Mean + SD of 9 images from 3 nails). 
 
 
7.3.3.2  NR experiments 
Table 7.4 shows relevant details of the nails used in NR experiments. Similarly, the 18 
nail clippings were donated from 8 female volunteers and each condition/treatment was 






















































































Table 7.4: Source (volunteer code, hand and finger) and thickness of the nail clippings 
used in NR experiments. 



























* The first digit of the nail code represents the participant number. L and R stand for left 
and right hand, respectively. F + digit indicate the finger number where F1 is the thumb. 
Nail clippings donated by the same volunteer in different occasions are indicated by the 
letters ‘a’ (first donation) and ‘b’ (second donation). 
 
Again, the continuous application approach was first adopted. Figure 7.14 - Figure 7.16 
show representative confocal images of NR penetration into nail clippings following a 
7-day continuous application with the three gels. As before, the penetration of the 
marker was well demonstrated by dorsal and transversal images; the later showing 













   
Figure 7.14: Representative confocal images illustrating NR (red) penetration into the 
nail (grey) following a 7-day continuous application of the PF-127 20% formulation 
under occlusive conditions. Panel A shows the x-y planar images obtained by dorsal 
imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal re-
constructions of dorsal images. Panel C shows the transversal cuts used for estimating 















   
Figure 7.15: Representative confocal images illustrating NR (red) penetration into the 
nail (grey) following a 7-day continuous application of the PF-127 25% formulation 
under occlusive conditions. Panel A shows the x-y planar images obtained by dorsal 
imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal re-
constructions of dorsal images. Panel C shows the transversal cuts used for estimating 















   
Figure 7.16: Representative confocal images illustrating NR (red) penetration into the 
nail (grey) following a 7-day continuous application of the PF-127 30% formulation 
under occlusive conditions. Panel A shows the x-y planar images obtained by dorsal 
imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal re-
constructions of dorsal images. Panel C shows the transversal cuts used for estimating 








Figure 7.17 shows the T and %T values estimated for each nail and formulation. 
Relatively smaller inter-nail variability was observed with NR and no statistical 
differences were found among nails within each treatment group. Overall, NR 
penetrated less than 100 µm or 30% into the nails (Figure 7.17) and no significant 
differences were observed for the depth of penetration (T) attained with the different 
gels. The different %T observed for the 20% and 30% gels was, again, explained by 





Figure 7.17: NR penetration into nail clippings following a continuous 7-day 
application of PF-127 (20%, 25% and 30%) formulations under occlusive conditions. T 
and %T shown in the top panels and the bottom-left panel represent the average values 
measured for each nail (Mean + SD of 3 images) and formulation. The bottom-right 
panel illustrates the average T and %T for each PF-127 gel (Mean + SD of 9 images 
from 3 nails). The superscript letters represent statistical difference (p < 0.05) between 
the pairs of bars. 
 
The penetration of NR following discontinuous application of the same formulations 






























































































   
Figure 7.18: Representative confocal images illustrating NR (red) penetration into the 
nail (grey) following a discontinuous, un-occluded 7-day application (8 h on-16 h off) 
of the PF-127 20% formulation. Panel A shows the x-y planar images obtained by 
dorsal imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal 
re-constructions of dorsal images. Panel C shows the transversal cuts used for 















   
Figure 7.19: Representative confocal images illustrating NR (red) penetration into the 
nail (grey) following a discontinuous, un-occluded 7-day application (8 h on-16 h off) 
of the PF-127 25% formulation. Panel A shows the x-y planar images obtained by 
dorsal imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal 
re-constructions of dorsal images. Panel C shows the transversal cuts used for 















   
Figure 7.20: Representative confocal images illustrating NR (red) penetration into the 
nail (grey) following a discontinuous, un-occluded 7-day application (8 h on-16 h off) 
of the PF-127 30% formulation. Panel A shows the x-y planar images obtained by 
dorsal imaging every 2 µm (shown at 8 µm intervals). Panel B shows the x-z orthogonal 
re-constructions of dorsal images. Panel C shows the transversal cuts used for 








Figure 7.21 summarizes the absolute (T) and normalized (%T) depth of penetration 





Figure 7.21: NR penetration into nail clippings following a 7-day, (8 h on-16 h off) 
cyclical un-occluded application of PF-127 (20%, 25% and 30%) formulations. T and 
%T values shown in the top panels and the bottom-left panel represent the average 
measured for each nail (Mean + SD of 3 images). The bottom-right panel illustrates the 
average T and %T for each formulation (Mean + SD of 9 images from 3 nails). 
 
Again, there was small inter-nail variability and no significant differences were found 
among the nails within each treatment group. Overall, NR penetrated to ~50 µm or 15% 
of the total thickness. The 20% PF-127 gel delivered NR deeper (T) into the nail plate 
than the 30% gel statistically, although the differences were quite moderate. As 
previously observed with SF, the discontinuous treatment resulted in NR signals that 
were noticeably less intense and with thinner fluorescence bands than those observed 
for continuous treatment samples. 
 
7.3.3.3 Comparison between continuous and discontinuous application  
As discussed above, the continuous, occluded application resulted in significantly 
deeper (T, ~1.8-fold) penetration of both fluorescent markers than the discontinuous, 






















































































dorsal images with the fluorescence signals being less intense and decreasing faster with 
depth for discontinuous dosing. This was not too surprising as the discontinuous 
procedure reduced to one-third the length of the nail exposure to the formulations 
compared to the continuous approach. In addition, the occlusive condition of the 
continuous approach results in enhanced nail hydration and probably facilitates 
diffusion of the markers (32). Yet, the continuous, occluded treatment did not triple the 
penetration depth and it could be hypothesized that some diffusion is still possible 
during the untreated (formulation-free) periods. In any case, the discontinuous approach 
reflects better the practical use envisaged for these formulation or daily overnight 
application. A word of caution is required as this work has used only healthy nail 
clippings so future research is required using diseased nails. Given the %T attained in 7 
days, further optimization of these formulations will be required to promote drug 
permeation, maybe by incorporating a chemical enhancer (6, 33) or by wearing an 
occlusive layer on top of the formulation film to increase nail hydration (34). 
 
 
Figure 7.22: Penetration of SF and NR into the nail clipping following a 7-day 
continuous (C) and discontinuous (D) application with PF-127 (20%, 25% and 30%) 
gels. T (Mean + SD) values represent the average of 9 images obtained from 3 nails. 
The superscript letters indicate statistical difference (p < 0.05) between the pairs of bars 
(both T and %T). 
 
7.3.3.4 Penetration pathways of SF and NR across the nail plate 
An interesting finding of this work was the different penetration pathways followed by 
the two markers (Figure 7.23). As described in chapter 4, the red fluorescence of NR 
demarcated the onychocytes whilst the intracellular regions appeared darker. In contrary, 






















































to the physicochemical properties of the two compounds, primarily their logP. It could 
be hypothesized that SF, being highly water-soluble (log P = -1.52 (35)), can access the 
more hydrophilic keratin-filled onychocytes. The involvement of the transcellular 
pathway was reported for SF and Nile blue chloride during passive and iontophoretic 
nail permeation experiments (29). NR, on the other hand, is highly lipophilic (log P = 
4.07 (36)) and would follow predominantly the lipid-containing intercellular pathway.  
 
 
Figure 7.23: x-y planar images showing the localization of SF (left) and NR (right) at ~ 
20 µm into the nail.  
 
The significance of the intracellular path contribution to nail passive permeation will 
require further corroboration. But, if confirmed, these findings would provide a distinct 
difference with regards to passive skin permeation during which transport of both 
hydrophilic and hydrophobic permeants shares the common continuous, intercellular 
pathway across the stratum corneum (SC) (37-39). This has been explained by the 
unique morphology of the SC, which is described as a construction of impermeable 
coenocyte ‘flakes’ incorporated into a lipid matrix and the formation of the so-called 
cornified envelope. The SC lipids lining the outside of the corneocytes are covalently 
bound by ester linkage to the outer surface of the cell membrane to provide a 
hydrophobic, impermeable layer. Diffusion across the SC intracellular pathway is slow 
and inefficient and the corneocytes do not provide an alternative diffusion path for 
hydrophilic molecules. On the contrary, by being inaccessible, the corneocytes increase 
the diffusional path and contribute to the barrier function (40). While the key role of the 
tortuous intercellular pathway has been well documented for the SC (41-43), little 
information exists concerning the nail plate. This work suggests the contribution of both 





intracellular domains may be easier than in the SC. However, further investigation into 
the structural and physical properties of the nail is required to provide a clear 
mechanistic explanation. The findings here, nevertheless, provide useful information on 
which future research can be based. 
 
7.3.4 In vivo evaluation of PF-127  
Table 7.5 summarizes the feedback from 18 volunteers concerning the use of PF-127-
based lacquer, and/or nail lacquers in general, as topical nail drug delivery systems. 
Most participants responded favourably to the potential use of these formulations to 
treat nail disease. Two participants found the formulations inconvenient to apply and the 
drying time too long; further they perceived oral medications to be superior to topical 
treatments. Surprisingly, the less frequent (weekly, every other day) dosing patterns 
were not preferred and a daily application of the nail lacquer was considered acceptable 
as far as “the formulation is easy to apply and forms the film rapidly upon application”. 
 
Table 7.5: Summary of the feedback provided by volunteers on the use of nail lacquers 
as a treatment option for nail diseases. 
Questions Answers by participants (n out of 18) 





No problem at all 10 
Acceptable 6 
Only if no alternative 2 
Not at all 0 
Preferred dosing interval 
Once daily 8 
Every other day 5 
Once weekly 5 
 
Placebo 20%, 25% and 30% PF-127 gels were applied to healthy human nail plates and 
the gelling behaviour was examined. Table 7.6 summarizes the results. The three 
formulations formed gels on the nail surface within 10 minutes post-application. The 
physical appearance of the film was examined (Table 7.6). Bubbles were mostly 
observed with films formed using 20% PF-127 and film coatings resulting from the 
30% PF-127 were uneven, probably due to its high viscosity. Overall, the gel with 25% 
PF-127 provided the best performance being highly rated for the shiny, homogenous 






Table 7.6: Appearance of films formed following the application of placebo gels 
containing 20%, 25% and 30% of PF-127 to the nail plates of healthy volunteers. 
Film appearance Participants (out of 18) 
20% PF-127 25% PF-127 30% PF-127 
Gel formed within 10 minutes Yes Yes Yes 
Good/Shiny 8 10 6 
Contain bubbles 4 0 0 
Viscous/Streaky 0 2 6 
 
7.4 Conclusions 
The potential use of 20%, 25% and 30% PF-127 thermoreversible gels as formulations 
for topical nail drug delivery was investigated using SF and NR as models for 
hydrophilic and lipophilic actives. The formulations provided a prolonged release in 
vitro profile for both markers with the release being faster for the 20% PF-127 gel. The 
formulations delivered both fluorophores into the nail plate as shown by LCSM imaging, 
following 7-day continuous and discontinuous applications. The latter mimicked a 
potential practical application of the formulations and, given the shorter exposure times, 
resulted in less penetration than the occluded, continuous treatments. Overall, none of 
the vehicles delivered the dyes across the whole nail thickness and the delivery 
performance of the three formulations was very similar. The confocal images suggested 
the transcellular and intercellular pathways to be predominant for SF and NR, 
respectively. Finally, the in vivo study suggested that PF-127 based thermogelling nail 
lacquers would be well accepted as topical nail treatments. The best in vivo 
thermogelling behaviour and film appearance was shown by the 25% PF-127 gel. 
Further optimization of these formulations is required to provide faster delivery of drugs 
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Chapter 8 : Conclusions and Perspectives 
 
In this thesis, the use of various non-destructive imaging techniques to assess nail 
permeation has been investigated. The objectives were to visualize and characterize the 
mechanism of drug uptake into the nail and, using this information, (a) to evaluate the 
potential of polymeric particle-based delivery systems for topical nail treatment; (b) to 
investigate the effect of microneedle and chemical enhancer treatment on drug uptake 
and permeation; and (c) to develop a new thermoreversible hydrogel-based formulation 
as a treatment option for topical nail diseases. The ultimate goal is to develop an 
underpinning science base with which to aid future improvement and optimization of 
topical nail formulations. 
In this work, nails obtained from healthy human subjects were used. In vitro release and 
nail permeation experiments evaluated the performance of the different formulation 
approaches investigated. The thermoresponsive hydrogel was also tested in vivo to 
assess its practical usefulness. The nano- and sub-micron particles were prepared from 
various polymers and other constituents so as to achieve sustained release of the loaded 
'active'; the particles were characterized for their size, morphology and entrapment 
efficiency. Laser scanning confocal microscopy (LSCM) and two-photon fluorescent 
(TPF) imaging enabled the localization of fluorescently-labelled nanoparticle reservoirs 
and the penetration of entrapped fluorophores (acting as model actives) on and within 
intact or microneedle-porated nails to be studied. Stimulated Raman scattering (SRS) 
microscopy, in contrast, tracked the diffusion of non-fluorescent compounds and 
permitted (semi-) quantitative analysis of their uptake kinetics into the nail. Delivery of 
an antifungal drug from sub-micron particles into and across the nail, and the effects of 
nail pre-treatment on drug uptake, were also evaluated. We now summarize the 
conclusions and perspectives of the various aspects of this research.  
 
8.1 Stimulated Raman scattering (SRS) microscopy 
SRS is a relatively new, label-free, high-resolution imaging technique based on the 
molecular vibrational frequency of a chemical bond of interest. In this thesis, SRS has 
been used for the first time to image the penetration of chemicals into the human nail in 
vitro. The time course of permeation of three solvents, water, propylene glycol and 
dimethyl sulphoxide, has been successfully tracked. Semi-quantitative analysis of the 





concentration-dependent manner, and thereby undermined the integrity of the tissue. 
Subsequently, SRS has enabled the release of a lipophilic compound, octyl 
methoxycinnamate, from polymeric nanoparticles (NPs) into the nail to be imaged. 
Although deuteration of the chemicals targeted for study (e.g., by replacing some or all 
C-H bonds by C-D) is not absolutely required, it is highly beneficial to improve image 
contrast because there is essentially no endogenous signal in the nail Raman spectrum at 
the relevant frequencies. An important future step is to validate a reliable correction 
procedure to account for the signal loss with imaging depth. This should ultimately 
allow the measured Raman signals to be directly correlated with the concentration of the 
chemical from which they originate. Together with further improvements in sensitivity, 
this will enable SRS to be broadly applicable to the study of the delivery of many 
different drugs from various formulations.  
 
8.2 Laser scanning confocal microscopy (LSCM) and two photon fluorescence 
(TPF) imaging 
LSCM and TPF are valuable techniques for the direct visualization of fluorescently-
labelled samples. While fluorescence imaging has been extensively applied to various 
aspects of skin research, including percutaneous absorption, its use for investigations of 
the nail is much more limited. In this thesis, the LSCM and TPF techniques provided 
mechanistic insight into the distribution and transport pathways of fluorophores into the 
nail. The optical sectioning capabilities of the methods were complemented by 
examination of mechanically-sectioned nail samples. The accumulation and 
confinement of fluorescently-labelled nanoparticles on the nail surface and within 
microneedle-created pores was clearly observed. In contrast, the release and diffusion of 
the fluorescent marker, Nile red (NR), from the originally-loaded particles into the nail 
was demonstrable.  
 
8.3 Pathways of nail permeation 
The uptake of hydrophilic and hydrophobic fluorophores, sodium fluorescein (SF) and 
NR, respectively, into the nail was imaged using LSCM. The former penetrated mainly 
via transcellular pathways, whereas the latter diffused predominately via the lipid-
containing intercellular regions, observations that have not been reported before. 
However, as only two compounds have been investigated, it is not yet possible to 





physicochemical properties. Nonetheless, the findings presented here form a useful 
basis for further fundamental research in this area.  
 
8.4 Polymeric particle-based delivery 
As anticipated, there was no evidence for particle penetration across the nail even the 
very small nanoparticles (only ~20 nm) were considered; there is simply insufficient 
free volume available, either trans- or inter-cellularly. The potential exists, however, for 
the particles to act as reservoirs for topical nail drug delivery and, in this research, the 
use of poly-methacrylate and poly(!-caprolactone) particles was evaluated. For the 
former, the high affinity of the associated ‘active’ for the particles, and the high 
crystallinity of the polymer, prevented any test of the hypothesis. In contrast, sustained 
release of associated ‘actives’ (the lipophilic model compounds, NR and OMC) from 
poly(!-caprolactone) particles and their distribution into the nail was demonstrated. The 
delivery of the antifungal drug, ciclopirox, into the nail from poly(!-caprolactone) 
particles with an oil-filled core was also determined and the amounts taken up exceeded 
the minimum inhibitory concentration against the primary pathogens causing 
onychomycosis. Even though drug delivery into the nail from the particles was less than 
that from a marketed commercial lacquer formulation, the particles may offer sustained 
release of drug over a prolonged period of time whereas the later suffers from 
significant drug precipitation rapidly after application (due to the evaporation of volatile 
solvent). Future work on particle-based formulations should allow the applied ‘payload’ 
of drug to be increased and the methods used to enhance drug permeation across the 
barrier to be optimized.  
 
8.5 Nail permeation enhancement strategies 
Drug permeation across the highly keratinized nail structure remains a significant 
challenge. Physical and chemical enhancement methods, specifically microneedle-
poration and penetration enhancer treatment, respectively, were evaluated. Further 
optimization of topical nail formulations may take advantage of these approaches. 
Microneedle-poration created sequestration sites for nanoparticles from which the 
associated ‘active’ could be released and then diffuses into the deeper nail over a 
prolonged period of time. Additional work is required to control the consistency of pore 





N-acetyl cysteine, a sulfhydryl (SH)-containing amino acid derivative, cleaves 
disulphide bonds in the keratin matrix. Permeation of ciclopirox was increased 
significantly when nails were pre-treated with 10% N-acetyl cysteine prior to 
microneedle-poration.  
Finally, hydration also promotes drug permeation by swelling the nail and increasing its 
porosity. A mechanism to maintain occlusion of the nail, therefore, should improve the 
performance of a formulation; alternatively, the concept of a ‘nail patch’ is perhaps 
worthy of consideration. 
 
8.6 Thermoreversible gel for nail delivery 
Finally, Pluronic PF-127 gels (at 20%, 25% and 30% w/v) as aqueous-based 
formulations for topical nail drug delivery were investigated. Prolonged in vitro release 
of (fluorescent) hydrophilic and lipophilic model actives from these gels was achieved 
and, as anticipated, the release was faster at the lower polymer concentrations used. 
LSCM imaging demonstrated the penetration of both fluorescent markers into the nail 
plate following topical application of the PF-127 formulations. However, the dyes did 
not permeate across the whole nail thickness during continuous or discontinuous 
treatment over 7 days and delivery from the three vehicles was very similar. In vivo, 
good acceptability and practicality of the PF-127-based thermogelling nail lacquers was 
demonstrated and further development is warranted, therefore, to increase the rate and 
extent of drug permeation from the gels (possibly taking advantage of the enhancement 
approaches examined here). Combination of the thermogelling lacquer with nano- or 
sub-micron particles to increase the substantiality of the formulation over prolonged 
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Participant information sheet 
 
Collection of fingernails by nail clipping 
 
You are being invited to take part in a research study. 
Before you decide on your participation, it is important for you to understand why the 
research is being done and what it will involve. Please take time to read the following 
information carefully and discuss it with others if you wish. 
Please, contact us if there is anything that is not clear or if you would like more 
information. 
Take as much time as you want to decide whether or not you wish to take part in this 
study. 
 
Thank you for reading this information sheet. 
 
Purpose of the study: 
The topical treatment of nail diseases, including fungal nail infections and nail psoriasis, 
is of limited success because of the poor permeability of the nail plate to drugs. The 
alternative is oral treatment (taken by mouth) but this exposes the whole body to the 
drug which results in frequent adverse effects and drug interactions.  
Our research team is looking into new ways of applying drugs to the nail, including 
improving the nail formulations, using penetration enhancers and the application of 
iontophoresis (small electrical currents). We are also investigating the possible inclusion 
of these drugs into nanoparticles as one of these alternative new formulations. It has 
been shown that these nanoparticles act as reservoirs of drugs and increase the passage 
of drugs across the skin. Because skin and nails have some similarities we think that 
these nanoparticles might also have potential for improving the delivery drugs to the 
nails.  
This study wants to answer the following questions: 
1) Do any of these new formulations (nanoparticles, lacquers, patches) or enhancement 
methods (iontophoresis or chemical enhancers) improve the nail penetration of drugs 
commonly used to treat nail diseases (for example antifungal drugs such as ciclopirox 
olamine, amorolfine and terbinafine)? 
2) Which properties of drugs determine how easily they permeated into the nail and 
which formulation or enhancement method works the best? 
3) What types of formulation (solutions, gels, creams, and patches) are more appropriate 
to deliver the drugs to the nail? 
4) How these new formulations compare to those available in the market? This will tell 





This is the reason for performing this fingernail collection: To do these experiments we 
need samples of human nails. Hooves from animals, e.g. pig and cow are different in 
their structure and composition to human nails, so if we use them we may get the wrong 
answers to the questions above. 
We require healthy volunteers to grow, and then donate their fingernail tips (8 mm 
length) to our research, so we can use the nails to perform experiments using different 
formulation techniques. 
The participants must be healthy and their nails should not present sign of any disease, 
psoriasis, brittleness, infection, roughness (pitted nails) or decolouration. This is 
important because diseased and healthy nails may behave differently.  
The chief investigator teaches to undergraduate pharmacy and pharmacology students. 
To avoid potential conflicts of interests, pharmacy and pharmacology undergraduate 
students at the University of Bath are also excluded from this study. 
 
Your participation in the research: 
It is up to you to decide whether or not to take part in this study. If you do decide to take 
part: 
You will be given a copy of this information sheet to keep for your records, and there 
will be some time (from 1 day minimum to 2-3 months) during which you will let your 
fingernails grow. During all this time, you can change your mind about it; you are still 
free to withdraw at any time and without giving a reason. 
Once the free edge of your fingernails has reached the minimal length required (8 mm), 
and if you still want to donate them; you will contact the research team. 
Then, you will be asked to sign a consent form and a researcher will carefully cut the 
free edge of your nails. You may prefer to cut the nails yourself. 
 
What is going to happen to you during the study? 
If you agree to participate, the following will happen: 
You will let your nails grow until their free edge has a length of at least 8 mm. 
Please, note that you can choose how many (1 to 10) nails, in which hand, and which 
nails you prefer to let grow.   
Depending on the starting length and individual differences, this growing period may 
take as much as 2-3 months. You can decide at any moment to stop your participation 
during this time and without giving a reason. 
Once the free edge of the nails has reached the right length, and if you still want to 
donate them to our research, you will contact the research team. You will be asked to 
come to our laboratories (5W 3.22) at the University of Bath and you will be given a 
consent form to sign. After you have given your informed consent, a researcher (or 
yourself) will cut the free edge of your fingernails with a standard manicure scissors. 
Your nail clippings will be made anonymous and identified with a code: Subject 1/nail 
1, Subject 1/nail 2 and so on. The researcher will fill a questionnaire to record the date 
of the donation, your name, age and gender, the finger and hand where each nail was 
harvested from and the use of nail cosmetics (if relevant). All this information will be 
kept separately from the nails so it will not be possible to identify the donor of each 
sample. The researcher will kept this information secure and only the research team will 
have access to it. 
Once, the nail collection is done, you will be allowed to leave the laboratories and your 
participation will be considered as finished. The total donation act will take a maximum 
time of 30 minutes. 
To acknowledge you for your time and contribution, we will pay you £4 per nail 
donated.  






We would expect you to avoid the use of nail cosmetics (specially nail lacquers) while 
your nails are growing. 
Some people may find unpractical or unpleasant to have long nails. You may decide to 
stop your participation at any moment, or just grow the nails you think more convenient. 
 
What will happen to my nails? 
Your nail clippings will be used for in vitro nail penetration studies. 
Most of the experiments will study the penetration of antifungal or antipsoriatic drugs 
into the nails using different testing methods or formulations and compare the results 
with that obtained with the treatments available in the market.  
Some other experiments will study the penetration of fluorescent compounds and/ or 
deuterated compounds into the nail. We use these markers because they are easily seen 
under a microscope. Subsequently, the nails will be examined under a microscope to 
determine the depth of penetration of the marker.  
By doing these experiments, we can tell if any of the proposed methods or the designed 
formulation is likely to result in an improved therapy of the nail diseases. 
Your nail clippings will NOT be used for DNA analysis or any other test concerning 
your genetic inheritance.  
At the end of the experiments the nail will be disposed of according to the regulations of 
the University of Bath that concerning the use of human tissues (autoclave and/or 
incineration).  
 
Can I get my nails back? 
If you agree to donate your nails to us, they will be considered as a gift and you will 
NOT retain any rights on them. For example, you can NOT claim them back. However, 
we will only use them for the research described in this form. 
 
Side effects: 
There are not side effects or risks expected from your participation into this study, other 
than those associated with nail clipping.  
Some people may find unpractical or unpleasant to have long nails. You may feel 
inconvenient to have very short nails just after the nail clipping. 
 
Possible benefits of taking part:  
There is no direct benefit for you as a result of your participation. This is a preliminary 
study which will hopefully help us to develop more effective ways to treat nail diseases 
 
If something goes wrong: 
The University of Bath has site specific insurance to cover research on healthy 
volunteers. Please note that this insurance does NOT cover any harm that you could 
cause with your nails to yourself, others or any items during the growing period. 
 
Acknowledgement: 
To thank you for your participation and time we will pay you 4 pounds per nail 
collected at the end of the experiment.  
 
Confidentiality of taking part in this study: 
All personal information collected during the course of this research will be kept strictly 
confidential. When the results are made public, these will not include any names, 




Your nail clippings will be made anonymous and identified with a code: Subject 1/nail 
1, Subject 1/nail 2 and so on. The researcher will record the date of the donation, your 
name, age and gender, the finger and hand where each nail was harvested from and the 
use of nail cosmetics (if relevant). All this information will be kept separately from the 
nails so it will not be possible to identify the donor of each sample. The researcher will 
kept this information secure. 
 
Results of the study:  
The results of this study will be published in thesis, scientific journals and/or presented 
during conferences, and/or internal reports. You will be allowed to have a copy of 
published articles upon request. 
 
Organization and funding of the research: 
This research is funded by the Department of Pharmacy and Pharmacology.  
The protocol has been reviewed by the University Research Ethics Approval Committee 
for Health. 
 
Contact for further information: 
We will be more than happy to answer to all the questions you could have about this 
research and your participation.  
Please contact: 
  
Wing Sin CHIU: wsc21@bath.ac.uk                       Phone: 01225 383900 
 
 Sarah Cordery:  sc342@bath.ac.uk                               Phone : 01225 384313 
 
 Dr Luis Nogueiras Nieto: l.nogueiras.nieto@bath.ac.uk   Phone : 01225383900 
 
 Dr Begoña Delgado-Charro: prsbd@bath.ac.uk          Phone: 01225 383969 
 
 
You will be given a copy of this information sheet and a signed consent form to keep. 
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Title of study:   Collection of finger nails by nail clipping. 
 
Researcher: Miss W. S. Chiu / Miss Sarah Codery / Luis Nogueiras Nieto, PhD 
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1. Name : ………………………………….. 
2. Subject code : …………………………… 
3. Gender of the participant : ......................... 
4. Age of the participant : .............................. 
5. The donation concerns (circle nail code): 
 
R.F.1  R.F.2  R.F.3  R.F.4  R.F.5 
 
L.F.1  L.F.2  L.F.3  L.F.4  L.F.5 
 





7. Let us know if you had any previous nails infections or problems (brittleness, 






Thank you for your participation!









Department of Pharmacy & Pharmacology   Dr M. B. Delgado-Charro 
Claverton Down     Tel. +44.1225.383969; fax +44.1225.386114 
Bath, BA2 7AY    Email:M.B.Delgado-Charro@bath.ac.uk 
 
Participant information sheet 
Can nail lacquers be formulated with thermo-gelling polymers? 
 
You are being invited to take part in a research study. 
Before you decide on your participation, it is important for you to understand why the 
research is being done and what it will involve. Please take time to read the following 
information carefully and discuss it with others if you wish. 
Please contact us if there is anything that is not clear or if you would like more 
information. Our contact details are at the end of this document. 
Take as much time as you want to decide whether or not you wish to take part in this 
study. 
 
Thank you for reading this information sheet. 
 
Purpose of the study: 
The aim of our research is to examine whether a type of ingredients (thermo-gelling 
polymers) used in medicines preparation can be used to make nail lacquers. Nail 
diseases such as psoriasis and fungal infection are typically treated with oral medication, 
but this approach exposes the whole body to the drug which is not ideal. It would be 
much better to apply the medication only to the area affected that is, the nail, so the rest 
of the body is less exposed to the drugs and its possible adverse effects.  
There are some medicated nail lacquers in the market which avoid this problem but their 
efficacy is limited and, for example, they can only be used in mild fungal infections. 
These nail lacquers are very similar to cosmetic nail varnishes and are based on organic 
solvents that evaporate upon application leaving a thin film on the nail plate. However, 
it is thought that when this happens the active drug forms crystals that, being trapped in 
the film, are not able to penetrate the nail. This chain of events renders the drug inactive 
in practical terms. 
In our research group we are looking into alternative ways to formulate medicines to 
treat locally nail diseases. Ideally, the alternative formulation should remain on the nail 
plate after application and keep the drug in solution so it can be delivered to the nail 
Previous work suggests that aqueous formulations made with a special type of polymers 
(known as poloxamers or thermo-gelling polymers) could be an interesting choice. The 
aqueous solutions of these polymers have some interesting properties: they are liquid at 
low temperatures but can form a gel as the temperature increases. Potentially, they 
could be easily painted in the nails as a liquid, once in contact with the nail and as the 
temperature rises, they would form a thin gel film similar to a nail lacquer. Because 
these formulations are based on water soluble components they can be easily washed off. 
We envisage that a patient would apply them at night time and remove them in the 
morning simply by washing hands or showering. Studies on isolated nail clippings have 




these studies cannot tell us whether they would form quickly a thin gel on the nail of 
people at normal body temperature. That is, whether they would be convenient to use in 
practical situations. 
This study tries to clarify this point and will test the performance of un-medicated 
aqueous solutions of thermo-gelling polymers. To do this we plan to apply these 
solutions on the nails of healthy volunteers and observe their behaviour. We specifically 
want to answer these questions: 
Are these formulations easy to apply? Do they spread easily on the nail? 
Do these formulations form a thin gel in an acceptable time? If the time required is too 
long they would not be will not be practical. 
How much of the solution is required for covering one nail? 
What happens once these solutions are applied? Are the films aesthetically acceptable?  
To do this we will recruit healthy volunteers and test the formulations on their nails. 
The formulations tested will not contain drugs as we primarily want to test their 




To participate in this study you should, for your own safety and for the results of the 
experiment to be valid: 
be healthy and not suffer from skin disease or allergies or nail disease. 
not have any cosmetic treatment currently applied on your nails (for example, nail 
varnish, nail extensions, fake nails). You can participate if you have applied these 
treatments in the past. 
 
Your participation in the research: 
It is up to you to decide whether or not to take part in this study. If you decide to take 
part, please contact one of the researchers. Then: 
1. You will be given a copy of this information sheet to keep for your records. 
2. You will be asked to sign a consent form, you will be given a copy of the consent 
form. 
3. If you change your mind, you are free to withdraw at any time and without giving 
a reason. 
 
What is going to happen to you during the study: 
" Your participation involves a maximum of ~30 minutes. 
" The test, application of the formulation and observations, will take place in the 
research laboratories of the principal investigator (Dr Delgado-Charro) at the 
Department of Pharmacy & Pharmacology at the University of Bath (5W 3.22). 
" You should not apply any nail cream or cosmetics (other than standard hygiene) to 
your nails before the study commences. You should not have any cosmetic 
treatment currently applied on your nails (for example, nail varnish, nail extensions, 
fake nails). 
 
The step-by-step procedure will be: 
1) You will be asked to fill a questionnaire (age, gender, recent use of nail cosmetic 
treatments or nail medicines, confirm your healthy status and lack of skin and nail 
allergies and diseases).  
2) The researcher will apply the liquid formulation to all your nails. During this time 
we will ask you to seat and keep your hands steady, preferably flat on the desk.  
3) The researcher will record the time required for the formulation to form a gel on the 




abandon the experiment, you will receive you £5 acknowledgement, the formulation 
will be cleaned from your nails and your participation will stop. You are welcome to 
add your observations and comments to the questionnaire. 
4)  If the gel forms and remains steady on the nail, the researchers will examine its 
integrity and appearance and may take some pictures. These pictures will be 
restricted to your hands and nails and will not include your face. 
5) You will be invited to comment on the use of medicated nail lacquers, on the films 
tested or the test in a questionnaire. 
6) Your participation will be acknowledged with £5 and your participation will end.  
7) Because the nature of the film (aqueous solution of water soluble components) it is 
expected that the film will be fast removed with just one routine hand washing. If 
you wish, you can remove the film from your nails before leaving the laboratories. 
8) Should you, at any time, experience discomfort or feel unwell, the experiment will 
be stopped. You will still receive your £5 acknowledgment. 
 
Possible adverse effects: 
1) We do not expect that you will experience side effects because we will use aqueous 
solutions of components approved for preparing medicines and because the films 
will stay on your nails for a very short time. However, it is always possible for a 
participant to experiment some irritation or unexpected reaction or allergy to any 
chemical. 
2) To limit any risk, the researchers will ensure that only the nail plate is painted with 
the formulation and will avoid the skin around the nail.  
3) You must remain seated during the experiment while the formulation is applied, 
while we wait to see whether it forms a film on the nail and while we examine its 
behaviour and appearance. You may find this uncomfortable so we have limited the 
waiting time to maximum 10 minutes. 
 
Possible benefits of taking part: 
There is no direct benefit for you as a result of your participation. This is a basic 
research study designed to help us develop a new formulation to treat nail diseases. 
 
Recognition of your time: 
To thank you for your participation and time, we will pay you £5 at the end of the 
experiment. You will receive this amount even if the experiment is stopped before 




All personal information collected during the course of this research will be kept strictly 
confidential. When the results are made public, they will not include any names, initials 
or any type of information which could result in your identification. 
The researcher may ask for permission to take some photographs during the experiment. 
If you agree, the pictures will only include your treated hands and nails. 
 
Results of the study: 
The results of this study will be published in scientific journals and/or presented during 
conferences and/or internal reports. You will be allowed to have a copy of any 
published articles upon request. 
 
Organization and funding of the research: 




Undergraduate MPharm research projects fund. 
 
The protocol has been reviewed and approved by the Research Ethics Committee for 
Health of the University of Bath. 
 
Contact for further information: 
We will be more than happy to answer any questions you have about this research and 
your participation.Please contact: 
Principal investigator & supervisor: 
Dr. B. Delgado-Charro: prsbd@bath.ac.uk  Tel. 01225 383969 
Postgraduate student: 
Wing Sin Chiu: W.Chiu@bath.ac.uk 
Undergraduate students:  
Wing LEUNG: wtl28@bath.ac.uk Wai Han KOH: whk25@bath.ac.uk 








































Department of Pharmacy & Pharmacology   Dr M. B. Delgado-Charro 
Claverton Down     Tel. +44.1225.383969; fax +44.1225.386114 
Bath, BA2 7AY    Email:M.B.Delgado-Charro@bath.ac.uk 
 
Participant Identification Number for this study: 
 
CONSENT FORM for the study: 
Can nail lacquers be formulated with thermo-gelling polymers? 
 
Undergraduate Researchers: Wing LEUNG and Wai Han KOH: 
PG student: Ms Wing Sin Chiu 
Principal Investigator, PG and UG students’ supervisor: Dr. M. Begoña Delgado-Charro 
 
Name of Participant              Date   Signature 
 
Researcher taking consent form  Date   Signature 
  
 Initial box 
1. I confirm that I have read and that I understand the information sheet 
dated 16/10/2013 (version 1) for the above study and have had the 
opportunity to ask questions 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my legal 
rights being affected. 
 
3. I understand that the researchers may take pictures of my hands and 
nails during the test. These pictures will NOT include my face. 
 
5. I have not any skin or nail disease / allergy.  
6. I have not any cosmetic treatment currently applied on my nails (for 
example, nail varnish, nail extensions, fake nails).  
 
6. I understand that all the information I have provided will remain 
confidential and secure, under lock at Dr Delgado-Charro’s office after 
the study is completed and/or at the University of Bath computers/data 
storage systems. Anonymity will be kept so I will not be identified in 
any manner (through pictures, initials or names) in publication and 
reports resulting from this study. 
 





Department of Pharmacy & Pharmacology   Dr M.B. Delgado-Charro 
Claverton Down      Tel. +44.1225.383969; fax +44.1225.386114 
Bath, BA2 7AY      Email: M.B. Delgado-Charro@bath.ac.uk 
 




Participant Identification Number: 
Age :………………      Gender :…………… 
 




2. Are you currently wearing any cosmetic nail treatment (for example, nail varnish, nail 
extensions, fake nails)? 
 
3. Would you consider nail lacquers (in general and the ones tested today): 








3.c. Would you use them as a treatment if you had to apply them: 
 Please choose one of these answers:   
Yes, no problem at all / acceptable / only if there is no alternative / Not at all. 
 
a. Once a day?        
b. Every other day? 
c. Once a week?  
 




Let us know if you have any other comments about the experiment: 
……………………………………………………………………………………………
……………………………………………………………………………………………















Figure 1: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 19LF1, 












Figure 2: Images of transversally sectioned nails: (A) 19LF1, (B) 1LF3 and (C) 16LF4. 












Figure 3: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 19RF1a, 












Figure 4: Images of transversally sectioned nails: (A) 19RF1a, (B) 16RF4 and (C) 2RF5. 












Figure 5: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 19RF1b, 












Figure 6: Images of transversally sectioned nails: (A) 19RF1b, (B) 1LF2 and (C) 3RF5. 












Figure 7: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 10LF3, 












Figure 8: Images of transversally sectioned nails: (A) 10LF3, (B) 3LF1 and (C) 12LF4a. 












Figure 9: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 3LF5, (B) 













Figure 10: Images of transversally sectioned nails: (A) 3LF5, (B) 1RF1a and (C) 12LF2. 












Figure 11: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 5RF5, (B) 












Figure 12: Images of transversally sectioned nails: (A) 5RF5, (B) 1RF1a and (C) 













Figure 13: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 1RF2a, 











Figure 14: Images of transversally sectioned nails: (A) 1RF2a, (B) 3RF2 and (C) 2RF5. 












Figure 15: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 10LF2, 











Figure 16: Images of transversally sectioned nails: (A) 10LF2, (B) 3LF2a and (C) 












Figure 17: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 16LF3, 












Figure 18: Images of transversally sectioned nails: (A) 16LF3, (B) 3LF2b and (C) 













Figure 19: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 19RF2, 












Figure 20: Images of transversally sectioned nails: (A) 19RF2, (B) 3LF3 and (C) 1RF2b. 













Figure 21: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 19RF3, 











Figure 22: Images of transversally sectioned nails: (A) 19RF3, (B) 3LF4 and (C) 12LF3. 













Figure 23: x-z orthogonal re-constructions of dorsal images. Left panel: reflectance 
signal from the nail plate. Right panel: SF fluorescence. Images from nails (A) 12LF5, 












Figure 24: Images of transversally sectioned nails: (A) 12LF5, (B) 5LF4 and (C) 19RF4. 
Scale bars = 200 µm. 
 
 
